ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000081.1|Kedarcidin_1 # 289 # 1575 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.706	BGC0000081.1|Kedarcidin_1 	289	1575	+	Loose	500	28.4906	CTX-M-37	46.88	3001899	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGCCCGTACGCAGACGACCCGCCACACTGATCGCGTTGAGCACCCTCGCGCTGCTCGTCGGCGCGGTGCCCGCGCACGCCGGACAAGCGCGTGCCGGGCAGGACCAAGCGCTACCCGCTCCCACCTGTAGTGAGGTGCCCCGGGAACTACCCGTCCACGAGTTCACCGACCACCGGGAACTCGGCGTCGAACTCGACCGCGTCGAACGGGTCAGCGCCGGCCGCGTGCGGGTGGACCTGCTCGGCCGGAGCAACCGCGGCCGGGAGGTCTGGGGAGCCCGGGTGGGCACCGGCCGCAAGGTGGTGCTGCTGACCAGCGAGATCCACGGCAACGAGAAGACCGGCACGGACGCGTTGCTGTCCCTGCTCGACTGGGTCGGGACCAGCGACAGCGCCAAGGCCAGGCGCTGGCGCAGCGAGCTGACCATCGTCGCCGTCCCGAAGATGAACCCCGACGCCGCCGAACTGGACCGGCGCGCCAACGACATGACCTGGGACGAGGTCACCGCGCGCTTCCCGCACCTGCGGGGCAGCGGACCGGCGTGGAACTACTACACCGGTTCGGTGCAGGGCGACGACTACTCCACCCGGCCGGGGTTCGACATCAACCGCGACTACCACCCGGACCTGGACTACGTGCCGCGCAAGGAGGACTTCCCCGGCACGTCCGCGCGACCCGGCTGGTACATCTCGCCCGAGACGCGCATCATCCGTGACCTCTACCGCGGGCTCACCGCCGAGTTCGGCAAGGTGGACACCTACATCGACCTGCACCACCAGGGCGCCTGCTACGTGATGCCCGACGCCCGCGACCGGTTCGTCACGCTCTCGATCTCCGGCAAGTTCGTCGACGACCCGGCCACCACGCCGGGACTGGAGAAGTACGCGGGCAAGTACGACCTGGACTACTCGAAGCGGCTGAACGTCGCCGTCCACAACGCACTCCAGGCCGCCGCCGCGAACCGGCCGGTGTTCGGGGACGTCACCCTCTACCCGCAGGACATCAACCTGCCGGGCACCGGGCTCGGGGCCTTCGCGCTCAACGGCAGCGGCACCGTCCTGTTCGAGGTCCGCGGGCAGACGCAGACCCTGGGCCAGCAGCACCGCGCCACCCTGACCCGCGCCGTCTACATCGGACTGGACGGTGTGCTGTCCAGCATCGCCAGCGGCCAGGTGCACCGCCTCGCGCCGGCCGACTACGACCGCATCCCGCCACGCGGGCCGAACATCGGTGAACCCGGCGAGGACGCCGAGCGCACCGCCGGCGACGTGCTGGAGTTCGGCTGA	MPVRRRPATLIALSTLALLVGAVPAHAGQARAGQDQALPAPTCSEVPRELPVHEFTDHRELGVELDRVERVSAGRVRVDLLGRSNRGREVWGARVGTGRKVVLLTSEIHGNEKTGTDALLSLLDWVGTSDSAKARRWRSELTIVAVPKMNPDAAELDRRANDMTWDEVTARFPHLRGSGPAWNYYTGSVQGDDYSTRPGFDINRDYHPDLDYVPRKEDFPGTSARPGWYISPETRIIRDLYRGLTAEFGKVDTYIDLHHQGACYVMPDARDRFVTLSISGKFVDDPATTPGLEKYAGKYDLDYSKRLNVAVHNALQAAAANRPVFGDVTLYPQDINLPGTGLGAFALNGSGTVLFEVRGQTQTLGQQHRATLTRAVYIGLDGVLSSIASGQVHRLAPADYDRIPPRGPNIGEPGEDAERTAGDVLEFG	MVKKSLRQFTLMATATVTLLLGSVPLHAQTADVQQKLAELEQQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	147.08	gnl|BL_ORD_ID|1858|hsp_num:0	2017			18	114	
BGC0000081.1|Kedarcidin_2 # 1648 # 2217 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0000081.1|Kedarcidin_2 	1648	2217	-	Loose	400	36.965	MexL	25.15	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCCGTCCACCGTCCGTCCACGACGACGAGCTCTACGACCGCCTGGCCGAGGTGTTCCGCACCGCCGGCTACGAGGGCGCGTCCCTGAACGCCCTGGCGGAGTCCGCGGGCTTGAAGCGCGCGAGCCTCTACCACCGCTTCCCCGACGGCAAGGCGCAGATGGCCGAGGCGGTCCTCGAGCGGGTGCACCGGCTGTTCGACGGGCTGCTGAAGCCGATGCGCACCGACACCGACGCGCGTGCCGGTGTCACCCGGTCCGCGGAGCTCATCAGCGAGTTCTACGGCGGCGGCCTGCTGTCGTGCGTGCTGGACACCCTGCCGCTGAGCGGGGCGCCGGAACGCGTCCGCCGCCGCGCCGGCGCGGTGGCCGACGTGTGGATCTCCGCCATGGCCGAGGTCGCCCGCCGCGCCGGGCGCGCCGAGGCGGACGCCCGTGCCGTGGCCGAGGACGCGTTCGCCCAGGTCGAGGGCGGCCTGGTGTACGGCAGGCTGTTCGGCGACGGCGGGCCGTTCGAACGAGCCCTCACCCGGCTCCCCGACCTGCTGCTCGGCGTGGAACGCGCCTGA	MARPPSVHDDELYDRLAEVFRTAGYEGASLNALAESAGLKRASLYHRFPDGKAQMAEAVLERVHRLFDGLLKPMRTDTDARAGVTRSAELISEFYGGGLLSCVLDTLPLSGAPERVRRRAGAVADVWISAMAEVARRAGRAEADARAVAEDAFAQVEGGLVYGRLFGDGGPFERALTRLPDLLLGVERA	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	89.15	gnl|BL_ORD_ID|4690|hsp_num:0	2219			84	573	erythromycin; tetracycline; triclosan
BGC0000081.1|Kedarcidin_3 # 2375 # 3217 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAAGG;rbs_spacer=7bp;gc_cont=0.702	BGC0000081.1|Kedarcidin_3 	2375	3217	+	Loose	600	49.2914	EstT	23.36	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGCCGTACATCACGGTGGGACAAGAGAACAGCGCGGAGATCAAGCTCCACTACACCGACCGCGGCACCGGGCGACCCGTGGTGCTGATCCACGGCTACCCGCTGTCCGGCGCGTCCTGGGAGAAGCAGGAGCAGGCGCTGCTCACCGCCGGCCACCGCGTGATCACCTACGACCGGCGCGGCTTCGGCAAGTCCGACCAGCCCGACACCGGCTACGACTACGACACCTTCGCCGACGACCTGGACAAGGTGCTCGCCACGCTCGACCTGACCGACGTGACGCTGGTCGGCTTCTCGATGGGCACCGGCGAGGTGGGCCGCTACCTCGCCCGGCACGGCGCCGCGCGCGTGGCCAAGGCGGCATTCCTGGCCTCCCTGGAGCCGTTCCTGCTCAAGACGGACGACAACCCCACCGGGGTGGACGCCTCCGTGTTCGAGGGCATCCAGGCCGCGGCCAAGGCCGACCGCTACGCCTGGTTCGACCAGTTCTACCGCGACTTCTACAACCTGGACGAGAACCTCGGCACCCGGATCAGCGAGGCCGTCGTGCGGACCAGCTACGCGGTGGCCGCCGGCGCGGGCGCGAAGGCGTCCTGGGCCGTGGTGCCCACGTGGCTGACGGACTTCCGGGCGGACATCCCGAAGGTCGCCGAGACCGGCGTGCCGACGCTGATCGTGCACGGCACCGCCGACCGCATCCTGCCCATCGACGCCAGCGGGCGCGAGTTCGCCAAGCGGTTGCCGAGCGCGGAGTACGTGGAGATCGAGGGCGCGCCGCACGGGCTCCTGTGGACCCACGCGGACGAGGTGTCCGAACTGCTGGTGCGCTTCCTGGCCAAGTAG	MPYITVGQENSAEIKLHYTDRGTGRPVVLIHGYPLSGASWEKQEQALLTAGHRVITYDRRGFGKSDQPDTGYDYDTFADDLDKVLATLDLTDVTLVGFSMGTGEVGRYLARHGAARVAKAAFLASLEPFLLKTDDNPTGVDASVFEGIQAAAKADRYAWFDQFYRDFYNLDENLGTRISEAVVRTSYAVAAGAGAKASWAVVPTWLTDFRADIPKVAETGVPTLIVHGTADRILPIDASGREFAKRLPSAEYVEIEGAPHGLLWTHADEVSELLVRFLAK	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	91.50	gnl|BL_ORD_ID|4956|hsp_num:0	5948			147	891	tigecycline
BGC0000081.1|Kedarcidin_4 # 3286 # 4566 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=6bp;gc_cont=0.681	BGC0000081.1|Kedarcidin_4 	3286	4566	-	Loose	500	26.9498	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	25.0	3003393	protein variant model	I194T	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGTTTAATTTCCGGAACGATGCCGCGCACCCTCGCGACGAGTCGGCGCGCATTCGCGGAGCGATCGGCGCGACGGTGGCGGCGACAGCCCTCCTGGTCGGCCCGTCGGCGGTGGCGGGCCCACCGGAGGCGGACGTCGTGGCGGGCGAGATCGGGGTCGGCGAGGCGCAGTCGTTCTGGCTGCACCTCAACAGCACGCCGGTCTCCGACGAGATGGCCGCGGCGGAGGCCAAGCGGCGGCAGTACGTCGTGCTGAACGCCTGGGAGGGCGACCTCCTCAAGAAGCTGAAGGCGAGCAACCCGAAACTGACCGTCCTCGTGTACAAGGACCTGTCCTCCACCCGCTCCTACGCCTGCAAGAACGGCGCGGACGACCAGCACCTGCCCACCGGCGTCGGGTTCTGCGCGGCCGAGCGCGAGCACCCCGACTGGTTCATGACCGGCCCGGACGGCAAGAGGTTCGAGTACAGCGGGTACTCGGGGCACTGGCAGATGGACATCGGCAACACCGCCTACCAGGACGCGTGGGCCACCAACGTCATCAAGGACGCCAAGGGGACCGGCTTCGACGGCGTGCTCATGGACAACGCGCTGTTCCCGTGCGACGCCTACCACAGCGGCGTGTGCCCGAAGAAGTACCCGACCAACGAGGCGTTCCAGGCCGCGTACACCTCGATGCTGTCCAACCTGAAGGGCCGGTTCGCCGAGGCGAAGCTGAAGACGGTGGCCAACCTGTCCAACGCGCGCCTGCACGGCAACGCGTGGGACACCTACATCGACCACGTGGACGGCGGTTTCGACGAGTGGTGGCTGGTGTTCAGCGACACCGACCTGGTGTCCGAGTACCCCCAGGGCTGGAGCAGGCAGGTCGCGGAGATCACCGCCAGCGAGGCGCGCGGGAAGATCGTGATGGTGCAGCCGCACTTCACCGCCGGCAAGGACCAGCCGCAGCGGTACGCCATGGCGAGCTACTACATGGCGATCGGTGACAAGGCCGCGATCACGCCCATGGCACGTGCCGACGCCTATGGCGACCCGACCCCGGAGACCCCGATCTACGAGTGGCGACTCGGCCAGGCGGCCAAGCCCTACTACTCGGTGGCGAACAACGTGTTCCGGCGCGACTTCACCTGCGGCACGGTCGTGGTGAACGCCAACCCGACGAACTCGGCCGCCGTGAAGGTGGACCTCGGCGGCACGCACATGGACGAGAAGGGCGCGAACGTGACCTCGGTCGACCTCCCGGGCACCTCGGGGGCGGTCTTGCGCAAGTCCTGCTAG	MFNFRNDAAHPRDESARIRGAIGATVAATALLVGPSAVAGPPEADVVAGEIGVGEAQSFWLHLNSTPVSDEMAAAEAKRRQYVVLNAWEGDLLKKLKASNPKLTVLVYKDLSSTRSYACKNGADDQHLPTGVGFCAAEREHPDWFMTGPDGKRFEYSGYSGHWQMDIGNTAYQDAWATNVIKDAKGTGFDGVLMDNALFPCDAYHSGVCPKKYPTNEAFQAAYTSMLSNLKGRFAEAKLKTVANLSNARLHGNAWDTYIDHVDGGFDEWWLVFSDTDLVSEYPQGWSRQVAEITASEARGKIVMVQPHFTAGKDQPQRYAMASYYMAIGDKAAITPMARADAYGDPTPETPIYEWRLGQAAKPYYSVANNVFRRDFTCGTVVVNANPTNSAAVKVDLGGTHMDEKGANVTSVDLPGTSGAVLRKSC	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	158.36	gnl|BL_ORD_ID|1964|hsp_num:0	1574			447	657	isoniazid
BGC0000081.1|Kedarcidin_5 # 5103 # 5903 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GAAGG;rbs_spacer=8bp;gc_cont=0.752	BGC0000081.1|Kedarcidin_5 	5103	5903	-	Loose	200	26.5646	vanT gene in vanE cluster	34.04	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGATGATCTGCGGAACGCGGTGTCCGACTTCGCCGAGGCAGGAGACGAACTCGACGCCCTCGTCGCCGGGCTGGACGAGGCGGGGTGGCGGACGCCCACGCCGGCACCGGGCTGGACCGTCGCACACCAGATCGCCCACCTCGCCGCCACGTTCCGGATGGCCACCACCGCGGTCACCGACCCGGACGGCTTCCGGGCGCTGCTGGGCCGATTGAGCGACAACTTCGCCGCCAACGTGGACGCCGCGCTGGCCGAGTACCTGGCCGAGCCGCCGCACGTGCTGCTGGCCCGGTGGCGGGAGGAGCGCGCGGCGGCCGGGAAGGCGCTCGCGGGTGCGGTGCCCGACCAGCCGGTGCCGTGGCTGGTGCGGCCGATCCCACCGGTCGTGCTGGCCGCCGCGGGCCTGATGGAGATGTTCGGGCACGGGCAGGACGTCGCCGACGCGCTCGGTGTGCGGCGCGAGCCGACCGACCGCCTCCGCCGCCTGGTCGAGTTCGGGGTGCGCACCTGGGACTTCGGCTACCAGGCACGCGGCCTCACGCCGCCCGCGGTGGAGTTCCGCTTCGAGGTGACCGGACCGTCCGGCGCGCTGTGGGCGTTCGGGCCGGAGGACAGCCCGGAGCGGATCTCCGGACCCGCCAACGACTTCTGCCTGCTGGTCACCCGACGCCGCCACCACGCCGACCTGTCCCTGACCGCCACCGGCGACCACGCCGAGCACTGGTTGGAGATCGCGCAGGCGTACCGCGGCCCGGCCGGCGCCGGTCGCGCGCCCGGCCAGTTCGGCCGCGGGAACTGA	MDDLRNAVSDFAEAGDELDALVAGLDEAGWRTPTPAPGWTVAHQIAHLAATFRMATTAVTDPDGFRALLGRLSDNFAANVDAALAEYLAEPPHVLLARWREERAAAGKALAGAVPDQPVPWLVRPIPPVVLAAAGLMEMFGHGQDVADALGVRREPTDRLRRLVEFGVRTWDFGYQARGLTPPAVEFRFEVTGPSGALWAFGPEDSPERISGPANDFCLLVTRRRHHADLSLTATGDHAEHWLEIAQAYRGPAGAGRAPGQFGRGN	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	37.89	gnl|BL_ORD_ID|4680|hsp_num:0	1308			120	258	vancomycin
BGC0000081.1|Kedarcidin_6 # 5994 # 6998 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.767	BGC0000081.1|Kedarcidin_6 	5994	6998	-	Loose	500	25.0238	OXA-529	35.48	3005759	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATCGGACCGCTGGCGGGCCTTCCCCTGCGCGGGGTCAGGCACGTGACGCCGGTGCGACCCGGTGCGGCGCGCGGTGTGGTGCGCGAGGTCTACCGGCAGGTCGGCCGGGATTTCGGCATGATCGCGCCGCCGGTGGCGCTGCACTCCCCCGCGCCCGCCGCGCTGGCCGCGTGCTGGGCGTTGCTGCGCGAAACGCTGATCGTCGGGTCGGCCGACCGCGCCGCCAAGGAGAACGCGGCGGCGGCGGTGTCGGCCGCCAACTCCTGCCCGTACTGCGTCGAGGTGCACGAGGCGGCGGCGCTCGCCCTCGGCGAGGGGCCGGACGAGCGGCTGGCGGCCTGGGCACGTGGTGGCCCCGCGCCCTTCCCGGCCGCGTGGGCCGCGGAGTTCACCGGCGTGGCGGTCGCGTTCCACTACCTCAACCGCGTGGCCAACGTGTTCCTGGACGATTCCCCCCTGCCACCGCGGATGTCCGACCGCGCACGCGGCTGGGGGCTGCGTGTGCTGGGCCGGGTCGTGCGCCGGACCGCGCGGCGACCGCGGGACGTCGGCACGGCCGGCGCGCTGCTGCCCGCCGCACCGCTCCCGGTCGACCTGGCGTGGGCCGCGAGCGCACCGCACGTCGCCGACGCGCTCGCACGCGTCGCCGCCGCCGTCGAGCGTGGCGGTGAACGCTCGGTGCCGCAAGGGGTTCGCGAGCACGTCGCCGCGCGACTGTCCATCTGGGCCGGTGAGCCACCACCCGGTCCGAGCCGCGCCTGGGTGGAGGACGAGGTCGCCGACCTCCCGGACGCGGACCGCCCGGCGACACGACTGGCGCTCGTGACCGCGCTCGCCTCGTACCAGGTCGACGACGCGGTGGTCACCGCGTTCCGCCGACACCGCCCCGACGACCGGAGCCTGGTCGAACTGGTCGCGTGGGCGGGTTTCACCGCCGCCCGCCGGTCGGGCGCGCTGCTGGCCGCGCGCCCGACCGCCGAGCACGAACCAGGAAGATCGTGA	MIGPLAGLPLRGVRHVTPVRPGAARGVVREVYRQVGRDFGMIAPPVALHSPAPAALAACWALLRETLIVGSADRAAKENAAAAVSAANSCPYCVEVHEAAALALGEGPDERLAAWARGGPAPFPAAWAAEFTGVAVAFHYLNRVANVFLDDSPLPPRMSDRARGWGLRVLGRVVRRTARRPRDVGTAGALLPAAPLPVDLAWAASAPHVADALARVAAAVERGGERSVPQGVREHVAARLSIWAGEPPPGPSRAWVEDEVADLPDADRPATRLALVTALASYQVDDAVVTAFRRHRPDDRSLVELVAWAGFTAARRSGALLAARPTAEHEPGRS	MNIKALLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTLGDAMKASAIPVYQDLARHIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	121.90	gnl|BL_ORD_ID|3794|hsp_num:0	4864			387	480	cloxacillin; oxacillin; cefalotin
BGC0000081.1|Kedarcidin_7 # 7020 # 7676 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.767	BGC0000081.1|Kedarcidin_7 	7020	7676	-	Loose	450	25.0238	cphA4	29.79	3003100	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	GTGCGCACGGCACTGAGCACCCGGGCCGCGGTCGGCTCCCTGGTCGCCGGAGCACTGGTGCTCGTGATGGCGACGCCGGCCGTGGCCCAGGGCCACGACCACGTGATCACCTCGCCGATCGTCATCGGCCCGCTGGTGCCGCGCCTGGCGATGCTCGGCGCGATGCCCGTGGTCACCGGCTTCGCGTTGCTGCGGACGTTCGTGCCCACCCCGGGCCGGACGACCTCGGCGGCGGTGGCCTGGGCCGCCGCGGTGCTGGTGGTGCTCCAGCTGATGCTGACCGACGTGCTGGACATGCCGCCGCAGGTCGCGGTCCTCGCCCTGGCCGTGGCGAGCGCGCCGCTGCTGCCGATCCTGTCGCGGAACCCGCGGCACACCCGGCTCAGCGGTGTCGCGCCGTGGGCGATCGCGGTGTCCGCGGCTGTCGCCGCGGTGGTGTTCGCCCGCGCCTGGCTGGGTGCCGCGGAGGAGCAGGCGCTCGGCGCGCTGCTGCACACTGCCCTGGTGCTCGCCCTGCCCGGCCTGTCGTGGGCCGCGGCCTGGCGGCCCCGCTCCCGCGGGGCGCGGGTCGTGGTCGGCGCGGTCGCCGCGCTGCTGGCCTGCGCCGTGATCGCGGCGACGGCGCAAGTGGCCGTGATGCGGCCGTTCGACGCGTAG	MRTALSTRAAVGSLVAGALVLVMATPAVAQGHDHVITSPIVIGPLVPRLAMLGAMPVVTGFALLRTFVPTPGRTTSAAVAWAAAVLVVLQLMLTDVLDMPPQVAVLALAVASAPLLPILSRNPRHTRLSGVAPWAIAVSAAVAAVVFARAWLGAAEEQALGALLHTALVLALPGLSWAAAWRPRSRGARVVVGAVAALLACAVIAATAQVAVMRPFDA	MMKGWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSVVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRVGGNAYWKSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYEELIKAAAAV	85.83	gnl|BL_ORD_ID|736|hsp_num:0	803			210	348	
BGC0000081.1|Kedarcidin_8 # 7661 # 8206 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.685	BGC0000081.1|Kedarcidin_8 	7661	8206	-	Loose	600	26.9498	LMB-1	27.47	3005018	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	LMB beta-lactamase	ATGAGCCACGTCGTGGAACCACCGTTCCGCCTCAGCCCGCCGATCGCCGCGCTCAACCTGCGGTGGCACCGGTTGGCCCTGTACGGGTACCTGGCGATCGTGCTCGGGCACTGGGCCGAGCACATCACCCAGGCGATCCAGATCTACGCGCTCGACTGGCCCCGGCCCGCGGCCGGTGGCGTGCTGGGCCTGGTGTTCCCGTGGTTGGTCACCTCGGAGTGGCTGCACTACGGCTACGCCGTCGTGATGCTGGTCGGGTTCGTGGTGCTGCGGCACGGTTTCTCGGGTCGGGCCCGCCGCTGGTGGGACACGGCGCTGTGGATCCAGGTCTGGCACCACTTCGAGCACCTGCTGCTGCTCCTCCAGGCGCTGACCGGCGCGTACCTGCTGGGCGCGGTCCAGCCGACCAGCATCGCGCAACTCGTCTTCCCCAGGGTCGAGTTGCACCTGTTCTACAACGCGATCGTGTTCGCCCCGATGGTCGTCGCGATGGTCCTGCACCGACGTCGGCATTCGTCGGACATGTGCTCGTGCGCACGGCACTGA	MSHVVEPPFRLSPPIAALNLRWHRLALYGYLAIVLGHWAEHITQAIQIYALDWPRPAAGGVLGLVFPWLVTSEWLHYGYAVVMLVGFVVLRHGFSGRARRWWDTALWIQVWHHFEHLLLLLQALTGAYLLGAVQPTSIAQLVFPRVELHLFYNAIVFAPMVVAMVLHRRRHSSDMCSCARH	MTLAKSFRCFCLVTTLSSMAMLAGCGGTAPVTVLSPPPADWVNSCKDWDDWDKAGPPYRIYGNSYYVGTCGISAILITGDNGHILIDGATEAGAKVIAANIDRLGFSLRDVKLLLQSHEHFDHVAGLAQLQQQSGAKLLASPAAAPVLTSGVVAAADPQAGMHEPFPAVRVDGLVTAGQVVTLGKLSLLPVATPGHTPGALSWQWSSCEAGQCQVLVYADSLSPVSSDSYRFSEHLTYLNAYRASLHKLAALDCQILLTPHPSASNMRTRLQSSAGLTDTQGCVVYADAITQRLEQRLIKETTQ	59.54	gnl|BL_ORD_ID|2750|hsp_num:0	3761			273	531	
BGC0000081.1|Kedarcidin_9 # 8203 # 9840 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=9bp;gc_cont=0.724	BGC0000081.1|Kedarcidin_9 	8203	9840	-	Loose	600	29.261	Streptomyces venezuelae rox	26.13	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAGCGCCGAGGAGAGCACCGACGTCCTCGTGATCGGCAGCGGGTTCGGCGGCGCGATCACCGCCTACCACCTGGCGGCGGGCGGCGCGCGCGTCGTGGTCCTGGAGCGCGGGCCGTGGCTGGAGGGCAAGGACTTCGAGCACGACTTCCTGCTCGGCTCCTCCTACACGCGCGTCTTCGACTTCGTCGCCGGCGACGGCATGAGCGTGCTCAGCGGCAACTGCGTCGGCGGCGGCAGCGTCGTCTACTTCGCGGCCCTCCCCCGCGCGCCCCGGTTCGTCTTCGAGCGCCACGGTTCGATCGGCCGTCGCATGTGGCCCGCCGCGTTGTCCCGCGACTCGCTCGACCCCTGGTACGACCGCGTGGCCGAGGCCATCCCGGTGCGCAAGCAGGACTGGTCCGACGTGACCTACGCGGGCGGCCTGTGGGCGGCGGCCTGCCACCACGCGGGGCGGACCGCGAACCCCGTGCCCAGCGGTGTCGACAACTCGCTGTGCACGAACTGCAACTGGATGATGGCGGGCTGCCGGTTCGACGCCAAGCAGTCGCTGCTGCTCAACTACCTGCCCGGCGCGGTGGCGCACGGCGCGGAGGTCCGGCCGCTGCACGAGGTGCAGCGGATCGAGCGCACCGACGACGGCGGCTACCGCGTGCACTACGACCACGTCGACGGCGTCGACTACCGGGTCCACACCGGTTCCGGGACCATCACGGCGAAGATCGTCGTGCTGGCCGCGGGCGCGGGCGCGACACCGGTGATCCTCCAGCGGTCCGAGGAGGGCCTGGGCGCCCTGCCGCACGCGGTCGGCCGGTACTTCTCCGGCAACGGCGAACGGCTCAACACCGCCGTCGTCAACGAGGACCGCGTGCGCGACGTGCTCGGCCTCGACCGCGGCGACGGGCGCGCCTACCTGGCGAACCAGATCGGCAAGGGCCCGGTGGTGGCCAGCTGGGACCGCCTGGACGCCGCGCTGCCCGAGTACGAGCGCTTCTCCCTGGAGCAGCTGTACTTCCCGCCCGGCCTGGGCACCATCCTCGCCCAGGCCGCCGTCCCGGAGGGCAGCCCGTCGTGGTTCGGCGTGGCGAAGAAGGAAATGCTCAGCCGCTGGCAGTCGTGGCTGACCGTCTTCGAGATGGTCGAGGACGACAACGAGGGCGTGTTCGGCCCGCCGCCGCCGACCGGCAACGCCTACCGCATCTCGCAGCAGATGCTCGGGCGCGGCACGCTGAGCTACGAGCCGACGGCGAACACCAGGCGTGCCTGGGCGCTCGCGGACGCCGAGGTCAAGGACATCCTGGAACGCGACGGGCTGGCCACGGTGACGCCGTGGACCAATGACGTGGTGGGCGCGTACACGGTGCACCCGCTGTCGTCCTGCCGCATGGGCGACGACCCGGCGACCTCGGCGCTGGACGACCGCCACGAGTTGCGCGGTCACCCCGGCATCTTCGTCACCGACGGCTCCGCGGTGCCCGGTGCGCTCACCGTCAACCCGGCCATGACCATCGCGGCCCTGGCCGAGCGCGCCGTGCCCGGCATCGTCGAAGCAGCACGTGCCCGGGGGGTGCAGGTCACGTATGGCGCTCCGCTGCCGGGCAGCGGCGCCACCAGTCCGATGGTCAGGAGTGCGCCATGA	MSAEESTDVLVIGSGFGGAITAYHLAAGGARVVVLERGPWLEGKDFEHDFLLGSSYTRVFDFVAGDGMSVLSGNCVGGGSVVYFAALPRAPRFVFERHGSIGRRMWPAALSRDSLDPWYDRVAEAIPVRKQDWSDVTYAGGLWAAACHHAGRTANPVPSGVDNSLCTNCNWMMAGCRFDAKQSLLLNYLPGAVAHGAEVRPLHEVQRIERTDDGGYRVHYDHVDGVDYRVHTGSGTITAKIVVLAAGAGATPVILQRSEEGLGALPHAVGRYFSGNGERLNTAVVNEDRVRDVLGLDRGDGRAYLANQIGKGPVVASWDRLDAALPEYERFSLEQLYFPPGLGTILAQAAVPEGSPSWFGVAKKEMLSRWQSWLTVFEMVEDDNEGVFGPPPPTGNAYRISQQMLGRGTLSYEPTANTRRAWALADAEVKDILERDGLATVTPWTNDVVGAYTVHPLSSCRMGDDPATSALDDRHELRGHPGIFVTDGSAVPGALTVNPAMTIAALAERAVPGIVEAARARGVQVTYGAPLPGSGATSPMVRSAP	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	114.50	gnl|BL_ORD_ID|4833|hsp_num:0	5820			1131	1410	rifampin; rifaximin; rifapentine
BGC0000081.1|Kedarcidin_10 # 9837 # 10406 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.754	BGC0000081.1|Kedarcidin_10 	9837	10406	-	Loose	950	26.5646	adeK	50.0	3000782	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCGATCAGGTGACTCGGACGACCGGCGGAGCCGGACCGCGACCCTGGAGTCCTTCGCCGACACGATCGTCCCGGGTGCGAAGCGCGCACCCGACGACCGGGCGATCGCGGGCGCGGCCACCGGTGGTGGCGCCGTCGCGGCGGGCGCGCTGGAGCTGCTGGAGCAGCCCGCACCCGGCCTCGCCGCCGGGCTCGACCACTACGCGGCCGGGCTGAACGCCCACGCGGAGGCGTACGCGGCCGAGCACGGCGTGGACCTGGAAACCGGGTTGCCCGCGTTCGTGGCGCTGCCGTTCGAGCACCGGACGGCGCTGGTCGCGCGGTTGACCACGCCCGGCCACCCGGAGAAGGACGGCTGGGTGCTGCTGGCCCTGTTCTGCACCATGGCGTTCGACACCGCTCCGCACATGCGCACCGCGGACGCCCTCGCCACGGGCCACCCCGGACTGGCGACAATGGGCTTCGCACCACCGCAGGCCGACGGCCTGTGGCGGTTCGGCGAGTTCTCCTACGGCCGGCCGCTGGCCGACCTCCACCCGGCCACGACGCCCTCGGGCAGCCCCGCATGA	MRSGDSDDRRSRTATLESFADTIVPGAKRAPDDRAIAGAATGGGAVAAGALELLEQPAPGLAAGLDHYAAGLNAHAEAYAAEHGVDLETGLPAFVALPFEHRTALVARLTTPGHPEKDGWVLLALFCTMAFDTAPHMRTADALATGHPGLATMGFAPPQADGLWRFGEFSYGRPLADLHPATTPSGSPA	MQKVWSISGRSIAVSALALALAACQSMRGPEPVVKTDIPQSYAYNSASGTSIAEQGYKQFFADPRLLEVIDLALANNRDLRTATLNIERAQQQYQITQNNQLPTIGASGSAIRQVSQSRDPNNPYSTYQVGLGVTAYELDFWGRVRSLKDAALDSYLATQSARDSTQISLISQVAQAWLNYSFATANLRLAEQTLKAQLDSYNLNKKRFDVGIDSEVPLRQAQISVETARNDVANYKTQIAQAQNLLNLLVGQPVPQNLLPTQPVKRIAQQNVFTAGLPSDLLNNRPDVKAAEYNLSAAGANIGAAKARLFPTISLTGSAGYASTDLSDLFKSGGFVWSVGPSLDLPIFDWGTRRANVKISETDQKIALSDYEKSVQSAFREVNDALATRANIGERLTAQQRLVEATNRNYTLSNARFRAGIDSYLTVLDAQRSSYAAEQGLLLLQQANLNNQIELYKTLGGGLKANTSDTVVHQPSSAELKKQ	39.05	gnl|BL_ORD_ID|1536|hsp_num:0	1664			1257	1323	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0000081.1|Kedarcidin_11 # 10892 # 11668 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGGAGG;rbs_spacer=4bp;gc_cont=0.705	BGC0000081.1|Kedarcidin_11 	10892	11668	+	Loose	400	66.2402	mtrA	33.98	3000816	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAGGGCGACGTCGAGCACGCGGTCCGGAAAGTCGTCGAGACGATGCGGGAGAGGCCCGGCGAGCAGTTCACGATCGACGACATGGCTCGCACGGCGATGTTCAGCAAGTTCCACTTCACCAGGATGTTCCAGCGCGTCACCGGGGTGTCCCCCAGCAGGTTCCTCGCCGCGGTGCGGTTGCAGGAGGCCAAGCGGCTGCTGGTCTCGACGTCGTTGAGCGTCACCGAGATCAGCCTCCGGGTGGGGTACAACAGCGTCGGCACCTTCAGCTACCGCTTCCGCACCAGCGTCGGCCTCTCGCCGTCGCTGTACCGGGAACTGGGTGAGTGCACGCAGCAGATGTGCCTGGACAGCAAGCCGCTGCTGTCGCCGTCCGCCGCGCCCGCGACGACCCTGCGCGGCCGGATCGGCCGACCGCGGGAGGGTGACGTCGGCCTGGTCTTCGTGGGGTTGTTCCCCGGCCGGCTGCCGCACGGCCGGCCGGTGCGCTGCACCGTCCTGCCCGGCCCCGGCTCGTACGTGCTGAACGACGTGGTGCCCGGTACCTGGTACCTGCTCACGCACTCGGTCTCCGCCGACCGCAGCGAGATGCTGCGCCTGCACGACCACGACCCCGGCCTGTTCATCGGCTCGATCGGACCCATCACCATCCGCCCCGGCACGAGCACCCGGCTGCCGGAGATCACGCTCCGGCCCGCCGACGCGCTCGACCCGCCGGTGCTGCTCTCGCTGGTGAGCCTGCGCACCAACGCGCTGGGCAGGCGCCGGGACTGA	MEGDVEHAVRKVVETMRERPGEQFTIDDMARTAMFSKFHFTRMFQRVTGVSPSRFLAAVRLQEAKRLLVSTSLSVTEISLRVGYNSVGTFSYRFRTSVGLSPSLYRELGECTQQMCLDSKPLLSPSAAPATTLRGRIGRPREGDVGLVFVGLFPGRLPHGRPVRCTVLPGPGSYVLNDVVPGTWYLLTHSVSADRSEMLRLHDHDPGLFIGSIGPITIRPGTSTRLPEITLRPADALDPPVLLSLVSLRTNALGRRRD	MDILDKLVDLAQLTGSADVQCLLGGQWSVRHETLQCEGLVHIVTAGSGYLCIDGETSPRPVGTGDIVFFPRGLGHVLSHDGKYGESLQPDIRQNGTFMVKQCGNGLDMSLFCARFRYDTHADLMNGLPETVFLNIAHPSLQYVVSMLQLESEKPLTGTVSVVNALPSVLLVLILRAYLEQDKDVELSGVLKGWQDKRLGHLIQKVIDKPEDEWNIDKMVAAANMSRAQLMRRFKSQVGLSPHAFVNHIRLQKGALLLKKTPDSVLEVALSVGFQSETHFGKAFKRQYHVSPGQYRKEGGQK	85.71	gnl|BL_ORD_ID|1431|hsp_num:0	1559			597	894	erythromycin; penicillin; azithromycin
BGC0000081.1|Kedarcidin_12 # 11701 # 13041 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.740	BGC0000081.1|Kedarcidin_12 	11701	13041	-	Loose	900	26.1794	iri	36.96	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCACCGCCCGACGTGCCGTGTCCCCACCGACCACGCCGCTGCGCGCGGCGCCCGGTCTGCTGCGCCGGCTGATCTTCGACCGGCTCGGGATGATGCGGTCGGCGGCGGCGGAGTACGGCGACGCGGTGAAGATCACCATCGGACCCAAGTCGCTGTACTTCTTCAACCACCCCGACCACGCCAAGCACGTGCTGGCCGACAACAGCGCCAACTACCGCAAGGGCATCGGCTACATCCAGGCCAGGCGCGCGCTCGGCGACGGTCTGCTGACCAGTGACGGCGAGCGGTGGCGGGAGCAGCGGCGGGTGGTCCAGCCCGCGTTCGCGCACAAGCGCATCGCGGCGCGGGCGGACGTCGTGGCGCGGGAGGCGGGCGCGTTGGTCGCCCGCCTCCGGGCGCGCGGCGCCACCGGGCCGGTGAACCTGGTGGACGAGCTGACCGGGTTCACGCTGGCCGTGCTGGGCCACACCCTGCTGGACTCCGACCTCGACGCCTTCACGGGTGCCGGCCAGGCGTTCGGCGTGGTGCAGGACCAGGCGATGTTCGAGATGGAGACGATGGGCCTGGTGCCCACGTGGGTGCCGCTGGCGGGGCAGCTCCGGTTCCGCCGCGCGCGCCGCTACCTGGACGACGTGGTCGCACGCCTCACCGCGGACCGGTTGCGCCACCCACGGCCGGAGGGCGACGACGTGTTGACCCGGCTGATCGCGGCCACCCGGAACAGCGACCCGAGGCGGCTGCGCGACGACCTGGTCACCCTGCTCCTGGCGGGCCACGAGACGACCGCCAGCACCCTGGCCTGGACGTGGTACCTGCTCGACCGGCACCCCGACGTGCTGCGCCGGGTGCGCGAGGAGGCGGTCGACGTGCTCGGCGACCGGCCGCCGACCTTCGCGGACCTGCCCCGGCTGACCTACACGTCCGCGGTGCTCAACGAGTCGATGCGGCTCTACCCGCCGGTCTGGATCCTGACCCGCCAGGCGAAGGAGGACGACGACGTCGCCGGCTACCGGGTGCCCGCCGGCTCGGACGTGCTGATCTGCCCGTACACGCTGCACCGCCACCCGGGCCTGTGGGACGAGCCGGACCGCTTCGACCCGGACCGCTTCAGCCCCGACCGGTCGAGCGGTCGGCCGCGCTACGCCTACCTGCCGTTCGGCGCGGGACCCCGGTTCTGCGTCGGCCAGCAGCTCGGCCTGGTGGAGGCGACGTTCGCGACCGCGCTGCTGGCGCGGGACCTGCGGCTGCGCACCGCGGCCGGGCACCGGGCGGTGCCGGAACCCATGCTGTCCCTGCGGATGCGCGGTGGGCTGCCCGTCACGGTGCACCCGGCGTGA	MTTARRAVSPPTTPLRAAPGLLRRLIFDRLGMMRSAAAEYGDAVKITIGPKSLYFFNHPDHAKHVLADNSANYRKGIGYIQARRALGDGLLTSDGERWREQRRVVQPAFAHKRIAARADVVAREAGALVARLRARGATGPVNLVDELTGFTLAVLGHTLLDSDLDAFTGAGQAFGVVQDQAMFEMETMGLVPTWVPLAGQLRFRRARRYLDDVVARLTADRLRHPRPEGDDVLTRLIAATRNSDPRRLRDDLVTLLLAGHETTASTLAWTWYLLDRHPDVLRRVREEAVDVLGDRPPTFADLPRLTYTSAVLNESMRLYPPVWILTRQAKEDDDVAGYRVPAGSDVLICPYTLHRHPGLWDEPDRFDPDRFSPDRSSGRPRYAYLPFGAGPRFCVGQQLGLVEATFATALLARDLRLRTAAGHRAVPEPMLSLRMRGGLPVTVHPA	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	93.11	gnl|BL_ORD_ID|729|hsp_num:0	796			1077	1206	rifampin; rifaximin; rifabutin; rifapentine
BGC0000081.1|Kedarcidin_14 # 13403 # 14455 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGAGGA;rbs_spacer=11bp;gc_cont=0.689	BGC0000081.1|Kedarcidin_14 	13403	14455	-	Loose	1000	26.1794	msbA	24.24	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGCGAAGGAGAACGCGCGGGTCTCACCGCGGCACGACGCCAAGGTGGTCATCGCGCTGCGCCGGTTCGCGATCTCGATCTCGATCTTCAACATCTTCGGCTACACGGTGCTCGGGTTCGAGCAGCCCTGGCTGTGGCCGTTCATCGCGCTGTTCACGGCTTACACCACGGAGTTCGTCCTGGAGTTCGTCGCGGCGAAGGCCGAGGGGCGTCCGCCGAGGTACGTCGGCGGCGGGGTGAAGGGCGTGCTGGAGTTCCTGTACCCGGCGCACATCACCGGCCTCGCGCTGAACATGTTGACCTACGTCAACGACCAGGTGCTGGTGATGGTGTTCGGCGTGATCGTCGCGGTGAGCGCGAAGTGGGTGCTGCGGGCACCGGTGCGCGGGCGGCTGCGGCACTACATGAACCCGTCGAACCTCGGTATCGCGGTCATCCTGCTGCTGTTCCCGTGGGCGAGCATCGCGCCGCCCTACCACTTCACCGAGCACGTGGACACCTGGGTCGGCTGGGTGATCGTGGCCGTCATCCTGGTGTCGGGCACGATGCTCAACGCCAAGCTGACCGGTCGTGTGTGGTTGGTCGGCGCGTGGCTGGTGGTGTTCGCGCTCCAGGCGGTGATCCGCGGTCTGGTCTTCGACACCTCGATCCCGGCCGCGCTGGGCATGATGACCGGCGTCGCGTTCGTGCTGTTCACCAACTACATGGTGAGCGACCCGGGGACGACACCGTCCAGGCCGTCCGCGCAGATCGCGTTCGGCGGTGGCGTCGCGCTGGCCTACGGCCTGCTGACCGCCGTGCACATCGCCTACGGCCTGTTCCTGGCGACGGCGGGCGTGTGCCTGATCCGCGGCATGTTCCTGTGGGGTGTGCACTTCGTGGACAAGGCGCGCGCCGAGCGCGCCGCCCTCGAAGCCACCGCGCGGGAAGCCGGGGTGACGGCGGACCCGATCGCCGTGCCGACGGGCAACGGCCACGCGCCGGCCACCGAGCCGGTCGCCGCGGAACCCGTTGTCGCCGAGCCGGTCGCGGATCACCGGGTGTCCCGATGA	MAKENARVSPRHDAKVVIALRRFAISISIFNIFGYTVLGFEQPWLWPFIALFTAYTTEFVLEFVAAKAEGRPPRYVGGGVKGVLEFLYPAHITGLALNMLTYVNDQVLVMVFGVIVAVSAKWVLRAPVRGRLRHYMNPSNLGIAVILLLFPWASIAPPYHFTEHVDTWVGWVIVAVILVSGTMLNAKLTGRVWLVGAWLVVFALQAVIRGLVFDTSIPAALGMMTGVAFVLFTNYMVSDPGTTPSRPSAQIAFGGGVALAYGLLTAVHIAYGLFLATAGVCLIRGMFLWGVHFVDKARAERAALEATAREAGVTADPIAVPTGNGHAPATEPVAAEPVVAEPVADHRVSR	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	60.14	gnl|BL_ORD_ID|2185|hsp_num:0	2423			240	438	metronidazole
BGC0000081.1|Kedarcidin_15 # 14460 # 16406 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.705	BGC0000081.1|Kedarcidin_15 	14460	16406	-	Loose	950	28.4906	fusH	50.0	3003026	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic inactivation	fusidic acid inactivation enzyme	ATGAACGCGAAAGTCGGCCCCCTGCGCGGCAAGCTGCCGGGGCTCCTCGCCGTGGTCGTGGTGGTGATCGGTTACTTCGTGGTGAGCCTGCCCACGACGTCGGCCGCCGAACAGGACCGGATCGCGGACAGGTACCGGTTCACGCCGATGGCGATCGCGCTGCCCGCCTCGGACAAGCACCAGTCCATTCGCGAGGTGAACAAGGACTACGAGCACATCCGGGCGTGGATCTCGTCGGTCGGCTCGGCGATCGCGATCAACGACCTCGACGGCGACGGCCTGGCCAACGACCTGTGCCTGGTGGACACCCGGACCGACCAGGTGGTCGTCACCCCGGCGCCGGGTCGCGGCGACGACCGGTACGCGCCGTTCGCCCTCAAGGCGGACCCGCTGCCGATGAACGACGTGATCGCCCCGATGGGCTGCGTCCCCGCCGACCTGAACGAGGACGGGCGGACGGACCTGCTGGTCTACTACTGGGGCCGCACGCCCGTCGTGTTCACCGCCCAGCCCGGTGAGAAGGGGCTCACCGCCGCTTCCTACCGGCCGGTGGAGCTGGACCCCGCCGCGAAGGCCGGCTACGACGGCCGGTACGCCGGTCCACAGTGGAACAGCAACGCCGCCACCGTGGCCGACTTCGACGGTGACGGGCACCTGGACGTCTTCGTCGGCAACTACTTCCCGGACGGGCCGGTGCTGGACGCGAGCGTCAGCGGTGGCGTCCAGATGAACGACACGATGTCGCACGCCTTCAACGCCGGCGGCAAGTACATCTACCGCTTCGACCCGTCCACCACCGACTCGCGGACCGCGAAGTTCACCCGCGTCGACGACGCCGTGCCGCAACCCGCCCGCCAGGGCTGGTCGCTGGCGGTCAGCGCGACCGACGTGGACCGCGACGGGTTGCCGGAGCTGTACATCGCGAACGACTTCGGCCCGGACCGCCTGCTGCACAACAGGTCGACGCCCGGTGAGCTGAAGTTCGCCGAGGTGCGCGGCACGCGGGACGCGGTCACGCCGAAGTCGAAGATCGTCGGCATCGACTCGTTCAAGGGCATGGGCGTGGACTTCGGCGACCTGGACCGCGACGGCATGTACGACATGTTCGTCAGCAACATCACCACCTCCTGGGGCATCCAGGAGAGCAACTTCCAGTGGATGAACACCGCCGCCGACGTCGCGGAGCTGCGTGCCCGGTTGGGCAGCGGCGAGGCGCCGTGGGTGGACCGCAGCGCGCAGGGCGGCACCGCCTGGTCGGGTTGGGGCTGGGACGTCAAGATCGGTGACTTCGACAACTCCGGCGAGCACGCGATCGTGCAGGCGACCGGGTTCGTCCGCGGCCAGACCGACCGGTGGCCCCAGCTCCAGGAGCTGGCCACCGCGCACGACTCCCTGCTGCACAACCCGTTGTGGTGGCCGAACGTCGGCGCGGGCGACGACATCGCGGGCAACCAGACGCTGCACTTCTTCGCCAAGGGCGAGGGCGACCGCTACACCGACGTCGCGGGCAGGCTCGGCCTCGCCGTGCCGGTGCCCACGCGCGGCATCGCGACCGGCGACGCGGACGGCGACGGCAGGCTCGACTTCGCGGTCTCCCGGCAGTTCGGCGAACCGGTGTTCTACCGCAACGAGAGCCCGGACACCGGGTCGTACCTGAACCTGCGGCTGCTGCACGAGGGCGGCCAGGGCGCGGGTTCGCCCGCCGTCGGCGCGGCGGTCACCGTCACCACGCCGGACGGGCGCACGCTGATCGACCGCGTCGACGGCGGCAGCGGCCACTCCGGCAAGCGCAGCCACGAGGTCCACATCGGACTGGGTGACGTGACGGAACCGGTGACCGTGCGGGTGCAGTGGCGCGATCGCTCGGCTCGGCTGCACGAACAGGAACTCCGACTGAGCCCGGGGCAGCACACGCTGCGGCTCGGCACGACCGCAGAGGAGGGCTGA	MNAKVGPLRGKLPGLLAVVVVVIGYFVVSLPTTSAAEQDRIADRYRFTPMAIALPASDKHQSIREVNKDYEHIRAWISSVGSAIAINDLDGDGLANDLCLVDTRTDQVVVTPAPGRGDDRYAPFALKADPLPMNDVIAPMGCVPADLNEDGRTDLLVYYWGRTPVVFTAQPGEKGLTAASYRPVELDPAAKAGYDGRYAGPQWNSNAATVADFDGDGHLDVFVGNYFPDGPVLDASVSGGVQMNDTMSHAFNAGGKYIYRFDPSTTDSRTAKFTRVDDAVPQPARQGWSLAVSATDVDRDGLPELYIANDFGPDRLLHNRSTPGELKFAEVRGTRDAVTPKSKIVGIDSFKGMGVDFGDLDRDGMYDMFVSNITTSWGIQESNFQWMNTAADVAELRARLGSGEAPWVDRSAQGGTAWSGWGWDVKIGDFDNSGEHAIVQATGFVRGQTDRWPQLQELATAHDSLLHNPLWWPNVGAGDDIAGNQTLHFFAKGEGDRYTDVAGRLGLAVPVPTRGIATGDADGDGRLDFAVSRQFGEPVFYRNESPDTGSYLNLRLLHEGGQGAGSPAVGAAVTVTTPDGRTLIDRVDGGSGHSGKRSHEVHIGLGDVTEPVTVRVQWRDRSARLHEQELRLSPGQHTLRLGTTAEEG	MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRTGAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRVMSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWGRFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL	127.31	gnl|BL_ORD_ID|65|hsp_num:0	75			759	837	fusidic acid
BGC0000081.1|Kedarcidin_16 # 16403 # 17404 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.728	BGC0000081.1|Kedarcidin_16 	16403	17404	-	Loose	400	26.9498	FusF	23.53	3004663	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic target protection	Target protecting FusB-type protein conferring resistance to Fusidic acid	ATGGAACGGGAGAGTGAATTGCTCACGACCTGGCGCGCCCTGCGCCGCCGAATTCTCACGCCGGACGTCTCCGCGACCCGGCTCGACGTCCGCGGTTTCCACCGCAAGGACGAACCGAGCACGGAATTGTTGGAGAAAGTCGGCCGGATCTTCCTCGCCGGTTTCGGCCACGCCGCCGAGGCCCGGACGCCGGCTGCCGCCGAAATCCCGCTCCAGCGGATCGAGCCGAGGTTCCGCGGATTCGCCTACGAGGGCGCCGCGATGGGTTTCGCGGTGCGCGACGGGCTGCCGTTCGGCCGCCGCGACCACACCACCCGGTTCCTCGCCGGCGAGCACGCCTCGCACCAGCTCTACATCGCCTACTGCGGCATCGGCTGGGCGATGGCCCGGCTGCCGCGGTTCCGGTGGCCGAACGCCGAGGCGTTCGACCCGCTGGTGCGGTGGCTGGTGCTCGACGGCTACGGCTTCCACCAGGCGTACTTCCACACCCGGCGCTACGTGCACGACCAGTACCGGGACCCGCGGTTCCCGTGGCCGTCCGCGGCGCTGTCCGACTACGCCAACCGCGTGATCGACCAGGGCATCGGCCGCGCCCTGTGGTTCGTCTGCGGCACCGACGCCGCTCGGGTGGCCGACACGATCGACTCGTTCCCCGAGTCCCGCCGGGCGGACCTGTACGCCGGGACCGGCCTCGCGGCGACGTACGCGGGCGGTGCGGACACCGCCGAGCTGCGGGGGTTGCGCGAGCGGGCGGGCCGGTGGCGCGGCCAGCTGGCGCAGGGTTCGGCGTTCGCCGCCGAGGCCCGCGTCCGGGCCGGCCTGGTCGTGCCGCACGTCGAGCAGGCCACCGCCGCCCTGTGCGGGACGACACCGGAGGTCGCCGCGACCGTCACCCAGGAAGCGATCCCGACCGAGCCGGTGACCGGTGAGCTGCCCGCCTACGAGGCGTGGCGGCAGCGGATCGCGGCTGAACTGCTTGTTCTCGGAGGTGTTGACACATGA	MERESELLTTWRALRRRILTPDVSATRLDVRGFHRKDEPSTELLEKVGRIFLAGFGHAAEARTPAAAEIPLQRIEPRFRGFAYEGAAMGFAVRDGLPFGRRDHTTRFLAGEHASHQLYIAYCGIGWAMARLPRFRWPNAEAFDPLVRWLVLDGYGFHQAYFHTRRYVHDQYRDPRFPWPSAALSDYANRVIDQGIGRALWFVCGTDAARVADTIDSFPESRRADLYAGTGLAATYAGGADTAELRGLRERAGRWRGQLAQGSAFAAEARVRAGLVVPHVEQATAALCGTTPEVAATVTQEAIPTEPVTGELPAYEAWRQRIAAELLVLGGVDT	MEKQIYPYQFNYIKERIAHLLNAYKSVNDLNTIASIKETTKIDIYQQFHQIDDTLTEAIEKLMNIRITKVQVDKILETLQTYVIPFEHPSKKQVEKTFRKIKKLKSPLISDEILLESTYIGWNDIASNRKFIIYYNEQGTLTGFYGDIANQTVKGYCAICNKESNVALFMRKTRTSGDGQYTKKGDYICFDSIKCNQQLSDITQFYQFVDKIHS	155.61	gnl|BL_ORD_ID|2205|hsp_num:0	3364			42	297	fusidic acid
BGC0000081.1|Kedarcidin_17 # 17452 # 18477 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.753	BGC0000081.1|Kedarcidin_17 	17452	18477	-	Loose	1500	25.7942	rphA	31.76	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	GTGCCCGGTCTGATCGGGTCCCTGCGCCGTCTCGCCCTCACCCCGTCCCTGCGCAGCACGGGTTTCGCCGCGCGCGGCTTCCCCGGCGCCGCCTCACCCGCGGTGACCCGCCTGGAGGCGATACCGCAGACCGTCGTCTGCGGGTTCGAGTGGGGCATCGACGCGCCCGACCGGTGGGAGCTGGAGCGCAAGCTCGAACTGGTCGACGTCGACCTGCGCGGGTTCGCCTACGAGGGCGCGGTCATGGCGACCACCGTGCGGGACGCGATGGGGCGCGGCAGCCGGACGCGCGACCTGCTCCTGGGCGGCGGTCGGCCACACCTGCTGCTGTCCTACATCGGCATCGGTTTCGCCATGGCGCGCCTGCCGCGCCGCCTGTGGAGCCGGGTGCTACCGGACCTGGACGAACTGCCGTGGCACCCGACCGCGGCGTGGCTCGTGGTGGACGGCTACGGCTTCGACCTCGCCTACTTCCACACCGAGCGCTGGGTGCACCGGCAAGAGCTGCCCCGGCCGTACCCGTGGCTCGGCGACAGCGCCTACTTCATGCGGGCGTTCGACCAGGGCGTCGGGCGTGCGTTGTGGTTCATCCACGGCGCGCGGGCGGCGGGTGTCGCCGCCGCGGTGGCGGGGTTCCCCGCCGGGCGGCACGCCGACCTGTGGAGCGGCGTGGGCCTCGCGGCGGCGTTCGCGGGCGGCTGCGACGAAGCGGACCTCGCGGCGCTGCGGCACGCGGAGGGCGGCCACCGGGCGGAACTCGCCCTGGGCGCGGCCCTCGCGGCGAAAGCCCGTGCCGCCGCCGGTTTCACCCCGCCGCACACCGCGGCGGCCACCGACGTGCTCACCGGGCTGCCGGCCGCCGAGGCCGCCGCGCTGGTCGATCGCACGGCCGTGCACGAACGCGGCGCCGCGGACGTTCCGCCGTACGAGCTGTGGCGCGCCCGGATTCGTGCGGAATTCGTCGACCGGGCTTCTTCCCGAGCTGATTCGCCCGGCACCGGCGGGCACCGAGCAGAACCGGAGTAG	MPGLIGSLRRLALTPSLRSTGFAARGFPGAASPAVTRLEAIPQTVVCGFEWGIDAPDRWELERKLELVDVDLRGFAYEGAVMATTVRDAMGRGSRTRDLLLGGGRPHLLLSYIGIGFAMARLPRRLWSRVLPDLDELPWHPTAAWLVVDGYGFDLAYFHTERWVHRQELPRPYPWLGDSAYFMRAFDQGVGRALWFIHGARAAGVAAAVAGFPAGRHADLWSGVGLAAAFAGGCDEADLAALRHAEGGHRAELALGAALAAKARAAAGFTPPHTAAATDVLTGLPAAEAAALVDRTAVHERGAADVPPYELWRARIRAEFVDRASSRADSPGTGGHRAEPE	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	39.42	gnl|BL_ORD_ID|890|hsp_num:0	910			612	867	rifampin; rifaximin; rifabutin; rifapentine
BGC0000081.1|Kedarcidin_18 # 18521 # 19480 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGGGAG;rbs_spacer=5bp;gc_cont=0.730	BGC0000081.1|Kedarcidin_18 	18521	19480	-	Loose	1080	26.1794	rosB	26.37	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCCGACCGATCGAGCCCGCGGCACCGCACGGCGCACGTCGCCGACTTCCCGGTCGCCGCCACCCCGCTGCGCCAACGGGTCCACCGCCGCGGCCTCGTGGTGCTGCTCAGCTCGCTGGGCGGTTTCCTGCTCAGCGTCGTGTGGTCCGCCCAGTTCGTCGACGACGTCATCGGCGGCACCGTGGTGGACACCCTGCTCGGCGAGGGCACCCGGGACTCCGCGGTCAGCGGTGTCGGCACGGGCATCGTGTTCGCTCTCGTCTCCGGTCTGGCGGGCACGTTCACCGCGTGCAACATCGCCGCGTTCGGCGTGCTCGCGCCGATGCTCGACGGCTCCGGCAACCGGGTGCGCCGCGCGCTGGGCGCGATGCGCCCGCTGGGGTGGCTGGCGATCGGCATGTTCGCGGTGTCCGCGGCCTACGGCGTGGTCGTCGGGCTGGTCGGGACGTCGATGCCGCAGTTCTCCACCGCGGCGGGCAGCGGGATGCCCGCCCGGCTCGTGCAGTCGATGGTGGTGTTCGGGGTCATCGGCCTCGCCATGACCTACCTCGGCCTGGCGGCGCTGGGCCTGGTGCGCGACCCGTTCGCCCGCTTCCCCAACGCCCGCCTGGTGTTCTTCGGCGCGTTGATCGGCGGGTTCCTGATCGGCCGGCCGTTCCCGTTGTTCCGGGCGTTGTTCCGGGACGCCGCGGAGAGCGGCAACCCGCTCTACGGCGCGGCGGCGTTCTGCCTGCAATCCCTCGGCAACATCGCCCTCATGGCGGTGATCTTCCTGGTGATGGCGTACGCGGCCGGTGGCCGCGCGGGCCGGTGGCTGGCCGCCTCGCCGAACCGGGTCGCGATCATCACGGCCGCCGCGCTGATCGTCGCCGGGGTGTTCACGCTCCTCTACTGGGACGTCCGGCTGCTCGCCCGCCGGGACATCATCCCGTGGTACCCGACCGCGCCGTGGGCGTGA	MADRSSPRHRTAHVADFPVAATPLRQRVHRRGLVVLLSSLGGFLLSVVWSAQFVDDVIGGTVVDTLLGEGTRDSAVSGVGTGIVFALVSGLAGTFTACNIAAFGVLAPMLDGSGNRVRRALGAMRPLGWLAIGMFAVSAAYGVVVGLVGTSMPQFSTAAGSGMPARLVQSMVVFGVIGLAMTYLGLAALGLVRDPFARFPNARLVFFGALIGGFLIGRPFPLFRALFRDAAESGNPLYGAAAFCLQSLGNIALMAVIFLVMAYAAGGRAGRWLAASPNRVAIITAAALIVAGVFTLLYWDVRLLARRDIIPWYPTAPWA	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	56.66	gnl|BL_ORD_ID|466|hsp_num:0	507			723	981	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0000081.1|Kedarcidin_19 # 20001 # 25757 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.759	BGC0000081.1|Kedarcidin_19 	20001	25757	+	Loose	800	28.1054	Chlamydia trachomatis intrinsic murA conferring resistance to fosfomycin	30.99	3003785	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic target alteration	antibiotic-resistant murA transferase	ATGAACACCGAGCGGATCGCCGTAGTAGGCATCGGCTTGCGGTACCCGGACGCCGACTCACCCGACCAGCTCTGGGACAACGTCCTCGCCCGGCGGCGGGCGTTCCGGCGGTTGCCGGACGAGCGGCTCAACCACGCCGACTACTGGTCGGCCGACCCCTCGGCGCCGGACCGGCTGTACTCCGCCACCGCGGCTGTGCTGCGGGACTTCGAGTTCGACCGGGCCAGGTTCAAGGTCGCGGGGAGCACCTTCCGCGTGACCGACATGACGCACTGGCTCGCGCTCGACGTGGCGTCCCGCGCCTTGGCGGACGCGGGTTTCCCGGACGGTGAAGGGCTGCCGAACGAGTCCACGGGCGTCTTCGTGGGCAACAGCCTCACCGGGGAGTTCGTTCGGGCCAACATGATGCGCCTGCGGTGGCCCTACGTCCGCCGCACGGTCGCCGCCGCCCTCGCGGGGAAGGGTTGGGGCGACGGGGAATCGGCCGACTTCCTGCGTGAGCTGGAGGCGGCGTACAAGGCGCCGTTCCCGCCCACCGACGAGGACTCGCTGGCGGGCGGGCTGTCCAACACCATCGCGGGCCGCGTGTGCAACCACTTCGACCTGCGCGGCGGCGGCTACACCGTGGACGGCGCCTGCTCGTCGTCGCTGCTGTCCGTCGTCACCGCCGCGAACGCCCTGACCAAGGGGACGCTGGACGTCGCCGTGGCGGGTGGCGTGGACCTGTCGCTGGACCCGTTCGAACTGGTCGGCTTCGCCAAGACCGGCGCGCTGGCGACCGGTGAGATGAAGGTGTACGACCGCGACTCCAACGGTTTCTGGCCCGGCGAGGGCTGCGGCATGGTCGTGCTGATGCGCGAGTCCGAGGCGTTGCGGCGCGGGCTGCGCGTGTACGCCGTCATACCCGGGTGGGGTGTGTCGTCGGACGGCAAGGGCGGCATCACCCGCCCGGAGGCGGGCGGTCACCGCCTCGCCATGGCCCGGGCGTACGCGCTCGCGGGCTACGGCGTGGAGTCCGTCAGCTACTTCGAAGGGCACGGCACCGGCACGGCGGTGGGCGACGCGACCGAGATCGAGGCGTTGTCCTCGGCCCGGCGCGCCGCCGACCCCGACGCCCGGCCCGCCGCGTTGAGCAGCATCAAGGGCAACATCGGGCACACCAAGGCCGCGGCGGGTGTCGCCGGGCTCATCAAGGCGGTCATGGCGGTGCACCACCAGGTGATCCCGCCGGGCACCGGCCACGACAACCCGCACCCCCGGCTGCTCGACGGCGACGCCGCGCTCTACGTGCCGCGCACGGCCGAGCTGTGGCCCGCCGACCGACCGGTCCGCGCGGGTGTGTCGGCACTGGGCTTCGGCGGCATCAACACCCACATCACCGTGGAGCAGGCCGCCGCGGTGCGGCGGCGGACGGCGCTGGACGACCGGACGCGGGAAGTCGTGGCGGGCGGCCAGAACGCCGAGGTGCTCCTGCTCGACGCGCTGGACGCGGAGGAGTTGGGCCACGAGGCCGAGCGGCTGGCGGCGGTGGCGGCCAAGCTCGCCCAGGCCGAGCTGGGCGACCTCGCGGGCGCGCTGGCGTCCCGGTTGTCCGGTGGCGCGCTGCGCGCGGCGGTCGTGGTGACGAGCGCCCGGGACGCCGAGCGGGCGCTCACCCGCCTGGCCGAGCTGTGCGCCGAGGGGCGGACGCGTGCGCTGCTGCCCGAGGAGGGCGTTTTCCTGGGTCGGCCGACCGACGACCCGAAGCTGGTGTTCGCGTTCCCCGGCCAGGGTTCCCACCGCCCCGAGCCGGGCGCGTTCCGCCGCCGCTTCCCCGCCGCGTTCGCCGGTCGGGAGGCGCCGGTGCAGGGTGACCACGTGGCGACCGAGGTGGCGCAGCCGCGCATCGTCGCGGGTTCGCTCGCGGCCCTGGAGGTGTTGCGGGAGCTGGGTGTCGACGCCACCGCGGCGGTCGGGCACAGCCTCGGCGAGCTGACCGCGCTGCACTGGGGCGGCGCGCTCGCGGCGGACCGGGTGCTGGCGCTGGCCGCGGTGCGTGGCCGGGTGATGGCCGAGGCGAGCCGGGGCGGTGGGGCGATGGCGAGCCTGACCACCGGCCCCGAGCGGGCGCGCCGGCTCATCGGTGGCGAGGAAGTGGTGATCGCGGGCTACAACGGCCCGAGCCAGACGGTGGTCTCCGGTCCGGCGGACGCGGTGCGGCGGGTCTGCGCCGCGGCCGAGGCGGACGGGGTGACCGCGGTCCGGATCGCGGTGTCCCACGCGTTCCACTCCGACCTCGTCGCACCCGCGGCGGCGGCGATGGTGGGCCACTTGGCGGAGTTCGACTTCGACCGTCCACAGCGGACGGTGGTGTCCACGGTGACCGGCGACGTGCTCGACCCGGACGCCGACCTGCGCGACCTGCTGCGCGAGCAGATCGTGGGCGCGGTGCGGTTCCACGAGGCCGCCGCGCGGGCGGCGGACGGCGCGGACCTGGTGGTCGAGGTGGGGCCGGGCCGGGTGCTGAGCGGTCTGCTGGCCGAGGTGGCGCCGGACGTGCCCGCGCTCTCGACGGACGTGGACAGCCGGTCGCTGGCCCCGTTCCTCCAGGTGGTCGGCGCGGCGTTCGCGCTGGGCGCGCCGCTGCGGACCGACGTGCTGTTCGCCGGCCGCGCGCTGCGCCCGTTCCCGCTCGACGGCGGGATGACGTTCCTGGCGAGCCCGTGCGAAGCCGCGCCCGCCCTGGACACCGGCCGGGCGGAGGAGTTCGCCCCCGCGCCGATCGCGGAGGCCGTCGTCGCCGAGGGGTCGACGCTGGACCTGCTCCGCGACCGGGTGGCCGAGCGGGTGGAACTGCCCGTGGCGTCCATCGGTGCGGACACCCACCCGATGGACGACCTGCACCTCAGCTCGATCACCATCGGCCAGATCGTCAACGAGGTCGCCCGCAGCCGCGGCCAGGCCGCGTTGGCGACCGCGCCGAACTTCGCGACCGTGCGGCTGGGTGAACTCGCCGGGATGCTCGACGCCCTGGCCGAGACCGGGCGCGAGGAGGAGTCGCGTGGCGCGGTGCCCGGCGTCGCGGCGTGGGTCCGGGCGTTCTCGGTGGACCACGTCGACGCGGGACCGCTGCCGGCCGCGCCCGCCGCGGGCCGGTCGGGCGCCTGGGCGGTGTACGCGCCGCCGGACCACCCGCTGGCGCAGCCCCTGCACGCCGCGCTGGCCGGGGCGGGCATCGGGGACGGCGTGCTGCTGTGCCTGCCCGAGCGCGGTGACGGCCACGACGACCTGATCCTCGCGGCGGGCAAGGCCGCCGCGGCGGCCGGTGGCCGGTTCGTCGTGGTGGAGCAGCGCCTCGGCGCGGCGGGCCTGGCCAAGACGCTGCACCTGGAGCACCCGGAGGTCACGACCACCGTGGTCCGGCTCGCGGACGTGATGCCCGCCGACCCGGTCGCCGCGGGCGTGGCGGTGCGCCGCGTGGTCGCCGAAGCGGCGGCCACGACGGGCTTCGCCGAGGTGCGCTACGACGAATCCGGGGCACGCACGACACCCCGGTTGCGGGCGCTGCCCGTGCACGCGGAGGACGGCGCGGCGCAGGCCGCGCTCGGCCCGGACGACGTGCTGCTGGTGGCGGGCGGCGGCAAGGGCATCACGGCGGAGTGCGCGCTGGCGCTGGCGAAGGACTCCGGGGCGGCGCTCGCGCTGCTCGGCCGCGACGACCCGGCCGACCACCCGGAACTCGCGGCCAACCTGGCGCGGATGGACCTGGCCGGCGTCCGGTACCGCTACCTGCGGGTCGACGTGACGCGACCGGAGGCCGTGCGGGACGTCGTCGCGCGGGTCGGGGCGGAGCTGGGTCCGGTGACCGCCGTGTTGTACGGCGCGGGCCGCAACGAGCCCACCGGTCTGGCCGCGCTGACCCCGGACGAGCTCCGGCGCACCCTGGCGCCGAAGGTGACCGGGTTGCGCGCCGTGCTGGACGCCGTCGACGCGGAGCGCCTGCGGCTGCTGATCACGTTCGGCAGCGTCATCGGCCGGGCCGGGCTGCGCGGGGAGGCGCACTACGCCACGGCGAACGACTGGGCGACCGAGCTGACGCTCGACCACGGCCGGGCGCACCCGCACACCAGGGTGCTGGCCCTGGAGTGGTCGGTGTGGTCAGGCGCGGGCATGGGCGAGCGGCTGGGCGTCGTGGAGGCGTTGATCCGCGAGGGCATCACGCCGATCTCGGTGGAGGAGGGCCTGACCGTGCTGCGGCGCGTGCTCGCCGACCCCGCCGCCGGGCCGGTGCTGGTGATCAGCGGGCGCGCGGGCGACCTGCCCACGCTGGCGCTGGAGCGGCGGGAGCTGCCGCTGAAGCGGTTCCTGGACCGGGTGCTGGTGCACTACCCCGGTGTCGAGCTGGTCACCGAGGCCGACCTGTCCGCGTCCGGCGACCTCTACCTGGCCGACCACGAGCTGGACGGCGACCTGCTGTTCCCCGCCGTGTTCGGGATGGAGGCGATGGCGCAGGTGGGTTCCGCGCTGGTCGCCGCCGACGGGCCGCCGGTGCTGGAGGACGTCGAGTTCCCCCGGCCGATCGTGGTGCGGCCGGGTGGGCAGACCACCGTGCGGGTCGCGGCGCTGGTGCGGGAAGCGGGCGTCGTGGACGTGGTGCTGCGCAGCGAGGAGACCGGTTTCGCGGCCGACCACTTCCGCGCCCGGCTGCGGTTCCCCCGCCCCGGGCTGACCGGTGGCGAGCCCGTGCCCGACCTGCCCGCCGTGCCGGTCGACCCGCACACCGCGCTCTACGGCGGGATGCTGTTCCAGGGCAAGCGGTTCCAGCGGCTCCAGGCGTACCGGAAGGTGAGCGCGCGGCACGCGGTGGCCGAGCTGTCCACGACCGCGCCCGGACCGTGGTTCGCCGCGTTCCTGCCGCAGGCGCTGGAACTGGCCGACCCCGGCGTGCGGGACGCGGTGATGCACTCGCTCCAGTGCTGCGTCCCGGACGCGACGCTGCTGCCGCGCGGTATCGAGGCGCTGCACCTGGCCGCCCCGTCCGACCTGGACACCGGGCACGTCGTGGTCGACGCGCGGGAGCGATCGCAGGACGGGGACAGCTACACCTACGACATCGACGTCCGCACGCCCGCGGGTGAGCTGGTGGAGCGCTGGCAGGGGTTGACCCTGCGGGCGGTGCGCCGCGGCTCGGGCAGCGGACCGTGGGTGCCCGCGATGCTCGGGCCCCACCTGGAGCGTGCGCTGGAGGACGTGCTCGGCCGCCGGTTGGCGGTCGTGGTGGAACCCGGCACCAGCGGTCGGGGCGGCGGTGGCACCGAGGTGGCGCTGAGCCGGGCCCTCGGCCGACCCGCCGGGGTGCGCTACCGCCCGGACGGCAAGCCGGAGGTGGCGGGCGCGCAGGTGTCCGCCGCGCACACCGGCGGGCTGACCTTCGCCGTCGTGGGCGGCGGTCGCCTCGGGTGCGACGCGGAGTCCGCGGTCGAGCGATCCGCGGAGGACTGGGCCGCGTTGCTGGGGCGCGACCAGGAAGCGGTCCGCGACCTGGTGGCGGCCGAGACCGGCGAGCCGGCCACCGTGGCGGCCACCCGGGTGTGGTCCGCGCTGGAGTGCCTGCGCAAGACCGGCGCCACCACGCAGGCGCTGACCGTGACGGACGTGCGGCCCGGCGGTTGGGTCGTGCTGTCGGCGGGCAACGCCTTGGTCGCCACCTGGGCGACCACCGTGGCGGGGCAGGCCGGGCCGACCGTGTTCGCCGTCCTCGTCGGGGAGGGGAGCTGA	MNTERIAVVGIGLRYPDADSPDQLWDNVLARRRAFRRLPDERLNHADYWSADPSAPDRLYSATAAVLRDFEFDRARFKVAGSTFRVTDMTHWLALDVASRALADAGFPDGEGLPNESTGVFVGNSLTGEFVRANMMRLRWPYVRRTVAAALAGKGWGDGESADFLRELEAAYKAPFPPTDEDSLAGGLSNTIAGRVCNHFDLRGGGYTVDGACSSSLLSVVTAANALTKGTLDVAVAGGVDLSLDPFELVGFAKTGALATGEMKVYDRDSNGFWPGEGCGMVVLMRESEALRRGLRVYAVIPGWGVSSDGKGGITRPEAGGHRLAMARAYALAGYGVESVSYFEGHGTGTAVGDATEIEALSSARRAADPDARPAALSSIKGNIGHTKAAAGVAGLIKAVMAVHHQVIPPGTGHDNPHPRLLDGDAALYVPRTAELWPADRPVRAGVSALGFGGINTHITVEQAAAVRRRTALDDRTREVVAGGQNAEVLLLDALDAEELGHEAERLAAVAAKLAQAELGDLAGALASRLSGGALRAAVVVTSARDAERALTRLAELCAEGRTRALLPEEGVFLGRPTDDPKLVFAFPGQGSHRPEPGAFRRRFPAAFAGREAPVQGDHVATEVAQPRIVAGSLAALEVLRELGVDATAAVGHSLGELTALHWGGALAADRVLALAAVRGRVMAEASRGGGAMASLTTGPERARRLIGGEEVVIAGYNGPSQTVVSGPADAVRRVCAAAEADGVTAVRIAVSHAFHSDLVAPAAAAMVGHLAEFDFDRPQRTVVSTVTGDVLDPDADLRDLLREQIVGAVRFHEAAARAADGADLVVEVGPGRVLSGLLAEVAPDVPALSTDVDSRSLAPFLQVVGAAFALGAPLRTDVLFAGRALRPFPLDGGMTFLASPCEAAPALDTGRAEEFAPAPIAEAVVAEGSTLDLLRDRVAERVELPVASIGADTHPMDDLHLSSITIGQIVNEVARSRGQAALATAPNFATVRLGELAGMLDALAETGREEESRGAVPGVAAWVRAFSVDHVDAGPLPAAPAAGRSGAWAVYAPPDHPLAQPLHAALAGAGIGDGVLLCLPERGDGHDDLILAAGKAAAAAGGRFVVVEQRLGAAGLAKTLHLEHPEVTTTVVRLADVMPADPVAAGVAVRRVVAEAAATTGFAEVRYDESGARTTPRLRALPVHAEDGAAQAALGPDDVLLVAGGGKGITAECALALAKDSGAALALLGRDDPADHPELAANLARMDLAGVRYRYLRVDVTRPEAVRDVVARVGAELGPVTAVLYGAGRNEPTGLAALTPDELRRTLAPKVTGLRAVLDAVDAERLRLLITFGSVIGRAGLRGEAHYATANDWATELTLDHGRAHPHTRVLALEWSVWSGAGMGERLGVVEALIREGITPISVEEGLTVLRRVLADPAAGPVLVISGRAGDLPTLALERRELPLKRFLDRVLVHYPGVELVTEADLSASGDLYLADHELDGDLLFPAVFGMEAMAQVGSALVAADGPPVLEDVEFPRPIVVRPGGQTTVRVAALVREAGVVDVVLRSEETGFAADHFRARLRFPRPGLTGGEPVPDLPAVPVDPHTALYGGMLFQGKRFQRLQAYRKVSARHAVAELSTTAPGPWFAAFLPQALELADPGVRDAVMHSLQCCVPDATLLPRGIEALHLAAPSDLDTGHVVVDARERSQDGDSYTYDIDVRTPAGELVERWQGLTLRAVRRGSGSGPWVPAMLGPHLERALEDVLGRRLAVVVEPGTSGRGGGGTEVALSRALGRPAGVRYRPDGKPEVAGAQVSAAHTGGLTFAVVGGGRLGCDAESAVERSAEDWAALLGRDQEAVRDLVAAETGEPATVAATRVWSALECLRKTGATTQALTVTDVRPGGWVVLSAGNALVATWATTVAGQAGPTVFAVLVGEGS	MPGIKVFGETVLRGSVRVSGAKNATTKLLVASLLSDQRTILKNVPNIEDVRQTVDLCRVLGAIVEWDQQAQVIEIHTPRILLSKVPPQFSCVNRIPILLLGALLRRCPYGIFVPILGGDAIGPRTLHFHLEGWKKLGAEIVISDEGYWASAPNGLVGAHITLPYPSVGATENLILASVGAQGRTIIKNAALEVEIIDLIVFLQKAGVEITTDNDKTIEIFGCQDFYSVEHFIIPDKIEAASFGMAAVVSQGRIFVEQARHEHMIPFLKVLRSIGGGFSVHENGIEFFYDKPLKGGVLLETDVHPGFITDWQQPFAVLLSQSEGCSVIHETVHENRLGYLKGLVKMGAHCDLFHECLSAKSCRYSTGNHPHSAVIHGPTPLQATDLVIPDLRAGFAYVMAALIAEGGASWIENTEMLDRGYTDWRGKLERLGAKVLARDAVSVYV	431.98	gnl|BL_ORD_ID|2351|hsp_num:0	2291			567	765	fosfomycin
BGC0000081.1|Kedarcidin_20 # 25759 # 26202 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=6bp;gc_cont=0.714	BGC0000081.1|Kedarcidin_20 	25759	26202	+	Loose	750	25.409	LRA-10	32.35	3002489	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase	ATGCCGAGCTACTACGAGATCCGGCACACCGTCGGGTTCGAGGAGACCAACCTCGTCGGCAACGTCTACTACGTGAACTACCTGCGCTGGCAGGGCCGGTGCCGGGAGATGTTCCTGCGCGACCACGCGCCGGGCGTGCTGGCCAGGGTGATGGACGACCTGAAGCTGTTCACCCTGAAGGTGGAGTGCGAGTTCTCCGCCGAGCTGGCCGCGTTCGACGAGCTGTCGGTGCGGATGAGCCTGGAGGACCTGACCCGGACGCAGATCCAGGTCGGCTTCGACTACGTCCGGCTCGGCGCGGGCGGTGAGGAGCCGGTCGGGCGGGGCAGGCAGCGGATCGCGTGCATGACGGGCGACGGCGCGGCGGTCGCGCCCGTGCCGGTGCCCGACGAGCTGCGCACCGCGCTGGCGGCGTACCGGCCCGCGCCGGGGAGGGCGGGGTGA	MPSYYEIRHTVGFEETNLVGNVYYVNYLRWQGRCREMFLRDHAPGVLARVMDDLKLFTLKVECEFSAELAAFDELSVRMSLEDLTRTQIQVGFDYVRLGAGGEEPVGRGRQRIACMTGDGAAVAPVPVPDELRTALAAYRPAPGRAG	MAIAILSSCFAPLASRAADDSARIRAIVDQAIRPVMAEHDVPGMAVAVTVDGQPFVFNYGVASRESNTPVSDATLFELGSISKTFAATLASYAQVTGKLSLDDHPGKYMPQLKGSAIDKATLLNLGTYTAGGLPLQFPDDVSDQQMASYFQHWKPKAAPGVQRTYSNPSLGLFGHLTSLALKSRFTDALETNVLTQMGMKSTYVHVPQSAMANYAWGYDQANKPGRMNPGVLADGIYGIRSTAADMIRYVQANIAPGKLETPLRRAVEGTHVGYFKVGGMVQGLGWEQYPYPVSLQQLQAGNSTTMAWEANPAQKLTPPSVPSGATLFNKTGSTSRFGAYVAFVPEKKIGIVILANKNIPGPDRIKAAHAILEQL	39.20	gnl|BL_ORD_ID|1915|hsp_num:0	2119			207	309	
BGC0000081.1|Kedarcidin_21 # 26199 # 26690 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=GGGGAG;rbs_spacer=6bp;gc_cont=0.758	BGC0000081.1|Kedarcidin_21 	26199	26690	+	Loose	500	30.0314	TEM-146	26.97	3001013	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	GTGACGGCGACCGCGGGACCGGTGTCGCTGCGCGAGGCGATGTCCCGGTTCGCCACCGGGATCGTCGTGCTGACCGCGGGCGGCGAGCACAGCCACGGGATGACGGCCAACGCGTTCAGCTCGGTCTCGCTCGACCCGCCGCAGGTGCTGTGCTGCGTGACCCGCACGGCCCGGATGCACCGGGCGATCACCTCGGCGGGGTGCTTCGCGGTCTCGGTGCTGAGCGCGGAGCAGGAGGCGACCGCCCGCTACTTCGCGGGCGGCCGGCGGCCCGACGGGGCGACCCAGTTCGACGCGGTGGACTGGGCGCCGGGCCCGTGCACCGGCGCGCCGCTGCTGGGCGGCGCGCTGGCGTGGCTGGAGTGCGAGCTGGCCGAGGCGCACGAGGGCGGCGACCACACCATCTTCGTCGGCCGGGTGCTCGGCTCGAACCGGGGGCCCGACCGGTCGGCGCTGCTGTACTTCGGCGGCGCGTACCACCGGTTGGCCTAG	MTATAGPVSLREAMSRFATGIVVLTAGGEHSHGMTANAFSSVSLDPPQVLCCVTRTARMHRAITSAGCFAVSVLSAEQEATARYFAGGRRPDGATQFDAVDWAPGPCTGAPLLGGALAWLECELAEAHEGGDHTIFVGRVLGSNRGPDRSALLYFGGAYHRLA	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLPDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSHGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	56.99	gnl|BL_ORD_ID|1066|hsp_num:0	1154			531	792	ampicillin
BGC0000081.1|Kedarcidin_23 # 28167 # 28589 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.712	BGC0000081.1|Kedarcidin_23 	28167	28589	+	Loose	1900	25.7942	TriC	27.08	3003681	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGACGTCCACACCCGAGAACACCGGGACCCAGGCCGACGGCGCCGCCGTCGCGGCGCTCACCCGGCGAGTGGTCGCCGCGTGGGCCTACCACGACGCCGAGGCGTTCGCCGGCGTGTTCACCGAGGACGGGACGATGATCCTGCCCGGTGTCTACTGCAAGGGCCGCGAGCAGATCGCGGCGCACATGGCGGACGCGTTCCGCAACCAGTACAAGGGCACCCAGGTCACCGGCACGCCGATCGACATCAGGTTCTTCGGCCCCGACAGCGGTGTGCTGCTCACGCAGGGCGGCGTGCTGAAGCCCGGCACCACCGAGGTGACCGAGGACAGCGCGATCCGCGCGTCGTGGGTCGTGGTGCGGCAGGACGGCGAGTGGCGGCTCGCCGCGTACCAGAACAGCCCCCGCGATGACCGCTGA	MTTSTPENTGTQADGAAVAALTRRVVAAWAYHDAEAFAGVFTEDGTMILPGVYCKGREQIAAHMADAFRNQYKGTQVTGTPIDIRFFGPDSGVLLTQGGVLKPGTTEVTEDSAIRASWVVVRQDGEWRLAAYQNSPRDDR	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	13.79	gnl|BL_ORD_ID|2004|hsp_num:0	2194			1848	1983	triclosan
BGC0000081.1|Kedarcidin_24 # 28579 # 29970 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.754	BGC0000081.1|Kedarcidin_24 	28579	29970	+	Loose	760	27.7202	tet(X3)	33.33	3004719	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACCGCTGAACGCGTGGTGGGCGACCGGGCGGTGGTGCTCGGCGGCAGCATGGCCGGGTTGTTGGCGGCCCGCGTGCTCGCCGACTCGTACGGCGAGGTGGTCGTGGTCGACCGGGACGGGTTGACGGGCACCACCGCGGCCCGGCGCGGCGTGCCGCAGGGGCGGCACGTGCACGGCCTGCTCGCCCGCGGCCAGCAGGTGCTGGACGAGCTGTTCCCCGGCTTCACCGAGGAGGCCGTCGCCGACGGCATCCCGACCGGCGACCTCGGTGAGCTGCGCTGGTTCTTCCACGGTCGGCGGCTGCGGCCCGAGCCCACCGGCCTGGTGTGCGTCTCCGCGACCCGGCCCCGGCTGGAGGCCCTGGTCCGCAACCGGGTCGCCGCGCTGCCGAACGTGCGGTTCCTGGAGCACCGCTCCGTGGACGGGCTGACCGCCACGCCGGACCGCCGGGCGGTCACCGGGGTGCGCGTGCGCGGCGAGGGGTCGGACGCCGCGGTGGAGGAGCTGACCGCCGACCTGGTGGTCGACGCGACCGGGCGTGGTTCCCGCACCCCGGCGTGGTTGTCCGAGCTGGGTTACGCCCGGCCGGAGGAGGACCGGATCCGCATCGACCTGAGCTACACCACGCGGATCTACCGCCCGCGGGACGGCCGGGCGCTGGTCGACGACCTGTCGATCAACCCGGTCTCGTCGCCGTCGCACCCGCGTGGCGCGTTCCTGTCCAGGATCGAGGACGGCTGCTACGTCCTCTCGCTCACCGGCGTGTTCGGCGACGCCGCGCCGACCGACCCGGAGGGGTTCCTGGACTGGGTGCGCTCCCTGCCGGTGCCCGACATCCACGAGGTGATCCGGGACGCGGAACCGCTGGGCGACCCGGTGCAGTTCCGCTACCCGCACAGCGTGCGGCGGCGGTACGAGCGGCTGACCGCGTTCCCGGACCGCCTGCTGGTCATGGGCGACGCGCTGTGCAGCTTCAACCCCGTGTACGGGCAGGGCATGACCGCCGCGGCGCTGGAGGCGGTCGAGCTGCGCGAGCACCTGCGGGCGGGCACGCCCCGGCCGCTGGAGTACCTGCGCGCGGTCGCCCGCGTCATCGACGTGCCGTGGGACATGTCGGCGGGCGGCGACCTCGCCTACCCGCAGGTGACCGGGCGGCGTTCGCTCAAGGTGCGGGTCGGCAACGCCTACATGGCGAAGGTCCAGGCGGCGGCGACCGGGGACGGCGCCATCACCAGGGCGTTCATGCGGGTGGCCGGCCTGGTCGACCCGCCGGGGTCGATGATGCGGCCGGGGATGGTGCTGCGCGTGCTGCGCGGCGCGCGGAAGGTCGGCCGGTCCCGCCCGGTGGACGGCCCGGTGGTCGCGGCCGGTGGGGCGCGGGCCGAGTGA	MTAERVVGDRAVVLGGSMAGLLAARVLADSYGEVVVVDRDGLTGTTAARRGVPQGRHVHGLLARGQQVLDELFPGFTEEAVADGIPTGDLGELRWFFHGRRLRPEPTGLVCVSATRPRLEALVRNRVAALPNVRFLEHRSVDGLTATPDRRAVTGVRVRGEGSDAAVEELTADLVVDATGRGSRTPAWLSELGYARPEEDRIRIDLSYTTRIYRPRDGRALVDDLSINPVSSPSHPRGAFLSRIEDGCYVLSLTGVFGDAAPTDPEGFLDWVRSLPVPDIHEVIRDAEPLGDPVQFRYPHSVRRRYERLTAFPDRLLVMGDALCSFNPVYGQGMTAAALEAVELREHLRAGTPRPLEYLRAVARVIDVPWDMSAGGDLAYPQVTGRRSLKVRVGNAYMAKVQAAATGDGAITRAFMRVAGLVDPPGSMMRPGMVLRVLRGARKVGRSRPVDGPVVAAGGARAE	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL	119.33	gnl|BL_ORD_ID|4801|hsp_num:0	3401			915	1041	tigecycline; tetracycline
BGC0000081.1|Kedarcidin_25 # 30019 # 31245 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGAGA;rbs_spacer=4bp;gc_cont=0.708	BGC0000081.1|Kedarcidin_25 	30019	31245	-	Loose	1900	28.4906	acrB	37.88	3000216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCACCGAACACCCCCGTGGCGCTGGACGTCAACGGGAGCGACATCCACGCCGAAGCCGCCGCCCTGCGCGCGCAGGCCCCGGCGGTGCGGGTCACCCTGCCCGGCGGGGTCACCGCGTGGTCGGTCACGAGCCACGCCGCGATCAAGTCGATCCTGACCGACCCCAGGGTGACCAAGAGCGCGCGCAACCACTGGCCCGACTTCATCGAGGGCCGCGTGCCCGGTGACTGGGAGCTGATCAGCTGGGTCGCCATGGACAACATGGTCACCGCGTACGGCAAGGACCACGTGCGGTTGCGAAGGCTGGTGGGCAAGGCGTTCACCCGCCGCCGCACCGAGTCGATCCAGCCGCGCGTGGTGGAGCTGACCGAGGGGCTGCTGGGCGCCCTGGCCGCGACGCCGCCGGGCGAGGTGGTGGACCTGCGCGAGCGCTTCGCCTACCCGCTGCCCGCCATGCTGGTCGCCGACCTGATCGGCATGTCCGAGCAGGCCCGCGCCGCCACGGCGAAGGTCATCGACATGATGGTGGACACCACCGTCACGCCGGAGCAGGCGCAGGCCGTCCTCCAGGGTTGGCGTGGCGCGATGTCCGACCTGATCGCCGAGAAGCGCCGCACGCCCGGCGACGACATCACCAGCGACCTGATCGCCGCGCGGGACGAGGACGGGTCGCGGTTGAGCGAGCAGGAGATGGCGGACTCGATCTTCGCCATCCTCGGGGCCGGCTCGGAGACCACGATCAACTTCTTCGACAACGCCATCACCGCGCTGCTGACCCACCCCGAGCAGCGCGACCTGGTGCTGTCCGGCCAGGCGTCGTGGGACGACGTCATCGACGAGACCCTGCGCGTGCAGTCGCCGCTCGCGAGCCTGCCGCTGCGGTACGCGGTGGAGGACATCCGGCTGGACGAGGTCACCATCCCGAAGGGCGACCCGATCCTGGTCAACTACGCCGCCGTGGGCCGCGACCCCGCGCTGCACGGCGGCACCGCCGACGACTTCGACATCACCCGGGCCGACAAGGAGCACCTGTCCTTCGGCCACGGGCCGCACTACTGCCTGGGTGTCGGGATCGCGCGCATGGTCGGCACCATCGGCCTGTCCACGTTGTTCGAGCGGTTCCCGGACATGCGGCTGGCCGTGTCCGTCGAAGAACTCCAGCCGCTGCCGACGTTCATCATGAACGGCCACCGGGCGCTGCCGGTCCGGCTGACCTCCGGGTGA	MAPNTPVALDVNGSDIHAEAAALRAQAPAVRVTLPGGVTAWSVTSHAAIKSILTDPRVTKSARNHWPDFIEGRVPGDWELISWVAMDNMVTAYGKDHVRLRRLVGKAFTRRRTESIQPRVVELTEGLLGALAATPPGEVVDLRERFAYPLPAMLVADLIGMSEQARAATAKVIDMMVDTTVTPEQAQAVLQGWRGAMSDLIAEKRRTPGDDITSDLIAARDEDGSRLSEQEMADSIFAILGAGSETTINFFDNAITALLTHPEQRDLVLSGQASWDDVIDETLRVQSPLASLPLRYAVEDIRLDEVTIPKGDPILVNYAAVGRDPALHGGTADDFDITRADKEHLSFGHGPHYCLGVGIARMVGTIGLSTLFERFPDMRLAVSVEELQPLPTFIMNGHRALPVRLTSG	MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH	38.89	gnl|BL_ORD_ID|1011|hsp_num:0	1104			2406	2601	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000081.1|Kedarcidin_26 # 31279 # 32433 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.736	BGC0000081.1|Kedarcidin_26 	31279	32433	-	Loose	400	31.9574	TxR	37.21	3005008	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCGCCGCTTCCGCATAGCCGTCCCCGAAGCCGACCTGGCGGATCTCCGCCGACGCCTGGCCGACACCCGCTGGCCGGACGAGCTGCCCGGCGTGGGCTGGTCCCGCGGCGCTCCCGCGGACTACGTGCGGGACCTGGCCGAGCACTGGCGCACTCGCTACGACTGGCGCGCCACCGAGGCGGAGCTGAACCGCCACCCGCAGTTCCTCACCGAGATCGACGGCGCGACGGTGCACCTGCTGCACGTCCGCTCCCCCGAGCCGGACGCCACGCCGCTGCTGCTCACCCACGGCTGGCCGGGTTCGGTCGCCGAGTTCCTGGACGTCATCGGCCCCCTCACCGACCCCCGCGCGCACGGCGGCGACCCGGCGGACGCCTTCCACCTGGTGATCCCGTCCATCCCGGGCTACGGGTTCTCCCGGCCGCTCACCCAGACCGGCTGGGACGTGCCGCGCATCGCCAACGCCTGGGCGGAGCTGATGCGCCGCCTCGGGTACGACCGCTACGTGGCGCAGGGCGGCGACGCCGGGTCCGTGATCTCCCTGGCCCTGGGCGCGATGCACCCCGACCACGTGCTCGGGGTGCACGTGAACATGCTCATGACGTTCCCCTCCGGCGACCCGGCGGAGATCGCCGGGCTGGACGCCGTCGAGCTGGAGCGGCTGGGTGCGCTCGGGCGGTTCGACCAGGAGCTGTCCGGCTACATGAAGGTCCAGGCCACCCGGCCGCAGACGTTGGCCTACGCCCTCACCGACTCGCCGGTCGGGCAGCTGGCCTGGATCGTCGAGCGGTTCCGGGACTGGACCGACTCGGCGGAGGCGCCCGAGGACGCGGTGCCCCGGGACCGGATCCTGGACACCGTGTCGATCTACTGGCTGACCGGTACGGCGGGTTCCTCGGCGCAGTTCTACTACGAGGGCGCCGAGGCGGTGCGTCGCGCCGCGGCGGGCGAGCCCGGTCCCCCGGTGCCCGTCCCGGTGGGCGTGGCGGTGTTCCCCAAGGACATCTTCCTGCCGGTCCGCCGGTTCGCCGAGCGGGACATCAGCACCATCACCCGCTGGACCGAGTTCGACCGGGGTGGCCACTTCGCCGCCCTGGAGCAACCCGAACGGCTCGTCGGCGACATCCGGGCGTTCGCCCGCTCCCTGGCCTGA	MRRFRIAVPEADLADLRRRLADTRWPDELPGVGWSRGAPADYVRDLAEHWRTRYDWRATEAELNRHPQFLTEIDGATVHLLHVRSPEPDATPLLLTHGWPGSVAEFLDVIGPLTDPRAHGGDPADAFHLVIPSIPGYGFSRPLTQTGWDVPRIANAWAELMRRLGYDRYVAQGGDAGSVISLALGAMHPDHVLGVHVNMLMTFPSGDPAEIAGLDAVELERLGALGRFDQELSGYMKVQATRPQTLAYALTDSPVGQLAWIVERFRDWTDSAEAPEDAVPRDRILDTVSIYWLTGTAGSSAQFYYEGAEAVRRAAAGEPGPPVPVPVGVAVFPKDIFLPVRRFAERDISTITRWTEFDRGGHFAALEQPERLVGDIRAFARSLA	MKVQKCKATIHRRSLDADPLLPLIGNSTCISELRNKLKKYAQCDAEVLIQGETGVGKGMCARIIHELSSRHIYPFVEVNCGAIPSGLIASELFGHEKGAFTGAISDRIGFIQKANKGTLFLDEIGDMPPDLQIHLLHFLESKQIHKVGADKIIDVDCRVIAASHVDLKSEVIQGGFREDLFYRQNILPLTIPPLRKRGEDTVILSERFLEELSNGKVQSMSPEVKKKLLKHKWPGNVRELRNVIQRAIVMCEDNTLHIADLGLDNNERQLLPSVEQIDLDYLLKAIEDNKHNMSAAARNLGISRTTLYRLIKKYNLPI	120.75	gnl|BL_ORD_ID|4724|hsp_num:0	3753			618	732	tetracycline
BGC0000081.1|Kedarcidin_27 # 32982 # 33701 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=AGAGG;rbs_spacer=6bp;gc_cont=0.700	BGC0000081.1|Kedarcidin_27 	32982	33701	+	Loose	500	24.6386	OXA-62	42.11	3001792	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGTGCGCGGGCAGCAGGATGGGGCGCGGTGGCGCGAGCGCGTCGTGCCCGAGCCGAAGGAGAACCCGGTGACCCTGCCGCGGACCGCGTCCCGCGCCGACTGGCTGGAGGCGCGCAAGTCGTTGCTGGCCAAGGAGAAGGAGCTGACCCGCGCGCGGGACGCGCTGAGCGCCGAACGCCGCCGGCTGCCCGTGGTGGAGGTCTCGCCGGACTACGCGTTCCAGGGCCCCGACGGGTCGGTGCGGCTGGTCGACCTGTTCGACGGCCGCCGCCAGCTCATCCTCTACCACTTCATGGGCGCGATCCCGGGTTACGGCTGGTGCCCGGTGTGCTCGTTCTGGATCGACAACGTCGGTCACCCGGCCCACTTCCACGCGCGTGACACGACGTTCGTCGTGGACTGCCCCGAGCCGTGGTCCGAGGTCGAGGCGTTCGTCGCGCGGATGGGCTGGACGGTTCCTTTCGTGTCGTCCCACGGCACTTCCTTCTACGAGGACTTCCACGTGGAACTGGGCGGCGCGCCGGGCGAGGTGGACGCGCCCGGCGTCAGCGTCTTCCTGCGCGAGGGCGACGCCGTCTTCCACTCGTACTCGACCTACCGGCGCGGCAGCGACCACCTCAACGGGACGTACGCCTATTTGGACCTCACCCCGCTGGGCCGTCAGGAGGACCACCTGGAGGACAAGATGGACTGGATGCGCCTCCACGACGAGTATTGA	MVRGQQDGARWRERVVPEPKENPVTLPRTASRADWLEARKSLLAKEKELTRARDALSAERRRLPVVEVSPDYAFQGPDGSVRLVDLFDGRRQLILYHFMGAIPGYGWCPVCSFWIDNVGHPAHFHARDTTFVVDCPEPWSEVEAFVARMGWTVPFVSSHGTSFYEDFHVELGGAPGEVDAPGVSVFLREGDAVFHSYSTYRRGSDHLNGTYAYLDLTPLGRQEDHLEDKMDWMRLHDEY	MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAALGRITERADWGKLFAAEGVKGTIVVLDARTQTYQAYDAARAEKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKPRRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRRYAQAKLNEVGYGNRTIGGAPDAYWVDDSLQISAREQVDFVQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDIGWWVGWIERDGNITSVAINIDMLSEADAPKRARIVKAVLKDLKLI	83.86	gnl|BL_ORD_ID|1293|hsp_num:0	1411			636	693	cloxacillin; oxacillin; cefalotin
BGC0000081.1|Kedarcidin_28 # 33828 # 36095 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.696	BGC0000081.1|Kedarcidin_28 	33828	36095	+	Loose	1280	50.0618	macB	31.96	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGTACGGCAACATCGAGGTCCGGTCCGCCCGCGAGAACAACCTCCAGGAGGTCTCGCTGGACCTGCCCAAGCGCAAGATCACGGTGTTCACCGGCGTATCCGGTTCCGGCAAGTCCTCACTGGCCTTCGGCACCATCGCGGCGGAGTCGCAGCGGCTGATCAACGAGACCTACCCGGGTTACGTGCAGGCGGTCATGCCGCGCTACGGCCGGCCCGACGTCGACTCGCTGGCGAACCTGTCCACCGCGGTCATCGTCGACCAGCAGCGCATGGGCGGCAACTCGCGCTCGACGGTGGGCACCGCGACCGACACGTACGCGTTGCTGCGCCTGCTGTTCTTCCGCGCCGGCTCGCCGCCGGTGGACAACCCGAAGGCGTTCTCCTTCAACGACCCGCAGGGCATGTGCCCCGAGTGCGAGGGCATCGGTCGGCGGTCCGCGCTGGACGTGGACGCGCTGGTGGACCGGTCGAAGTCCCTCCAGGAGGGCGCGATCCTCTGGCCCGCGTTCGCGGTCGGCACGACCTACTGGCGCTTCTTCATCATGTCCGGCCTGTTCGACAACGACAAGAAGCTGGCCGACTACACCGCGGACGAGTGGGACGCCCTGCTCAACCTGCCGGAGAAGAAGATCACCGTCGAGGGGCCGGCGCGCACCAGCGGCAGCTTCACCTACGAGGGCCTGCTGCCGAAGTTCAAGCGGCTCTACGTGAGCAAGGGCGCGGACCACGTCCAGCCCAAGCTCCGCGACGCCTACGAGCGCGTGGTGACCACCGCGCCCTGCGACGCCTGCGACGGCAGCCGCCTCGGCCCGGCGGCGCTGGCGTGCCGCCTCAACGGCCGCAGCATCGCCGAGTGCGTCGCGATGGAGGTCGAAGAGCTGGTCGGGTTCGTGCGCGCCGTCGACAACCCGACCGTCGCGCCCGCCGTGGCGTCGCTGGTGGCCCGGCTGACCGAGCTGGAGCGGCTCGGCCTGGGCTACCTCAGCCTGAACCGGGAGACCTCCACGCTGTCCGGCGGCGAGTCGCAGCGCGTGAAGATGGTGCGGCACCTGGGTTCCAGCCTGGTCGACATCACCTACATCTTCGACGAGCCCACCGTCGGCCTGCACCCGCACGACATCAGCCGCCTCAACGAGCTGCTGTGCCACCTGCGGGACAAGGGCAACACCGTCCTGGTGGTGGAGCACAAGCCCGAGGTCATGGCGATCGCCGACCACGTCGTGGACATGGGTCCCGGCGCCGGGCGCAAGGGCGGGCAGGTCGTCTTCGAGGGCACGTTCGCCGAGCTGGCGAAGTCCGGCACGCTCACCGGGCGGCACCTCAGCAGCCGCCAGGAGGTCAAGCGCACGCCGCGCGAGCCCACCGGGGCGCTCACCATCCGCAATGCCTCGCTGCACAACCTGCACGACATCAACGTGGACATCCCCACCGGCGTGCTCACGGTCGTGACGGGTGTCGCCGGCGCGGGCAAGAGCACGCTCATCCGGGGCTGCCTGCTGCGCAAGTACCCGGAAGCGGTGTTCATCGACGACAGCGTGTCCCGCGGGTCGCGGCGCTCCAACCCGGCGACGTTCACCGGCATCCTCGAGCCGATCCGCAAGGCGTTCGCCACCGCGAACAAGGTCAGCCCCGCGTTGTTCAGCGCCAACTCCGAGGGCGCGTGCCCGGAGTGCAAGGGCCTTGGCCTGATCTACACCGACCTCGCGCACCTGGAGCAGGTCGCGACCGTGTGCGACACGTGCGAGGGCAGGCGGTTCAGCGCCGACGTGCTGCGGCACACCCTGCGCGGGCGCGACATCAGCGAGGTGCTGGAGCTGTCCGTCGTGGACGCGCTGGAGTTCTTCACGGAGAAGCCCGTCGTGAAGGCGCTGAAGGCGCTCGACGACGTCGGCCTGGGCTACATCACGCTGTGGCAGCCGGTCAGCACGATGTCCGGCGGCGAGCGGCAGCGGCTCAAGCTGGCCAACGAACTCGGCCGCAAGTCGGGTGTCTACGTGCTGGACGAGCCGACCAGCGGCCTGCACATGAACGACGTGGACAACCTGATCGGCCTGTTCGACCGCCTGGTGGACAACGGCAACACGGTGGTCGTGATCGAGCACAACCTCGACGTGATCGCCCGCGCCGACTGGGTCATCGACGTCGGCCCCGGCGCCGGTCACCGCGGTGGCCGGATCGTGTTCGAGGGCACGGTCGCGCAGATGGCCGACAGCCCGGACTCGGTGACCGGCGACTTCCTGCGCCGCCGGGCGGAACTGGTCGGCTGA	MYGNIEVRSARENNLQEVSLDLPKRKITVFTGVSGSGKSSLAFGTIAAESQRLINETYPGYVQAVMPRYGRPDVDSLANLSTAVIVDQQRMGGNSRSTVGTATDTYALLRLLFFRAGSPPVDNPKAFSFNDPQGMCPECEGIGRRSALDVDALVDRSKSLQEGAILWPAFAVGTTYWRFFIMSGLFDNDKKLADYTADEWDALLNLPEKKITVEGPARTSGSFTYEGLLPKFKRLYVSKGADHVQPKLRDAYERVVTTAPCDACDGSRLGPAALACRLNGRSIAECVAMEVEELVGFVRAVDNPTVAPAVASLVARLTELERLGLGYLSLNRETSTLSGGESQRVKMVRHLGSSLVDITYIFDEPTVGLHPHDISRLNELLCHLRDKGNTVLVVEHKPEVMAIADHVVDMGPGAGRKGGQVVFEGTFAELAKSGTLTGRHLSSRQEVKRTPREPTGALTIRNASLHNLHDINVDIPTGVLTVVTGVAGAGKSTLIRGCLLRKYPEAVFIDDSVSRGSRRSNPATFTGILEPIRKAFATANKVSPALFSANSEGACPECKGLGLIYTDLAHLEQVATVCDTCEGRRFSADVLRHTLRGRDISEVLELSVVDALEFFTEKPVVKALKALDDVGLGYITLWQPVSTMSGGERQRLKLANELGRKSGVYVLDEPTSGLHMNDVDNLIGLFDRLVDNGNTVVVIEHNLDVIARADWVIDVGPGAGHRGGRIVFEGTVAQMADSPDSVTGDFLRRRAELVG	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	117.24	gnl|BL_ORD_ID|446|hsp_num:0	487			366	654	erythromycin
BGC0000081.1|Kedarcidin_30 # 37513 # 39054 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=9bp;gc_cont=0.691	BGC0000081.1|Kedarcidin_30 	37513	39054	-	Loose	1900	34.6538	MexI	26.62	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGAATGCGGACGTCTCCGCGCGCCTGCCGCTCACCGGGGCCGAATACCTCGAATCCCTGCGGGACGGCCGAGAAGTCTGGATACACGGGGAACGGGTGGCGGACGTGACCGAGCACCCGGCATTCCGGAACAACGCGCGGACCGTCGCCGGGCTGTACGACGCCCTGTGGGACTCGCCCGAGCGGGACGTGCTCACCACGACCACCGACACCGGCAACGGCGGGTTCACCCACCCGTTCTTCCGGCCGCCCGCGGACACCGGCGAACTGCGTGCCGGGCGCGACGCTATCGCCGCCTGGCAGCGCCGCTGCTACGGCTGGCTGGGCCGTTCCCCCGACTACAAGGCTTCCTTCCTGGCCACGCTCGGCGCGCACGCGGACTTCTACGAGCCGTTCGCGGACAACGCCCGCACGTGGTACCGCCGTTGCCAGGAACGGGTGCTGCACGTCAACCACGCGCTGGTGCACCCGCCGGTGGACCGGCACAAGCGGCCCGAAGAGGTCTCCGACGTGTACGTGCACGTCGACCGGGAGACCGACGCGGGTCTCGTGGTCAGCGGCGCCAAGGTGGTCGCCACCGGTTCCGCGCTGACCAACTACAACTTCATCGCGCACCACGGCCTCCGGGTGCGGGAAAAGAACTTCGCGGTGGTCTTCATGGCGCCGATGGACATCCCCGGCGTGAAGCTGTTCTGCCGCGCCTCGTACGAGTTGGCCGCGGCGACCACCGGTAGCCCGTTCGACTACCCGTTGGCCAGCCGGATGGACGAGAACGACGCGATCATCGTGTTCGACCAGGCGCTGATCCCGTGGGAGAACGTGTTCGTCTACGGCGACCTGGACAAGGCGAACACGTTCTTCCACAATTCCGGCTTCATGCCGCGGTTCGCACTGCACGGCGCGACCCGGCTCGGCGTCAAGCTCGATTTCATCTGCGGCCTGATGCTCAAGGCCGTGCAGATCAACGGCACCGACGACTTCCGCGGCGTGCAGGGCAACATCGGCGAACTGGTGGCCCTGCGGCACATGATCTGGGCGCTGTCCGACGCGATGATCGCGGGCGCGACGCCGTGGGCCGAGGACTACGTGCAGCCCAACCAGGAGTACGCCCTGGCCTACCGGACGCTCGCGCCCGGCGTGTACGGGCGGATGCGGGAGATCGTCCAGAACACCGTGGGCAGCGGGTTGATCTACCTCAACTCCGGCGTCGCCGACTTCCACAACCCGGAGGTGCGGCCCTACCTGGACCGGTACCTGCGCGGCTCGCACGGCCACACCGCCGAGCAGCGGGTGAAGGTGATGAAGCTGCTGTGGGACGCGGTGGGCAGCGAGTTCGGCGGTCGGCAGGAGCTGTACGAGCGCAACTACGCGGGCAACCCGGACGACAACCGGGCGCAGGCGCTGCGGGTGGCCCAGCGCTCCGGCGTCACGGACGGGATGCTGGAGCTGGTGGACCGGTGCCTGTCCGAGTACGACCTGAACGGGTGGACCACGCCCGGCATGGTCGACCCGGACCCGCGGCCGGGGGTGGCGGGATGA	MPNADVSARLPLTGAEYLESLRDGREVWIHGERVADVTEHPAFRNNARTVAGLYDALWDSPERDVLTTTTDTGNGGFTHPFFRPPADTGELRAGRDAIAAWQRRCYGWLGRSPDYKASFLATLGAHADFYEPFADNARTWYRRCQERVLHVNHALVHPPVDRHKRPEEVSDVYVHVDRETDAGLVVSGAKVVATGSALTNYNFIAHHGLRVREKNFAVVFMAPMDIPGVKLFCRASYELAAATTGSPFDYPLASRMDENDAIIVFDQALIPWENVFVYGDLDKANTFFHNSGFMPRFALHGATRLGVKLDFICGLMLKAVQINGTDDFRGVQGNIGELVALRHMIWALSDAMIAGATPWAEDYVQPNQEYALAYRTLAPGVYGRMREIVQNTVGSGLIYLNSGVADFHNPEVRPYLDRYLRGSHGHTAEQRVKVMKLLWDAVGSEFGGRQELYERNYAGNPDDNRAQALRVAQRSGVTDGMLELVDRCLSEYDLNGWTTPGMVDPDPRPGVAG	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	49.85	gnl|BL_ORD_ID|4683|hsp_num:0	1647			1881	2259	acriflavine; tetracycline; norfloxacin
BGC0000081.1|Kedarcidin_31 # 39289 # 40290 # 1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=AGAGGG;rbs_spacer=4bp;gc_cont=0.734	BGC0000081.1|Kedarcidin_31 	39289	40290	+	Loose	500	30.0314	chrB	31.65	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGGAGAACGACCAGATGAGTTCGAAGCTGTGGGCGATGGCGCGTCTCGCGACGCCCATGGCCGTCCGGGTGGCGGCGACGCTGCGGCTGGCCGACCACGTGGCGGCCGGGCGTGACCGCGCGGCGGACCTGGCCGCCGCGGCGGGCGCGGACGCCGACGCGGTGGAGCGCTTGATGCGCTACCTCTCGGTGCGCGGGCTGTTCGACCGCGACGACACCGGTCGGTACACCCTGACGCCGCTCGGCGCCGCGCTGCGCGACGACCACCCGTCGCGGTTGCGGCCCCGGTTGGACGTCGAGGGCTCGCTCGGCCGGGCCGAGCTGTCCTTCGCGCAGCTGCTGCACTCCATCCGCACGGGGGAGGCGTCGTTCCACCTCCAGTTCGGACGGACGTTCTTCGAGGACTGGGCGGCCGACCCGGAGCGGGCCGAGGACTTCAACAAGCTGACGTCCGACATGGAGTCGCGTTCGCCGGACATCGTCGCGGGCTACGACTGGGAGTCCCTGGGCTCGGTGGTCGACGTCGGCGGCGGCAACGGCGCGCTGATGCTGGCCCTGCTGCGCAAGTTCCCGACGTTGCGCGCCACGGTGCTGGAGATGCCGGACAACTCCGAGCCCGCGCGCAAGGCCGTCGCCGAAGCCGGTCTCGGCGACCGGTGCGACGTGGTGTCCCGCAGCTTCTTCGAGCCGCTGCCCGCCGGTGCGGGTGGCTACGTGATGTCGTTCGTGCTGCACAACTGGGGCGACGAGCAGGCACGCGCGCTGCTGCGGCGCTGCGCGGAGGCGGCCGGCGAGGACGGCGTCGTCCTGGTGGTCGAGCAGACCGGTCCGCACGGTGCGGCCACGCACACCGGGATGGACCTGCGGATGCTCGTCGTGACCGGTGGGAAGGAGCGGACCGCCGAGGACATGGGCGAGCTGGCGGCCGAGGTCGGCCTGCGGATCGCCGCGGTGCACCCGGCGGGCGCGTTCTCCATCGTCGAGATGCGCGCCGCGCGGTGA	MENDQMSSKLWAMARLATPMAVRVAATLRLADHVAAGRDRAADLAAAAGADADAVERLMRYLSVRGLFDRDDTGRYTLTPLGAALRDDHPSRLRPRLDVEGSLGRAELSFAQLLHSIRTGEASFHLQFGRTFFEDWAADPERAEDFNKLTSDMESRSPDIVAGYDWESLGSVVDVGGGNGALMLALLRKFPTLRATVLEMPDNSEPARKAVAEAGLGDRCDVVSRSFFEPLPAGAGGYVMSFVLHNWGDEQARALLRRCAEAAGEDGVVLVVEQTGPHGAATHTGMDLRMLVVTGGKERTAEDMGELAAEVGLRIAAVHPAGAFSIVEMRAAR	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	118.93	gnl|BL_ORD_ID|274|hsp_num:0	305			270	639	tylosin; chalcomycin; mycinamicin
BGC0000081.1|Kedarcidin_32 # 40331 # 41479 # 1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=GGGGAG;rbs_spacer=7bp;gc_cont=0.731	BGC0000081.1|Kedarcidin_32 	40331	41479	+	Loose	400	28.1054	vatF	24.83	3003744	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	GTGATCAACGTCTTCCAGCCGTCGCTGGGTGAGCGCGAACTGGCCGCGGTGGCCGAGGTGTTCGCGGGCAACTGGCTCGGCAAGGGCCCGCGCACGGCCGGGTTCGAGCGGGACTTCGCGGCGCACATCGGCGTCGAGGCGGAGCGGGTCGTCACGACGAACTCGTGCACCGAGGCCACCTTCATCGCGATGGACCTCGCCGGGGTCGGCGAGGGCGACGAGGTGGTGCTGCCGACGGTCAGCTTCGTCGGCGCGGGCAACGCCGTGGCCGCGCACGGCGCGCGCCCGGTCTTCTGCGACGTCGACCCGGCCACCCTCAACGCGACCGTCGACGACATCGAGGCCGCCCTGACGCCACGCACCAAAGCCGTGCTGCTGCTGCACTACGGCGGCTACCCCGGCGACGTGGTGGACATCGCGGCGCTGTGCCGCGACCGGGGCGTGCTCCTCATCGAGGACGCCGCGGCGGCCGTGGCGTCCGGTGTGGACGGCCAGGCGTGCGGCACCTTCGGCGACATCGGCGTGTGGAGCTTCGACTCGCAGAAGATCGTCGTCGCGGGTGACGGCGGCGCGTTGTCCGCCCGGGACCCGGAACTGGTCGCCCGCGCGGGCAAGCTCGCCTACTTCGGCCTGGAGCAGTTCAGCGGCTACAGCCAGGCCAAGACGACGTCGACGCGGTGGTGGGACTTCGACATCTCGTCGTTCTCCCGCCGCTCCATCATGAACGACGTCCAGTCCGCGATGGGCGCGGTGCAGCTGCGGCGGCTGCCGGAGTTCCTGGCCCGCCGCGCGGAGGTCGTCGCGCACTACGACCGCGAACTGGCCGACGTGCCGGGCGTGCTGCTCCCGCCCGCGCTGCCGCGGGGTCACCGCGGCTCGCAGTACCTGTACTGGCTGCGGCTCGACGCCCGCATCCGCGACCAGGTCGCGCGCGACCTCTACGACCGGGGCGTCTACACCACGTTCCGGTACCCGGCGCTGCACCGGGTCGCCGCCTACGGCTGGACCGAGCCGCTGCCCAGGGCGGAGGAGGCGGCGGAGCGCACGCTGTGCCTGCCGCTGCACCAGGCGTTGTCCGACGACGACGTCCAGACCGTGGTGGACGCGGTGCGCGACTCGGTGTCCCGCCGGTCCGGTGGGGGCGCGTGA	MINVFQPSLGERELAAVAEVFAGNWLGKGPRTAGFERDFAAHIGVEAERVVTTNSCTEATFIAMDLAGVGEGDEVVLPTVSFVGAGNAVAAHGARPVFCDVDPATLNATVDDIEAALTPRTKAVLLLHYGGYPGDVVDIAALCRDRGVLLIEDAAAAVASGVDGQACGTFGDIGVWSFDSQKIVVAGDGGALSARDPELVARAGKLAYFGLEQFSGYSQAKTTSTRWWDFDISSFSRRSIMNDVQSAMGAVQLRRLPEFLARRAEVVAHYDRELADVPGVLLPPALPRGHRGSQYLYWLRLDARIRDQVARDLYDRGVYTTFRYPALHRVAAYGWTEPLPRAEEAAERTLCLPLHQALSDDDVQTVVDAVRDSVSRRSGGGA	MEDKPILGPDPQCKHPMVGFSQVCFIKNTTQNPNIIIGDYTYYDDPQDSENFERNVLYHYPFIGDKLIIGKFCALAHGVKFIMNGANHKMSGLSTYPFNIFGNGWERVAPSRDELPYKGDTHVGNDVWIGYDVLIMPGVTIGNGAIISSRSVVTRDVPAYSVVGGNPATLIKNRFSAEVIGKLQTIAWWDWPIDAISRNLHLIVAGDIEALARAASEIDHT	172.85	gnl|BL_ORD_ID|2047|hsp_num:0	2260			165	597	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
BGC0000081.1|Kedarcidin_33 # 41479 # 42225 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.742	BGC0000081.1|Kedarcidin_33 	41479	42225	+	Loose	400	40.0466	Erm(30)	28.18	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGCCGTGGGCAGCACCTCGGTGTACGGCGACGCGTTGGGCGAGGTCTACGACCTGTTCTACCGGGGGCGTGGCAAGGACTTCGCGGCCGAGGCGGAGTGGGTGCGCCGGGTGGTGCGCGAGCGGCGGCCGGGCGCGCGGTCGCTGCTGGACGTCGCCTGCGGCACCGGTGAGCACCTGGCGCACCTGGTCGAGCACTTCCCGGACGCGGCGGGTGTCGAGCTGTCACCGGCGATGCGAGCGGCGGCCGAGCGCAAGCTGACCGCCACACCGGTGCACCAGGCCGACATGTTCGACTTCGACCTGGGACGGGTGTTCGACGCGGTGTGCTGCCTCACCGGTTCGATCGCGTACGCGGCCGACACCGCGGAGCTGGCACGCGCGGTCCGCGCGATGGCGCGGCACCTGCCGGTCGGCGGCGTGCTCGTGATCGACCCGTGGTGGTCGCCCGGGACGTTCCTCGACGGGCACATCGCCCACGACGTGGTCGAGGGGGAGGGCCGGACGGTGGTGCGGTTGTCCCGCTCGCACCGGATCGGCGACGTGTCCCGGCACGAGGCGCACTACCTCGCCGCGGACGCGACCGGTGTGCGGCACTTCAGCCAGGTGCAGGACCTCACCCTGTTCCCGGCGGAGGACTACCTCGCCGCCCTGGCCGCCGCGGGCTGCGAGCCCGAGCACCTCACCGACGTCGGCCAGCCCCGGCGCGGCCTGTTCGTCGGGGTGCGCCGGGAGGGCGGGCGATGA	MAVGSTSVYGDALGEVYDLFYRGRGKDFAAEAEWVRRVVRERRPGARSLLDVACGTGEHLAHLVEHFPDAAGVELSPAMRAAAERKLTATPVHQADMFDFDLGRVFDAVCCLTGSIAYAADTAELARAVRAMARHLPVGGVLVIDPWWSPGTFLDGHIAHDVVEGEGRTVVRLSRSHRIGDVSRHEAHYLAADATGVRHFSQVQDLTLFPAEDYLAALAAAGCEPEHLTDVGQPRRGLFVGVRREGGR	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	73.81	gnl|BL_ORD_ID|1123|hsp_num:0	1224			39	360	narbomycin; methymycin; pikromycin
BGC0000081.1|Kedarcidin_34 # 42222 # 42953 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.721	BGC0000081.1|Kedarcidin_34 	42222	42953	+	Loose	450	28.1054	tsnR	45.0	3003060	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (A1067)	ATGACCTACACCGAGCAGTTCGCCGAGATCTACGAGTTCATCTACCAGGGGCGGGGCAAGAGCTGGCCCGCGGAAGCCCACGAGGTGGACCGCATCATCCGCTCCCGCCGCCCGGACGTGGCGTCGTTGCTGGACGTCGCGTGCGGCACGGGCGCACACCTGGAGACGTTCGCGTCGCTCTACCGCGAGGTGGCGGGACTGGAGATCGCCGAGCCCATGCGGGAGCGGGCGAGCCGCCGGCTGCCGGGCGTGCCCGTGCACGCGGGCGACATGCGCGACTTCCGGTTGGGGCGCACCTTCGACGCGGTCACGTGCATGTTCAACGCGATCGGCTACGTGGGTTCGGTCGAGGAGCTGCGGGACGCCGTGCGGTGCATGGCCGAGCACACCGCGCCCGGTGGCGTGGTGGTCGTGGAACCGTGGTGGTTCCCGGAGAACTTCCTGGACGGGCACGTCGCGGTGGACAGCCGGCGCGTGGACGGCCTCGCGGTGGCGCGGGTGTCGCACACGACCCGGGAAGGCCGGCGGACGCGGCTGGAGGTGCGGTTCCTGGTCGGCGAGGCCGGGCACGGCATCCGGGAGTTCAGCCAGACGTCCGACCTCGTGCTGTTCACGCGGGACGAGTACCTGGCCGCGTTCGCCGACGCCGGGTGCCCCGCGGAGTACCTGCCCGACGGGTTGACCGGCCGGGGCCTGTTCGTCGGCGTTCGAGAGCGACCCGCCGGGTCGTAG	MTYTEQFAEIYEFIYQGRGKSWPAEAHEVDRIIRSRRPDVASLLDVACGTGAHLETFASLYREVAGLEIAEPMRERASRRLPGVPVHAGDMRDFRLGRTFDAVTCMFNAIGYVGSVEELRDAVRCMAEHTAPGGVVVVEPWWFPENFLDGHVAVDSRRVDGLAVARVSHTTREGRRTRLEVRFLVGEAGHGIREFSQTSDLVLFTRDEYLAAFADAGCPAEYLPDGLTGRGLFVGVRERPAGS	MANLDVIVDRSDPAVQRIVDVTKHSRSVVRTVLIEDIEPLTQSIRAGVEFTEVYGLDTVPFPGDLLAACEKRGIRVRLLSAAVANQVFKTEKKPKVFGIAKVPPAGRFADLESLSGDVVLLDGVKIVGNIGAIVRTRSALGAAGIVLVDSGLGTIADRRLIRASRGYVFSLPIVLATRDEALAFFRDGGMRPVVFEADGKLSIGELDGIDERLVLVFGSEKTGPSGEFAGVATESVSIPMNPAAESLNVSVSAGIALHRRARRNLSRPRG	90.00	gnl|BL_ORD_ID|148|hsp_num:0	49			516	636	thiostrepton
BGC0000081.1|Kedarcidin_35 # 43242 # 44525 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=AGAGA;rbs_spacer=3bp;gc_cont=0.734	BGC0000081.1|Kedarcidin_35 	43242	44525	+	Loose	700	47.3654	oleD	30.7	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCGTGCTGTTCCTGACCCCTCCCGGGCTGAAATCGCATCTGTACCTCCAGACGACCGTGGCGTGGGCGCTGCGCACCGCCGGGCACGACGTGCGCGTCGCCGGGCAGCCGGAGCTGGTCGAGGACCTGGCCGCCACCGGCCTCACCGGCGTGGTGGTGGGCGAGCGGCAGGCCGAGGTGCTGGCCGAGGTGGACGAGACCTCCGAGCCCGCCCCGCAGCCGATCCCCGCGACCGGTGACGGGCGGCTGCCCGTGCAGACCGACTACGCGCGTGACGACCCGCGCGGCGAGCTGTCGTACCTGACCACCAACTTCCTCCCGTTCCTCTACACCGACGACATGCTCGCCGAGCTGGTCGAGTTCGCCCGGGACTGGCGGCCCGACCTGGTGATCTGGGACCAGATGACCTACGCCGGGATGATCGCGGCCCGCGCCTGCGGCGCCGCGCACGCGCGCATCCTGTTCGGCGCGGACGGGTACGTGCAGCTGTGGCGGGCGCTGCCGGAGCAGGGCGGCGCGGACGACCCGATGCGCGAGTGGCTGGAGCCGGTCCTGGAGCGGTTCGGGTGCGGGCCGTTCGCCGACGACGCGGTGACGGGCCAGTGGACCGTGGACCCCATGCCGCCCTGGATCTGGCGGCCGTCCGGGGTGAGCTACGTGCCGGTGCGCACGCCCGCGTTCAACGGGACCACCGTGATCCCGGACTGGTTGCTGCGCAAGCCGGAACGGCGGCGGGTGTGCCTCACGCTCGGCATGACGCACCGCGAGGCGAACGTCGCGGAGGCGTCGGCGGCCGACCTGCTGGAGGCGGTGAGCGACCTCGACGTGGAGGTGGTCGCCACCTTCACCGGCAAGCAGTTGGAGGGCGTGGGCACCCTGCCGGACAACGTCCGCGCGGAGGACTACGTCCCGATGAACGCGTTGCTGCCGACGTGCTCCGCCGTCGTGCACCACGGCGGGACCTCCACGATGACCGCCGCCTACGAGCACGCCGTGCCCCAGCTCCTGGTGCCCAGCGCGTACTGGAGCGAGAAGTGGTACGGGCCCATCGCCCAGGGCAACGCCCTGGCCGAGCAGGGCGCGGGCCTGCTGCTGTCCGGGGACTCCGACCACCTCTCCGCGGCGGCGCTGCGCGACGGCCTGGTCCGGGTGCTCGACGAGCCGTCGTTCCGGCACAACGCCGAGCGGCTGCGCGCGGAGTGGGCGGCGGTGCCCACCCCGAACGACCTCGTGCCCGCGCTGGAAAGGCTGACCGGGCAATACCGGGGCACCCGGCCGTGA	MRVLFLTPPGLKSHLYLQTTVAWALRTAGHDVRVAGQPELVEDLAATGLTGVVVGERQAEVLAEVDETSEPAPQPIPATGDGRLPVQTDYARDDPRGELSYLTTNFLPFLYTDDMLAELVEFARDWRPDLVIWDQMTYAGMIAARACGAAHARILFGADGYVQLWRALPEQGGADDPMREWLEPVLERFGCGPFADDAVTGQWTVDPMPPWIWRPSGVSYVPVRTPAFNGTTVIPDWLLRKPERRRVCLTLGMTHREANVAEASAADLLEAVSDLDVEVVATFTGKQLEGVGTLPDNVRAEDYVPMNALLPTCSAVVHHGGTSTMTAAYEHAVPQLLVPSAYWSEKWYGPIAQGNALAEQGAGLLLSGDSDHLSAAALRDGLVRVLDEPSFRHNAERLRAEWAAVPTPNDLVPALERLTGQYRGTRP	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	102.89	gnl|BL_ORD_ID|1253|hsp_num:0	1367			831	1146	erythromycin; tylosin
BGC0000081.1|Kedarcidin_36 # 44761 # 48024 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.756	BGC0000081.1|Kedarcidin_36 	44761	48024	+	Loose	400	34.6538	vanR gene in vanG cluster	26.83	3002926	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCGCTTCGGTATTCTGGGCCCGTTGGAGGTGTGGACCTCGGCGGGCCAGTCCGTGCGCGTTCCGGAGGTGAAGGTCCGCGCATTGCTGGCGCACCTGCTGGTCAACCGGGGCCGCCGGGTGTCGGCGGGCCGGCTTATCGAGGACCTGTGGGGGGAAAACCTGCCGGCGAACCCGGCCGGGGTGTTGCGCAGCAAGGTTTCCCAGCTCCGCCGGGTGCTGGACGACGCCGAGCGCGGCGGGCGCGACCTGATCGAGTTCCGCTCGGCGGGTTACCTGCTGCGCACCGACGAGCAGTCCGTCGACGCCGACGAGTTCACCGCCGCCGTCGAGCGCGCGCGCGGCACGGCCGAGACGCGGGCCAAGGCGGCGCTGCTGGCCGATTCACTGGCGCTGTGGCGTGGTCCGGCGCTGGCCGACTTCGCGGACGAGGGTTTCGCCCGCGCCGCCATCGCCCGGCTGGACGAGCAGCGGTTGAACGCGCTCCAGGAGCAGGCCGAGGCGTGGCTCGCGCTGGGCGAACCCGACCGGTTGGCGGGTGAGCTGGCCGAGGTCGTGGCGCAGCACCCGTTGCACGAGCGGCTGCGCGCGCTCCTCATGCGCGCGCTGTACGTGTCGGGGCGGCAGGGCGACGCGCTGGACTGCTACCAGGACCTGCGGGTGCGCCTGCGGGAGGAACTGGGCGTCGAGCCGGGTCCCGAGCTGGTCGCGCTGCACCAGTCGATCTTGCGGCGCGAGCCGGCGCCGGGCAGCCGCCCGCCGGAACCCGAGGTGTCGCGGCCGAGGACTAACCTGCCGACGCCGCTGACCGAGCTGGTGGGCCGGGTCGAGGCCGTCGCGCTGACCCGCAAGCTGTTGGAGCGCGGCCGGTTGGTCACGATCACCGGCATGGGCGGTGCGGGCAAGACGCGGCTCTCCCTGGCCACGGCCGCGGAGCTGGTCGACCACTTCCCGTCCGGCGTGTGGCTGGTCGAGCTGACGGCGCTGGGCCAACCCGCCGCCGGCCCGGACGAGGCGCGCGGCGTCGACCCGGCGGCGGTGCGCGCCGCCGTGGTCGAGATGATCAGCACGGTGCTGGGCCTGCACGACCAGCCCGGCGGCCCGCGGTTGGCGGCCGGTGCGGACGAGGACGTGCGACGCCTGGTCGCGGCGTTGCGCGACCGGCGGATGCTGCTGGTGCTGGACAACTGCGAGCACGTGGTGGAGCCGGTCGCCCAGCTCTGCTCGCTGCTGCTCGCCGCGGCGCCGTCGCTGCGGGTGCTGGCGACCAGCCGGGAACCCCTGCGGGTGACCGGTGAGCTGCTGCACCCGCTGCCGCCGCTGGAGCTGCCGGGCCCGGACGAGGGCACCGACCCGGAGCGGTTGCTGCGCTACAGCGCCATCCACCTGTTCGTGTCCCGGGTCGCCGCCTCCAGCCCCGGTTTCGCGCTCACCACCGACAACGCCGCCGCCGTGGTCGAGATCTGCCGCCGGCTCGACGGGTTGCCGCTGGCGCTGGAGCTGGTGGCGACGAGGGTCCGCGCGCTGGGCGTGCAGCCGCTGGTGCGGCTGCTGGACGACCGGCTGCTCCAGCTCTCCTCCGGCAAGCGCGACGTGCCCGCGCGCCACCAGACGCTGCGCGGCATGATCGACTGGAGCTGGAGCCTGCTCGCACCGGCCGAGCAGGCGGTGCTGCGGCGGCTCGCGCTGCACTCCGGCGGCTGCACGCTCGCCGCCGCCGCGGAGGTCTGCTCCGGCGGCGGCGTGATCGCCGAGGAGGTGCCGGACCTGTTGGCGCGGCTGGTCGACTGCTCGCTGGTGGTGGCCGCGGAAGGGGTGGACGGACCCCACTACCGGATGTTGGAGTCCGTGGCCGCCTACAGCGTGGAGCGCCTGCGCGAAGCGGGGGAGACCGCCGAGTGGCAGCGGCGGCACGACGAGCACTACCTGTCCCTGGCCGAGCGCGCCGACCAGCGGCTGCGCGGGAGCGAGCAGCGGCGGTGGCTGCTGCTGCTGGACGCGGAGACGGTGAACCTGCGTGCCGCGCTGCACAGCGCGATCCGGCGCGGTGACGCGGCGATGGCGGTCCGGCTGTGCTGCGCGCTGGCCTGGTACTGGGTGCTGCGCGGCCGGCTCGGCGAAGGCCGCCGGTCGTTCGCCGCGGCGCTGGCCGTCGCGGGCCCGGTGCCCGAGGGCACCCGCACCACGGCGTTGCTGTGGTGGGCGGGCATGACGGCGATGGCGGGCGAGGACCCGGCGCCGGTGCTGGCGCGGGTCAGCGGGCGGGACGCGCCGCGGACGCCGGGCGACCGGCGGGGTGCGGCGCGGGCCGAGTGGCTGCTCGCCTCGGTCACCCCGAGCGATGTGGACAGACCGGAGGGCGAGGACAAGCTCAGCCGCGCCCTCGCCGGCTTCCGCGAGCTGGGCGACGACTGGGGCGTGGCGGTCGCGTTGAGCAGCCTGGCGTGGATCTCCTTGCTGCGCGGTGATTTCGCGGCGCTGCGCCGGGACGCGGAGCGCAGCCTGTCCCTCTTCCGCGAGCTGGGCGACGACTGGGGCATCCTCCAGGCCACCGACCCGCTCGCCGCCCTGGCCTACACCACCGGCGACCACGACCGCGCCGTCCAGCTCTGCTCGGACGGCCTGCGGACCGCCCGCGACCTCGGCCTGTGGCCGCAGTTCGCCTACTACCTCAACGAACTGGGCCGGCTCGCCCTGCTCGCCGGCGACTGCGCCCGTGCCCGGGACCTGCACGAGCGCGCCCGCACCCTGGCCGTCGAGCTGTCCAACCTGGCCGTGGCGCAGTACGCGGAGCAGGGGCTGGCCGTGGTGGCGCGCAGGCAGGGCGATTACGAGCTGGCGGAGCGGCACCTGCGGCCCCTGCTCGACGCGGCGCGGCAGGCGGAGTGGGGCGAGGAGGTCACGTCCCTGTTGGCGGAGCTGGGTTTCGTGGCCGAGCAGCGTGGTGACGCGGAGGCGGCCTTCGCCCTGCACCGCGAGGGTTACGAGGCGGCCCGCACGACCGGCGACCAGCGCGCGGTGGCGCGGGCGCTGGAGGGCCTGGCCGGCGCGCACAACCTCATCGGGCGGCACGACGTGGCCGCAAGGCTGCTCGGCTGCGCGGCGGCGGCGCAGAACTCCTTGGGCATCCAGGTGCCCGCGGCGGAGCGGTACGACGTGGACCGCGTGACCGACGCCGCGCGGGCGGCGCTCGGGGCGACGTGCTTCGAGGCGGAGTTCGCGGCGGGCGGCGCTTCGCGGCCCGACGAGTGCGTCCCGGCCTGA	MRFGILGPLEVWTSAGQSVRVPEVKVRALLAHLLVNRGRRVSAGRLIEDLWGENLPANPAGVLRSKVSQLRRVLDDAERGGRDLIEFRSAGYLLRTDEQSVDADEFTAAVERARGTAETRAKAALLADSLALWRGPALADFADEGFARAAIARLDEQRLNALQEQAEAWLALGEPDRLAGELAEVVAQHPLHERLRALLMRALYVSGRQGDALDCYQDLRVRLREELGVEPGPELVALHQSILRREPAPGSRPPEPEVSRPRTNLPTPLTELVGRVEAVALTRKLLERGRLVTITGMGGAGKTRLSLATAAELVDHFPSGVWLVELTALGQPAAGPDEARGVDPAAVRAAVVEMISTVLGLHDQPGGPRLAAGADEDVRRLVAALRDRRMLLVLDNCEHVVEPVAQLCSLLLAAAPSLRVLATSREPLRVTGELLHPLPPLELPGPDEGTDPERLLRYSAIHLFVSRVAASSPGFALTTDNAAAVVEICRRLDGLPLALELVATRVRALGVQPLVRLLDDRLLQLSSGKRDVPARHQTLRGMIDWSWSLLAPAEQAVLRRLALHSGGCTLAAAAEVCSGGGVIAEEVPDLLARLVDCSLVVAAEGVDGPHYRMLESVAAYSVERLREAGETAEWQRRHDEHYLSLAERADQRLRGSEQRRWLLLLDAETVNLRAALHSAIRRGDAAMAVRLCCALAWYWVLRGRLGEGRRSFAAALAVAGPVPEGTRTTALLWWAGMTAMAGEDPAPVLARVSGRDAPRTPGDRRGAARAEWLLASVTPSDVDRPEGEDKLSRALAGFRELGDDWGVAVALSSLAWISLLRGDFAALRRDAERSLSLFRELGDDWGILQATDPLAALAYTTGDHDRAVQLCSDGLRTARDLGLWPQFAYYLNELGRLALLAGDCARARDLHERARTLAVELSNLAVAQYAEQGLAVVARRQGDYELAERHLRPLLDAARQAEWGEEVTSLLAELGFVAEQRGDAEAAFALHREGYEAARTTGDQRAVARALEGLAGAHNLIGRHDVAARLLGCAAAAQNSLGIQVPAAERYDVDRVTDAARAALGATCFEAEFAAGGASRPDECVPA	MNEKILIVDDEKEIADLIELYLKNDGYKVYKFYNGIDALKCVESEKMDLAILDVMLPDVDGFHICQKIRERYFYPIIMLTAKVEDADKIMGLTIGADDYITKPFNPLEVAARVKTQLRRYVCYNNAADIEKENVLVTEYDINGLVINKNTHKCTLYGKAVTLTPIEFSVLWYLCENRGKVISSEELFENVWGEKFLDNNNTVMAHIGRLREKLKEPARNPKFIKTVWGVGYTIEE	462.55	gnl|BL_ORD_ID|1523|hsp_num:0	1635			459	699	vancomycin
BGC0000081.1|Kedarcidin_37 # 48605 # 50500 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.661	BGC0000081.1|Kedarcidin_37 	48605	50500	+	Loose	1150	33.8834	blaR1	24.24	3000217	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BlaZ beta-lactamase	ATGACGCTGGAATCAATGCCGCTGGCGGCGGGTTATCTCAAGGCGACCGCGCTCCAAGAGCCGCGGATCGCCCGGGAGACCGATATCCGCATCCACAACTTCGACGGCGGGGTAAGCCTCTTCGAGATGGCCAACTCCCTGTTCCGCGACGGAGCGCCGGACGTGCTGGCTTTTTCCGTCCTGGGCTGGAACTACCACGCCTTCGGAGCGCTGGCGGAAACCTTCAAGCAGCTCAACCCCGACGGCTGGGTGGTGTTCGGCGGCAACCACGTCTCGCACCAGGCCGAGCGGGTGTTCGGCACGTTCCCCGACGTGGACGTGGTGGTCAACGGGGAGGGTGAGTTCACCTTCCGCGAACTGCTGCTGGCCAACCTCGACGGGCGTTCGCCGGACGCGTTGCACGACATCCACGGCATCTCGTTCCGGGCGGACGGCGGTATCACGACCACCGAGGACCGGCCGCGGCTGGAGAACCTGGACGAGATCGGCTCGCCGGTCCTCACCGGCTCGGTGCCGCTGATCGGCGAGGACGGCGAGTTCCGCTACGACGTCGCGCTGCTGGAAACCAACCGCGGTTGCCCCTACAAGTGCTCGTTCTGCTACTGGGGCGGCGCGGTGGGGCAACGGGTGCGCGCGTTCTCGCGGGAGCGGTTGCGCCAGGAGGTCGAGGTCTTCGCGCAGCACCAGGTGCACACCATCGTGCTGTGCGACGCGAACTTCGGCATGTTGCCGATCGACGTGGAGTTCATCGAGGACGTGATCGCGATCCGGGAGAAGTACGGCTTCCCGAAGAGCATCGAGACGTCGTGGGCGAAGAACAAGTCCAAGGTCTTCTACAAGATAGTCAAGATGATGAAGGAAGCGGGCCTGCACAGCTCGTTCACCCTCGCGCTGCAAACCCTGGACGACAACACGCTCGACCTCATGAGCCGCCGGAACATGAAGGTCAACGACTGGGAAGAGCTGGCCGAGTGGCTGGACCGCGAGGGTATGCAGTGCTACGCCGAACTCATCTGGGGCGCGCCGGGTGAGACCGTCGAGTCCTTCATGAAGGGCTACGACCGGTTGGCCGCGCACGTGTCGCGGGTGGCGGTCTACCCGATGCTGATCCTGCCGAACACGACCTACCACCAGGACCGCAAGCGGTTCGGGTTGGTCACCGTGCGCGGCGACAGCGACGACTTCGAGTACCTGGTTTCCCACGACACGATGTCGGCCGCGGACAACCAGTACATGAACCAGCTGATCTTCTTCGCCCGGTTGGTGGCCGAGAACCCGGTGTTCCGCACCCTGTGGACGCCGTTGCGGGAACTGGGCGGCGTGTCCCAGTCGCAGGCGATCCGCTCGATGATGGAGTGGTTCGAGACGGCGGAGGACCAGGCTTCGCAGCCGTTCCGGTCGGGTCTGGAGAAGGCGTTCACCAACCCCGACGTGCTCGGCCCCGTGTCGGAGTACACCTACGGCAGCCGGGACGCCCGCGGCGCGCTGCGCCGCTGGTGGCGGGAGGCGATGCTGCCGCTGGTGCCGAAGGAGTGGGCCGACCTGCTGAGCAGGGTGTTCGAGTACGACATGCTGACGCTGCCGGTGTACACCAGCCCGGGGCGCGAGCCGTCGCACGAGGTGGTCAACGAGAGCCTGCCCGTCGAGGTGATCGAGGGCGAGCGCTTCTACGTCTGGCACGACGCGGTCCTGCCGTGCGACGCGCCGACCGTGGCGCGGGCGTTGAAGCACGGGGAGCCTTACGACCACTTGCTTGGCGAATGGCGCACCACGATGTACTACAAGGTCGGCGCGCACCACTTCGTCGGCTCGACCAACCACGAGGAGATCGTCTACTACTCGGGCCGTCCGGCGCGCGAGCTGTTCGGCCGTGGACAGGAAGGGGCAACCGCGTGA	MTLESMPLAAGYLKATALQEPRIARETDIRIHNFDGGVSLFEMANSLFRDGAPDVLAFSVLGWNYHAFGALAETFKQLNPDGWVVFGGNHVSHQAERVFGTFPDVDVVVNGEGEFTFRELLLANLDGRSPDALHDIHGISFRADGGITTTEDRPRLENLDEIGSPVLTGSVPLIGEDGEFRYDVALLETNRGCPYKCSFCYWGGAVGQRVRAFSRERLRQEVEVFAQHQVHTIVLCDANFGMLPIDVEFIEDVIAIREKYGFPKSIETSWAKNKSKVFYKIVKMMKEAGLHSSFTLALQTLDDNTLDLMSRRNMKVNDWEELAEWLDREGMQCYAELIWGAPGETVESFMKGYDRLAAHVSRVAVYPMLILPNTTYHQDRKRFGLVTVRGDSDDFEYLVSHDTMSAADNQYMNQLIFFARLVAENPVFRTLWTPLRELGGVSQSQAIRSMMEWFETAEDQASQPFRSGLEKAFTNPDVLGPVSEYTYGSRDARGALRRWWREAMLPLVPKEWADLLSRVFEYDMLTLPVYTSPGREPSHEVVNESLPVEVIEGERFYVWHDAVLPCDAPTVARALKHGEPYDHLLGEWRTTMYYKVGAHHFVGSTNHEEIVYYSGRPARELFGRGQEGATA	MTLPHILLSLVLITATILVIFFVRAVFYKQLSAKWRYHLWFLLITVLTLPFIPIHLLTGLSFFDQGRQQITPSAQKRFGFADQNEQWMVDFGTSVSRFDDTFIHAVFVSIWIGGMIFFLLLTLYHYAKLQRLVKAASRIQNQKVENAFSDCMAELQITNKLTNLESPAIQTPMTFGWLKTYILLPKNIELYLSDDEIRHVLLHELHHYKSKHIKVNYIFVVYQIVYWFHPLVWKAFKEMRLDRELACDTEVLLTLGQREYKAYGQTIMRFLERNSRFLYLTNPLHSSKKAFKNTKSYNIAFFYWRVKSGAQLKKPWVVFAGLTRFCIAQFPFLTATAVSTERYQFDESQAVVEDYSTYFAGNEGSFVLYSLTSDQFEIYNKEKSVRRVSPNSSYKIYTALMALELGVIGRDDSWLEWDGVEYEDEAWNSGQDLKSAMSQSVTWYFQELDERIKQRNIQSFVNQLDYGNKDLSGGLNHYWLESSLKISPVEQVELLHSFYTNQLDFKEEHVQFVKEVMKLEENQKGTLYGKTGTGIVNGHAINGWFIGFVETETDTYFFATNIQQKIMHMEARLLKSLYPFCQAKEFID	107.31	gnl|BL_ORD_ID|1900|hsp_num:0	2063			1299	1497	
BGC0000081.1|Kedarcidin_38 # 50497 # 51771 # 1 # ID=1_38;partial=00;start_type=GTG;rbs_motif=GGAAGG;rbs_spacer=9bp;gc_cont=0.751	BGC0000081.1|Kedarcidin_38 	50497	51771	+	Loose	550	26.1794	LRA-19	39.29	3002513	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	GTGAGCCAGAACCTCCCGGTCGGGCTGCGGCTCGTCGAAGGCATCCCGGACGACCGGTACCCGGACTGGTTGGACTGCTGGCTGGGCGTGTTCGGCGGCCCGGTGGGCTCCGAGCCCGCGCTGGTGGACTTCTACCGGCGCAACTACCCGCCGGAGCGAGGTCTCGCGGTCGCCGCCGAGGACGACGCGTACATCGCCACGAACATGGCGGTGGACCGGGAACTGGTGCTGCCCGGCGGGCACGTGGTGCCGGCCGCGGCGGGCACCGGCGGCTCCGCGCACCCGGCCGCCGCGCGTCAGGGCCTGATGCGGCTGACCGCCGACATGCTCACCCGCCGCGCGGTGGACGAGGACAAGGCCATCATGATCGGCGGCGCTTCCGAGTGGCCGATCTACGGCCGGTTCGGCGTCGGCCCGGCGACGTGGTGCGACGCGGTGGAGATCGACGTGCGCGCGGCGGGCCTGCGCGACGACGTGCCGGGCCGGGGCTTGCGACCGCGGCGCGTCACCGCGGAGCAGGCGCGTGAGCTGGCGCGGGAGCTGTACCGGCGCCAGGCGCTGGAGGTGCCCGGCGAGGTGCTGCCGCCCGCGGCCTACTGGGACCGGCTCACCGACGACCCGGCCCTGGGCCGGCTCGAGGAGTCGCTGGCGCTCGGCGTGCCCGGCCCGGGACCCCGGTTCTGCCTGGCGGTCGAGGACCGCGGCCTGGTGACCTACCGCGTCGCGCCGAACTGGACGGCGGAGAGCGCGCCGCACTCCACGTTGCACGTCATCGACTTCCTGGCGCTCGACGCGGAGGCCGAGGGCGCCCTGTGGCGGCACCTGTTCTCGGTCGACCTGGTGCGCGAGGTGCACGTGTGGCGGCTGGCCGTGGACAGCCCGTTGCGCTGGTGGGTCTCGGACGCGCGGCGCGTGCGCGCCAAGCGCCAGGACGCCCTGTGGCTGCGCCCGCTGGACGTGCCCCGCCTGCTGAGCACCCGCGAGTGGGCGTGCGACGGCACCCTCACCCTGAGCGTGCACGACCACCTCGGCTTCGCGGAGGGCACCTACCGGCTCACCGCCGAGTCGGGCAAGGCGTCGTGCGAGCGCACCACCACCGACCGCCCCGACATGGAGATGGACGTCAGCACGCTCGGCGCCATCCTGCTCGGCGGCAACCCCGCCGTCAGCCTGGCCCTCAGCGGTCGCATCCGGGCCGCCGAGGCCCGCGTCGCGCACCTCTGGGACACCATGGCGACCCCGGCACGCGCGCCCCACATCAGCTACTGGTTCTGA	MSQNLPVGLRLVEGIPDDRYPDWLDCWLGVFGGPVGSEPALVDFYRRNYPPERGLAVAAEDDAYIATNMAVDRELVLPGGHVVPAAAGTGGSAHPAAARQGLMRLTADMLTRRAVDEDKAIMIGGASEWPIYGRFGVGPATWCDAVEIDVRAAGLRDDVPGRGLRPRRVTAEQARELARELYRRQALEVPGEVLPPAAYWDRLTDDPALGRLEESLALGVPGPGPRFCLAVEDRGLVTYRVAPNWTAESAPHSTLHVIDFLALDAEAEGALWRHLFSVDLVREVHVWRLAVDSPLRWWVSDARRVRAKRQDALWLRPLDVPRLLSTREWACDGTLTLSVHDHLGFAEGTYRLTAESGKASCERTTTDRPDMEMDVSTLGAILLGGNPAVSLALSGRIRAAEARVAHLWDTMATPARAPHISYWF	MNSEMSQTSFKIRILVTCLLSIAQLTMAQQVQVTEPPITNQDWVKPYPPFRIVGNLYYVGTYDLACYLIVTPQGNILINTGLASSAPMIEASIKALGFKFSDTKILLTTQAHYDHVGAMAAIKKSTNAQLMIDEKDSPVMADGGSSDYELFGSTGSTYEPVKADRLLKNGDKITLGGTTLVMLHHPGHTKGSCSFLFDVKDESKSYKVLIANMPSIITSKKFSDIPTYPGIAEDYTYTFDAMKKVHFDIWLSSHASQFGMHSKHKPGEAYNPGVFIDRAGYDKAVGDLEDKFSKKKQADK	141.33	gnl|BL_ORD_ID|1339|hsp_num:0	1462			795	879	
BGC0000081.1|Kedarcidin_39 # 51787 # 53037 # 1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=GGAAGG;rbs_spacer=7bp;gc_cont=0.721	BGC0000081.1|Kedarcidin_39 	51787	53037	+	Loose	700	52.7582	oleI	33.98	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGGGTTCTGTTCGCCACCTACGCCGAGAACACCCACTACCAGAGCCTGGTCCCGCTCGCCTGGGCGCTGCGCACCGCGGGGCACGAGGTGCGGGTAGCGACGCAGCCGGCGCTGGTCGACACCGTCACGCGGTCCGGGCTGACCGCGGTGCCGGTCGGTGAGGACCACCGGTTCATGGAACTGCTCGCGACCAAGGAGTTCGACTGGGAGTGGGGCGCCCGGGTCGCGCACGCGCTGAAGACCGGCGGGCAGGACATGGACTACGACGGGTTGCTCCGGTTGTTCGACGAGGCGACCAACGACGTCGGCAAGGTGCTCAACGACCCGATGGTCGACGACCTGGTGGACTTCGCCCGCGCGTGGCAGCCGGACCTGGTGCTGTGGGAGAACTTCACGCTCGCGGGCGCGGTGGCGGCCCGGGTGACCGGCGCGGCGCACGCGCGGGTGCTGTGGGGCGTGGACGCGCAGACCCGGCTCTACCAGAGGTTCCGGGAACTGCTGGAGCAGCAGCCCGAGCAGCGGCGGCGCGACCCGATGCGGGACTGGCTGACCGAGGTGCTGGAGCGGCACGGCGCGACCTTCGACGAGCAGGTCCTCACCGGTCAGTGGACGGTCGACCAGGCGCCGCGCGGTATGCGGCTGTCGTTGGGCCTGCCCACGATCCCGGTCCGCTACGTCCCCTACAACGGGCCCGCCGTCGTGCCGGACTGGCTGCGCCGGCAGCCGGAGCGCCCGCGGGTGTGCATCACGCCGAGCATGTCCATGCGGCAGATGCTCGGCCACGACCCGGTCCCGGTGTCCGCGTTGGAGGTCTTCGCCGACCTGGACGTGGAAGTGGTGGCGGCGCTCGCGGTCGGCGACGACGAGCGGGTGAGCGTGCCGGACAACGTGCGCGTGGTGGATTTCGTGCCGATGCACGCGATCCTGCCGACGTGCTCGGCGATCGCGCACCTCGGCGGTGTCGGCGTGGCGTCCACCGCGGCCCTCAACGGCGTGCCGCAGCTGACGCTGGTCTCGCCCGACCTGTGGGAGGTCGAGGTGCGTGCCGACATGGTGCGCGACCTGGGCGCGGGCCTGAGCCTGCCGCTGCCGGAGCTGACGCCGGAGCTGTTGCGGGACAACGTCTTGCGACTGGTGGAGGAACCCGGTTTCCGGACGGCCGCGGAGAAGCTGCGGCAGGAGGTGCTGGCCGAGCCGTCGCCGAACGACGTCGTGGCCGAGCTGGAGCGGCTCGCCACCCGGCGGTGA	MRVLFATYAENTHYQSLVPLAWALRTAGHEVRVATQPALVDTVTRSGLTAVPVGEDHRFMELLATKEFDWEWGARVAHALKTGGQDMDYDGLLRLFDEATNDVGKVLNDPMVDDLVDFARAWQPDLVLWENFTLAGAVAARVTGAAHARVLWGVDAQTRLYQRFRELLEQQPEQRRRDPMRDWLTEVLERHGATFDEQVLTGQWTVDQAPRGMRLSLGLPTIPVRYVPYNGPAVVPDWLRRQPERPRVCITPSMSMRQMLGHDPVPVSALEVFADLDVEVVAALAVGDDERVSVPDNVRVVDFVPMHAILPTCSAIAHLGGVGVASTAALNGVPQLTLVSPDLWEVEVRADMVRDLGAGLSLPLPELTPELLRDNVLRLVEEPGFRTAAEKLRQEVLAEPSPNDVVAELERLATRR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	98.11	gnl|BL_ORD_ID|1684|hsp_num:0	1824			906	1209	oleandomycin
BGC0000081.1|Kedarcidin_41 # 53612 # 54712 # -1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=GGAAGG;rbs_spacer=6bp;gc_cont=0.744	BGC0000081.1|Kedarcidin_41 	53612	54712	-	Loose	700	25.7942	ADC-189	31.25	3006358	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGACGCTCGAACTGCACTGGTTCCTCCCCTCGCACGGCGACGGCCGCGAGGTCGCCAAGCGCGTCGACGGGACGATCCCGGTCGGCGCGCGCCGCGATCCCGACCCCGCCTACCTCACCCAGGTCGCGCTCGCCGCCGACCGGTTCGGCTTCAGCGGGATGCTGGTGCCGTTCGGCATGTTCTGCGAGGACCCGTGGGTGGTCGCGGCGGCGCTCGCGGGCTCGACCAGCCGCATCCGGTTCATGATCGCGCTGCGCCCCGGCCTGGTGTCACCGGTGCTGGCGGCGCAGGCCGCCGCGACGTTCCAGCGGGTGTCCGGTGGCCGCCTCCAGCTCAACATCGTGACCGGTGGCGACGCGGACGAACAACGCCGCTACGGCGACTGGCTCGACCACGACCAGCGCTACGCGCGCACCGACGAGTTCCTGGAGGTCTTCCACCGGGCGTGGTCGGGCGAGCGGTTCGACTTCACCGGCGACCACTACCGGATCTCGGCCGGTCTGGTGACCCGCCCCCATCCGGTGCGCCCACTGGTGCTGCTCGGCGGCTCTTCCGCCGCCGCGCGGCAGGTGGCGGCCCGGCACGCCGACGTGCTGCTCGCGTGGGGCGAAGCGCCCGCGGCGATGGGGCACTTCGTGGCGAGGGGCACCCGCGCCGCCGCCGAGACGGGGCGGGACCTGGCGTTCGGCACGCGGTTCCACGTGATCAGCCGGGACACCTCGGCCGAGGCGTGGCGGGTGGCGCGCCGGTTGCTGGACGGCATGGAGCCGGAGCGGATCGCGCAGGCGCAGCGCCGTTTCGCGGCCAGCGAGTCGGAGGGTCAGCGGCGGATGGCCGCGCTGCACGGCGGGCGCACCGATCAGTTGGAGGTGCACCCCAACGTCTGGGCGGGTTACGGGCTGGTGCGCCCCGGCGTCGGCACGGCCCTGGTGGGCAGCCACGAGGAGGTGGCCGAGCGCATCGCCGAGTACCACGCCCTCGGGCTGGACCACCTCATCCTGTCCGCGCAGCCCCACGTGGAGGAGGCGTACGCGTTCGGTGAGGGCGTCCTGCCGCTGCTGCGGGAGAGCGGCGTCGTGGCCGAGCCCGGGACGGCCTGA	MTLELHWFLPSHGDGREVAKRVDGTIPVGARRDPDPAYLTQVALAADRFGFSGMLVPFGMFCEDPWVVAAALAGSTSRIRFMIALRPGLVSPVLAAQAAATFQRVSGGRLQLNIVTGGDADEQRRYGDWLDHDQRYARTDEFLEVFHRAWSGERFDFTGDHYRISAGLVTRPHPVRPLVLLGGSSAAARQVAARHADVLLAWGEAPAAMGHFVARGTRAAAETGRDLAFGTRFHVISRDTSAEAWRVARRLLDGMEPERIAQAQRRFAASESEGQRRMAALHGGRTDQLEVHPNVWAGYGLVRPGVGTALVGSHEEVAERIAEYHALGLDHLILSAQPHVEEAYAFGEGVLPLLRESGVVAEPGTA	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIGLFRKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSYPATLQTLLDSSSEQIVMKPNKVTAISKEPSVKMYHKTGSTKGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLDAIKK	95.56	gnl|BL_ORD_ID|2194|hsp_num:0	4254			537	678	
BGC0000081.1|Kedarcidin_43 # 55701 # 56849 # -1 # ID=1_43;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=5bp;gc_cont=0.742	BGC0000081.1|Kedarcidin_43 	55701	56849	-	Loose	3000	29.6462	abcA	37.5	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGCCGGACATGCGGCTGGACGACAGCGACGAGGAGCGCGCGTTCCGCTCGGAACTGCGTGCCTGGCTGCGGACGGCGGTGCCCGCCGCGCCGGACGGTTTGCCACCACAGTGGACGGACGGCGAGCTGCGGGCGTGGAGTGCGGCGCTGCACGAGGCCGGTTACGCCGGCCTCACCTGGCCGGTGGAGCATGGCGGGCGCGGGTTGTCCCCCGCTCACCAGGCCGTCTTCGCGGAGGAGAGCGCGCTCGCCGAAGCACCCGACCAGGCCAACGTCATCGGGCTCAACATGGTGGGGCCGTCGATCATCGCGCACGGCAGCGAAGCGCAGCGCGCACACCACCTGCCACGCATCCTGTCCGGCGAAACCACGTTCTGCCAAGGGTTCTCCGAACCGGAGGCCGGTTCGGACCTCGCGGCGCTGCGCACCCGCGCGACCCCCGCGCCCGGCGGCTACCTGCTCAACGGCCACAAGCTGTGGTCGTCCTACGCGCACCTGGCCGACCACTGCCTCCTGCTGGCCCGCACCGACCCGGACGCGTCCCGGCACCGCGGCCTGTCCTGCTTCCTGCTCGACCTGCGCGCACCCGGCGTGGAGGTGCGCCCGCTGCGCAAGCTGTCCGGTGACGACTCCTTCAGCGAGATCGTCCTGCGCGACGTGTTCACGCCGGCGGACAGCGTGCTGGGCGCGCCCGGCGACGGCTGGCGGGTGGCGATGACCACCCTGGCGCACGAGCGGGGCACGTTCGGCATCGCCCTGACCGCGCGGCTGGCCGTGCAGCTCGCGCGCCTGCGCCGGACCGTCACCGCGTTCGGCGCGGACCGTGATCCGGTGGTGCGCCGGGAGTTCGCGGAGCTGCACGTCGAGCTGGAGGGTCTGCGCCACACCGGCTACCGCGCCCTGGCGACCCTCCTGCGCACCGGCGAGCCGGGACCGGAGAGCACGGTGGTCAAGCTCGGCTGGTCGCGGGCGAACCAGCGGCTGACCGCGCTCGCGTGCCGGGTGGCCGCCCGCGCCGACCACCCGTGGTCCGCGCACTGGACCCGGGAACGGCTGCGCGCGCGAACCAACACCATCGAGGGCGGCACGTCGGAGGTCCTGCTCGGCATCATCGCCGAGCGGGTGCTCGGGCTGCCCAGGTCGCGGTAG	MPDMRLDDSDEERAFRSELRAWLRTAVPAAPDGLPPQWTDGELRAWSAALHEAGYAGLTWPVEHGGRGLSPAHQAVFAEESALAEAPDQANVIGLNMVGPSIIAHGSEAQRAHHLPRILSGETTFCQGFSEPEAGSDLAALRTRATPAPGGYLLNGHKLWSSYAHLADHCLLLARTDPDASRHRGLSCFLLDLRAPGVEVRPLRKLSGDDSFSEIVLRDVFTPADSVLGAPGDGWRVAMTTLAHERGTFGIALTARLAVQLARLRRTVTAFGADRDPVVRREFAELHVELEGLRHTGYRALATLLRTGEPGPESTVVKLGWSRANQRLTALACRVAARADHPWSAHWTRERLRARTNTIEGGTSEVLLGIIAERVLGLPRSR	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	26.31	gnl|BL_ORD_ID|2167|hsp_num:0	2416			2748	2880	methicillin; daptomycin; cefotaxime; moenomycin A1
BGC0000081.1|Kedarcidin_44 # 56982 # 58172 # 1 # ID=1_44;partial=00;start_type=GTG;rbs_motif=GGCGG;rbs_spacer=13bp;gc_cont=0.743	BGC0000081.1|Kedarcidin_44 	56982	58172	+	Loose	1900	27.7202	AcrF	31.25	3000502	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGACCACGGATCTGGCTGACCGCACACCGGTCATCGTGGCGGCGGCCCGGACTCCCATCGGCCGCCGCGGCGGCGGGCTGGCCGGGCTCAAGGCGGTCGAGCTGCTGCGGCACGTGCTGCTGGAGGTGATCGCCCGGGGCGGGATCGAACCCGGCGACGTGGAGCAGGTCATCGGCGGCTGCGTCACGCAGGCGGGCGAGCAGAGCTTGAACGTCACCCGCAACGCGTGGCTGAACTCGGGGCACGACCCCGCTGTCGGCTGCACCACGGTGGACGTCTCCTGCGGTTCCGGGCAGCAGGCCAACCACCTCGTGTCGGCGCTGATCGCCGCAGGCGCCATCGACATCGGCATCGGCTGCGGCGTGGAGTCCATGAGCCGCGTGCCGATGGGCGTCAACCTGTACCAGGGTCCGGGCCACTACAAGGCGGCCGACTACCCGTGGGACGACCCGCCGCACGCGCAGTTCGGCGGCGCGGAGCGCATCGCGGACAGGCAGGGCATCACGCGTGCCGACGCCGACGCGTTCGGCGCGCTGTCCCAGCACCGGGCGGCCCGCGCGTGGCGGGAGGGGCGTTTCGACCGCGAGGTGACGCCCGTCGAAGCGCCGGTGGTGGACGGGGACGGCGCACCGACCGGCGAGGTGCGGACGGTGTCCCGCGACGAGGGGCTGCGGGAGACCGACGTGCGGGTGCTGGCCGGGTTGCGGCCGAACGTGGCGGACGGCGTGCACACGGCGGGTACGACCTCCCAGGTCTCCGACGGCGCGGCGGCGGTCCTGTGGATGTCGCTGGGCCGCGCGCGGGCACTGGGCCTGCGGCCCCGCGCCGCGCTGGCGCACCAGGTGGTCACCGGCGCCGATCCCTACTACCTGCTGGACGGCCCGGTCGTGGCCACCGAGCGGATCCTGCGCCGGTCGGGCTTGGCGATCGGCGACATCGACCTGTTCGAGGTCAACGAGGCGTTCGCGGCCGTGGTGCTGAACTGGCAGCAGGCGCACGACGTCGACCCGGCGCGGGTCAACCCGAACGGCGGCGCGATCGCGCTCGGCCACCCGCTGGGCGCCACGGGCACCCGCCTGCTGGTCACGGCCCTGCACGAGCTGGAGCGCGCGGACGCCGGGACCGCGTTGGTCACGATGTGCTGCGGCGGTTCGCTCGGCACCGCCTCCCTGCTGCGACGACTATAG	MTTTDLADRTPVIVAAARTPIGRRGGGLAGLKAVELLRHVLLEVIARGGIEPGDVEQVIGGCVTQAGEQSLNVTRNAWLNSGHDPAVGCTTVDVSCGSGQQANHLVSALIAAGAIDIGIGCGVESMSRVPMGVNLYQGPGHYKAADYPWDDPPHAQFGGAERIADRQGITRADADAFGALSQHRAARAWREGRFDREVTPVEAPVVDGDGAPTGEVRTVSRDEGLRETDVRVLAGLRPNVADGVHTAGTTSQVSDGAAAVLWMSLGRARALGLRPRAALAHQVVTGADPYYLLDGPVVATERILRRSGLAIGDIDLFEVNEAFAAVVLNWQQAHDVDPARVNPNGGAIALGHPLGATGTRLLVTALHELERADAGTALVTMCCGGSLGTASLLRRL	MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG	38.30	gnl|BL_ORD_ID|1353|hsp_num:0	1437			147	291	ciprofloxacin
BGC0000081.1|Kedarcidin_45 # 58181 # 59401 # 1 # ID=1_45;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.744	BGC0000081.1|Kedarcidin_45 	58181	59401	+	Loose	1500	32.3426	Escherichia coli gyrA conferring resistance to fluoroquinolones	25.0	3003294	protein variant model	A84P	n/a	fluoroquinolone antibiotic	antibiotic target alteration	fluoroquinolone resistant gyrA	TTGCTGGAGAACGAGTTCTTCGCCGAAGCACGCGACGACCGCACCGGTCCGCTGGACGGGCTGCGGGTCCTGGACGTCACCAAGGTGTGGTCCGGCCCGCTGGCCACGTGCGTGCTCGCCGACCTCGGCGCGGACGTGATCAGCGTGGAGCTGCCGCACGGTCGCGAGGGGCAGGTGCCGCCGAACATCCCCGGCACCGAGCTGTCGTGGTTCCGCGAGACGGTGCGGCGCAACAAGCGCAGCGTCGGGCTCGACCTGCGCCTGCCCGAGGACCGGGACGTGTTCCTCCGACTGGTGGCCACGGCGGACGTCGTGGTCGAGAACTACCGGCCGGGTGTGCTGGCCGGCTGGGGCGCCGGGTACGCCGACTGCCGCGCGGTGCGCCCGGACGTGGTGTACGTGTCGGTTTCCGGTTGGGGCCAGTACGGTCCGGACGTCGACCGGCCCGCGTACGACCCGGTGGTCCAGGCCGCCGCGGGGTGGATGGACCTCAACGGCCCGCCCGGCGGCGGACCGGTCCGCGCGCCCACCTTCATCGGCGACGAGCTGGCCGGGCTGCACGCGGCCATCGGCGCGCTCGCGGCGCTCGCGCACCGCGCGCGCACCGGCGAGGGCCAGCACGTCGACGTGTCCATGGTGGACGCCCTGCTGTTCGGCAGCAGCGGCCTGCCCACGCTCGCCGCGACCGGCGCGCCTCCCGCGCGCCTGGGCAACGAAACGGGTTTCGTCGTCCCCTCCAACGTCTACGAGTGCGCCGACGGCCACCTGTACCTGGCCGTGGCGCTCAACAAGCAGTGGCGTGCGCTGGCCGAGGAGATCGGACGGCCCGAGCTGGGCCGCGCGGACGGCTTCCGCACCAACGCCGAGCGGCTGGCCAACCGGGACGCCGTCAACGCCCTGGTGGCGCGGTGGTGCTGCGATCGCACGGTCGCGGAGGCGGTCGCCGCGCTGGCGGCGAGGGACCTCGTCGTCGCGCCGGTGCGCACCCTCGCCGAAGCCGTGGCGGACCCGCACGTGCGTGCTCGCGGGATGCTGCCGGAGGTCCGGCTGCGTGACGGTTCGGTGGTGCCGCTGGTCGGGCCGCCGGTGAAGTTCTCCCGCACGCCCACGGCGATCCGCCGACCCGCGCCCGCGCCGGGCGCGGACACCGCGGCGGTGCTCGCCGAGCTGGACCGCCGGTCGGCAACCGATGAGAAGCCTTTGCCGACAAGGGATCTATAG	MLENEFFAEARDDRTGPLDGLRVLDVTKVWSGPLATCVLADLGADVISVELPHGREGQVPPNIPGTELSWFRETVRRNKRSVGLDLRLPEDRDVFLRLVATADVVVENYRPGVLAGWGAGYADCRAVRPDVVYVSVSGWGQYGPDVDRPAYDPVVQAAAGWMDLNGPPGGGPVRAPTFIGDELAGLHAAIGALAALAHRARTGEGQHVDVSMVDALLFGSSGLPTLAATGAPPARLGNETGFVVPSNVYECADGHLYLAVALNKQWRALAEEIGRPELGRADGFRTNAERLANRDAVNALVARWCCDRTVAEAVAALAARDLVVAPVRTLAEAVADPHVRARGMLPEVRLRDGSVVPLVGPPVKFSRTPTAIRRPAPAPGADTAAVLAELDRRSATDEKPLPTRDL	MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMATNIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNVAAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVVVTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVYSMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVLTEFNRLRTAGKVAIKLVDGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTGVRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERNGLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVAEPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE	46.40	gnl|BL_ORD_ID|1972|hsp_num:0	1545			147	585	enoxacin; ciprofloxacin; levofloxacin; moxifloxacin; gatifloxacin; lomefloxacin; nalidixic acid; norfloxacin; ofloxacin; trovafloxacin; grepafloxacin; sparfloxacin; pefloxacin
BGC0000081.1|Kedarcidin_46 # 59487 # 60227 # 1 # ID=1_46;partial=00;start_type=GTG;rbs_motif=AGGAGA;rbs_spacer=4bp;gc_cont=0.725	BGC0000081.1|Kedarcidin_46 	59487	60227	+	Loose	275	26.1794	AAC(6')-I-48	52.78	3004638	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGGCCGAGCAACCCCGGGTCCTGGTGACCGGAGCCTCGCGCGGAATAGGCCGTGCGGTGGCGTTGCGGCTCGCCGCCGGCGGGTACGCGGTGGCCGGCTGCCACAGCGGCCCGAGCGACGCGGCGCGGCAGACCGAGGCGGAGGTGCGGGCGCTGGGCGTGCCGTGCCACTTCGGGACGTGCGACGTGTCGGACCACCGCGCGGTGGACCGGTTCGTCCGCGAGGCGGAGGACCGGATCGGCCCGCTCGGGATGCTGGTGAACAACGCGGGCATCAGCAAGGACGACCCGCTGGTGCTGTCCACCGCGGCGGACTGGGACCGCACGCTCGCCACCAACCTCACCGGCACGCGGAACCTCTGCCGCGCCGTGGTCTTCCGGTTCCTGAAGCAGCGCGGCGGCGCGGTGGTCAACATGTCGTCGGTGGCGGGCGTGCAGGGCAACGCCGGCCAGACCGCCTACGCGGCGAGCAAAGCGGGGATCATCGGGCTGAGCAAGTCGCTGGCGAAGGAGGTCGCGCCCCACGGGGTGCGGGTCAACGTCGTCGCGCCCGGTTTCATCGAGACCGACATGACCGGCGTGCTCGGCGAGAAGCTGCGCGCCAAGGCCCTCGACCGCATCCCGCTGGCCCGCTTCGGCACACCCGGGGACGTCGCCGAACTCGTCGAGTTCCTGCTGTCCGACCGCGCTTCCTACATCACCGGCCAGGTGTTCCACGTGGACGGGGGTATCGCGCTGTGA	MAEQPRVLVTGASRGIGRAVALRLAAGGYAVAGCHSGPSDAARQTEAEVRALGVPCHFGTCDVSDHRAVDRFVREAEDRIGPLGMLVNNAGISKDDPLVLSTAADWDRTLATNLTGTRNLCRAVVFRFLKQRGGAVVNMSSVAGVQGNAGQTAYAASKAGIIGLSKSLAKEVAPHGVRVNVVAPGFIETDMTGVLGEKLRAKALDRIPLARFGTPGDVAELVEFLLSDRASYITGQVFHVDGGIAL	MSKLGPTKPAPSMANTPVGNVVPCKTPDHPGWLELRLQLWPDGSTEEFLPEMAAACAEPDRFGQFLFLSPGGLAEGLVEVALRTDYVNGTESSPVAFLEGVFVVPASRGLGIARALVAAAEGWARDRGCTEFASDAEVSNVGSHAMHAALGFVETERVVFFRKVVAP	147.31	gnl|BL_ORD_ID|4965|hsp_num:0	3338			300	408	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000081.1|Kedarcidin_47 # 60224 # 60679 # 1 # ID=1_47;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=9bp;gc_cont=0.774	BGC0000081.1|Kedarcidin_47 	60224	60679	+	Loose	500	26.9498	almG	36.36	3004364	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	lipid A acyltransferase; polymyxin resistance operon	GTGACCGGGCAGGGCGTCATCGGGGAGGCGTCGCCCTGGCTGGCGCCGCACCCGCCCGTCGCGGCCCGGCCGATCACCGCCGTGGACCACTGGCGCGCCGTGCCCCACGACCAGGGCCTGACGATCACCTCGCGGGTGCGCGTGGACGGCGAGGAGCAGCACCTGCGCGGCCACTTCCCGAACCGACCGGTGTTCCCCGGCGTGTTCGCGATCGAGGCCGTGTGCCAGGCGATGGCCGCCGCCACCGCGGCCGGCGTGCCGCCACCCGGGCTGCGGGTGCTGCGCTCCGCGCGGTTCACCGCGCCGCTGCTCGGTGGTGACGAGCTGACGCTGGAGATCGACGCGCGCCCGCACGAGGGCGGCTGGGCCGTCGTCGCGCACGGCACCCGGCGGGACGGGACGCCGGCGGTGCGGATCACCGCCGACTTCGGACCGGGTGGTGCCCGTGACGCGTGA	MTGQGVIGEASPWLAPHPPVAARPITAVDHWRAVPHDQGLTITSRVRVDGEEQHLRGHFPNRPVFPGVFAIEAVCQAMAAATAAGVPPPGLRVLRSARFTAPLLGGDELTLEIDARPHEGGWAVVAHGTRRDGTPAVRITADFGPGGARDA	MRIFWLKALTSGLFYLPLSIKNGLCRLVAKPISRKKMAAALTQLNYALPDLGDVKKQAIVEQSTRLSLKNLLGFCHLKRYQYQVEQPDLVQEILDNQGGGIIVCPHMGVYDGVTWWLNQQGKKAVTIFGAGSSGDRPDENAMISQAAKLAGVPYLLRKQNLMLELAQRIKQGEWVVLHTDMRTEGVPVRWFGQATQLSATPFFLAHKLACPIYFHYALSEGMTQRLHFSRFALHQTDDLSRNIAQDAQQLADMMQQAITAHPEQWIWLYRRFK	55.31	gnl|BL_ORD_ID|2487|hsp_num:0	2878			462	561	colistin A; colistin B
BGC0000081.1|Kedarcidin_49 # 61192 # 61446 # 1 # ID=1_49;partial=00;start_type=ATG;rbs_motif=GGAAGG;rbs_spacer=9bp;gc_cont=0.663	BGC0000081.1|Kedarcidin_49 	61192	61446	+	Loose	275	23.0978	AAC(6')-Iv	32.43	3002566	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGCGCACGCGGAAAACCGTTTGGAAGAGCTGCGCGAGCTGGTCGCGGACGTGTTGGAGATCGAACCGGAGGAACTGACCGACACCGGTGACTTCATGGCCGACTACGAGGCGGACTCGTTGCGCGCGATCGAGATCCTGGCGCGCATCGACAAGCGCTACAAGGTCGAGATCCCGCAGGAGGAACTGCCCGGCCTGAGCAACCTGAAGGCCGTCCACGACGCGCTGGCGCGGCACTCCGGCGGGCGGGGCTGA	MAHAENRLEELRELVADVLEIEPEELTDTGDFMADYEADSLRAIEILARIDKRYKVEIPQEELPGLSNLKAVHDALARHSGGRG	MKIMPISESQLSDWLVLRCLLWPDHEEQHLQEMRQLITQAHCLQLLAYTDTQQAIAMLEASIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGIATGLVQHVEIWAKQFSCTEFASDAALDNQITHAMHQALGFQETERVVYFKKNIG	57.53	gnl|BL_ORD_ID|719|hsp_num:0	784			72	183	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000081.1|Kedarcidin_50 # 61450 # 62655 # 1 # ID=1_50;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.744	BGC0000081.1|Kedarcidin_50 	61450	62655	+	Loose	750	176.022	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.66	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGGTCCGGATCGCGGTGACCGGGCTCGGCCCGGTGTCGAGCATCGGGACCGGGGCCGCCGCGTTCGCCGCCGCGCTGCGTGCCGGGGCGTCCGGCGCCTCCCCGATCACCGGATTCGACGCCACCGGGTTCCCGTACCGGAACGCGGGTGAGGTGCGTGATTTCGACCCGCGCGCCCACCTGCGCCGGCTGGACCCGGAGCGGTGGGGGCGGTCGGGCCAGTTCGCCGCGAGCGCCGCGCGGTTGGCGGTGGCCGACGGCGGCCTGGACCCGGACCGGATCGACCCGGCGCGGGCGCACGCGGTCATCGGCACCACCAGCGGCGAGTCTGCGGTGGCCGAGGCGCTGACCGAACAGGTCGTCGGCGGGGGTTTCCCCGCCCAGGACCCGGACCTGGTCACGCGGCTGCCCGCGCACCGGCTGGCCAACGCGGTCAGCGAGGAACTGGGGCTGCGCGGCGAGTCGCTGACCGTGGCCACCGCGTGCGCGGCGGGCAACTACGCCATCGGGTACGCCTACGACCTGCTGGTGTCCGGTGAAGCGGACGTGGTCCTGGCCGGTGGCGCGGACTCGGTGTGCCGGTGGGCGCACGCGGGTTTCTACCGGCTCGGGGCGCTCACCGAGAGCCGGTGCTCGCCCTTCGACCGGGACCGGTCGGGCATCCTCACCGGCGAGGGTGGCGCGGTGCTACTGCTGGAGACCTTCGAGCACGCCGAGGCGCGCGGCGCGCGCATCCACGCGGAACTGCTGGGGTACGGGATGAACTGCGACGCACGGCACGCGGTCGCACCGGACGGGGCGAGCGTCGCGGAGTGTATGCGCCTGGCGCACCGCAATTCCGGCGTGCGCCCGGAAGACGTGGACTACGTGTGCGCGCACGGCACCGGCACGCCCACCAATGACCTGGTGGAGGGCCGGGCCATCCTGGAGGTGTTCGGGGCCGCGCCGCCGCCGGTCAGCTCCATCAAGTCGATGATCGGGCACACCATGGGCGCGGCGGGTGGGTTCGGCGCGATCGCGTGCGTGCTGGCGATCGCGGAGGGCTTCCTGCCGCCGACGATCAACTGGGCGAACCAGGACCCGGACCTGGCGGGCATCGACGTGGTGCCCAACCAGGCGCGGCCGGCGCGGGTGCGCATCGCCCAGAACGACGCGTTCGCGTTCGGCGGCAACAACGCCATCGTGATGCTGGGGGCGGTCGCGTGA	MVRIAVTGLGPVSSIGTGAAAFAAALRAGASGASPITGFDATGFPYRNAGEVRDFDPRAHLRRLDPERWGRSGQFAASAARLAVADGGLDPDRIDPARAHAVIGTTSGESAVAEALTEQVVGGGFPAQDPDLVTRLPAHRLANAVSEELGLRGESLTVATACAAGNYAIGYAYDLLVSGEADVVLAGGADSVCRWAHAGFYRLGALTESRCSPFDRDRSGILTGEGGAVLLLETFEHAEARGARIHAELLGYGMNCDARHAVAPDGASVAECMRLAHRNSGVRPEDVDYVCAHGTGTPTNDLVEGRAILEVFGAAPPPVSSIKSMIGHTMGAAGGFGAIACVLAIAEGFLPPTINWANQDPDLAGIDVVPNQARPARVRIAQNDAFAFGGNNAIVMLGAVA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	96.39	gnl|BL_ORD_ID|1968|hsp_num:0	1943			207	1242	isoniazid
BGC0000081.1|Kedarcidin_54 # 65684 # 66487 # 1 # ID=1_54;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.779	BGC0000081.1|Kedarcidin_54 	65684	66487	+	Loose	800	25.7942	cmlA4	27.43	3002694	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGCGGCGGTGGGTGAGCGCGCGCCCCGGGCGCACGTGCTGGCGCCGGGCGGACCGGGTGGTCCGCTGGTGGTGCTCGCCCACGGCCTGGAGGACGGCTGGACCGGGTGGCGTGCCGTGGCCGCGCACTGGCCGGCCGGTGCGCGGCTGGTCGCGCTGGACCTGCCGTGGCGCGCGGGCAACGACTACCGGTGGCGGCAGCGTGATCCGGGGTGGTGGCTCGCCGAGGGCCTGGCGCCGCTGGGCGCAGTGCCGGACCTGCTGGTCGGCCACTCGTTCGGCGCGAACGCCGCGCTGGAGCTGCTGTGCGCCGCCACCGAACCGCCACGTGCCGCGGCGTTGCTGTGCCCGCTGTACCGGGTTCCCGGCGCACCGCTGGGCGAGCACGCCGAGGGTCGGTCGCGGGCGGCGTTCGCGCGGCTGTTCCGGGAGGGCGTGCTGGCGCGGCTGGGTGAGCGGGCGGCGTCGATGGAGGAGGAGCTGCGGGACCGCGTCGTCGCGCTGGCCGCGGGCCAGGTGGGCGCGCCCGGTTTCCGCGCCGCGTTCGACCAGTACCACGCCAGCGCCGCCCTGCCGCTGGGCCGGGTCACCACGCCGACGCTCGTGCTCGGCGGCGGTGCCAACCCGACGCTGTCGCGGACCGAGGCCGCCGCGCTGGCCGACGGGATGCCCGGCGGGAGCCTCGTGTTCCACGACACCTACGACCACTTCTGCCACATCCGGCGGGCCCACGACGTCGTGGCGCAGCTCGTGCGCCTGGTCGAGCCCGCGCCGGCGGCACCGCGAGACGGAGGACCCCGATGA	MAAVGERAPRAHVLAPGGPGGPLVVLAHGLEDGWTGWRAVAAHWPAGARLVALDLPWRAGNDYRWRQRDPGWWLAEGLAPLGAVPDLLVGHSFGANAALELLCAATEPPRAAALLCPLYRVPGAPLGEHAEGRSRAAFARLFREGVLARLGERAASMEEELRDRVVALAAGQVGAPGFRAAFDQYHASAALPLGRVTTPTLVLGGGANPTLSRTEAAALADGMPGGSLVFHDTYDHFCHIRRAHDVVAQLVRLVEPAPAAPRDGGPR	MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTVQLTLATYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLAFTSLAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVTGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFFIAPGLIMGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWASQSVLGFIAPMWLVGIGVATAVSVAPNGALQGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRAKGSRGQGEHDVVALQSAESTSNPNR	63.72	gnl|BL_ORD_ID|897|hsp_num:0	971			480	765	chloramphenicol
BGC0000081.1|Kedarcidin_55 # 66484 # 67404 # 1 # ID=1_55;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=5bp;gc_cont=0.750	BGC0000081.1|Kedarcidin_55 	66484	67404	+	Loose	525	25.409	OKP-D-1	32.26	3006153	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OKP beta-lactamase	ATGACCGCCACCACCCGAGCCGAGCCGACCGTGCTGCACGCCCGTCCCGCGTTCGAGGGCGCCAACATCCGCACGTGGGTCGGGTTCAAGCACTTCGACTACCTGGTCGAGCAGGCGGTGTTGCAGTGGTTGCGCGACCGGGGGACCGGCGCCCGCGCGCTCTACCTGGAGCACGGCCTGGGCGCCGAGATCGTCGACTGCTCGCTGCAACTGCCCGCCGTGCTGGAGCTGGACGACGAGGTGCGCGTGGAGGCGGTGGAGGGGGACGCGGGCGACGGGCGGTTGTCCGTGCGGATCGCGGTGGAGCGCGACGGCGCGGAGGTCACCGTGCTGCGCGGGCGCGTGCGCGTGGCGCTGGTGCGGGAGCGCGGGGCCGACCGGCACCTCCCGGCACCCGCGGCGCTGGCGGCGCTGGAGGTGGCCGCGCTGCCCGAACCGCCGGGCGTGCCGCTCGCGGGTCGGCCCGCCGCCGAGGTGCTGGCGGAGCGACCCAACGCCTTCGTGTGGTCGTGGCGCGCGCCGTACTACTACTGCCACTTCTCCGACCGGGTCCAGCACTCGGGGTTCGTGCGGGCGCTGGAGGAGGTCGTGGACCGCTTCCTCGCCGACCGCGGCATCTCCGTCGGCCGCCTGCTGACCGAGCGGTCGTGGATCCCCGTGGTGTCCCGGGCGCGGGTGCGGCTGCTCGCCGCCGCGCACATGGAGGAAACCGTGCACACGGTGTTCCGCGTCGTGGACGTCCTGCGCGGCACGCTGTTCGACGCCGAGATGGACTGCTACGTCCAGCGGGGCGACGAGCTGGTGCCGGTCGCCACGGGTCGCATCCTGCACGGGTACGCCGTCGCGGCGGGCGACGGCGCGGGCGGGCTGGCCGAGCTGACCGACGACGTGGTGCGGGCGCTGACCGGGGGTGCCGCGTGA	MTATTRAEPTVLHARPAFEGANIRTWVGFKHFDYLVEQAVLQWLRDRGTGARALYLEHGLGAEIVDCSLQLPAVLELDDEVRVEAVEGDAGDGRLSVRIAVERDGAEVTVLRGRVRVALVRERGADRHLPAPAALAALEVAALPEPPGVPLAGRPAAEVLAERPNAFVWSWRAPYYYCHFSDRVQHSGFVRALEEVVDRFLADRGISVGRLLTERSWIPVVSRARVRLLAAAHMEETVHTVFRVVDVLRGTLFDAEMDCYVQRGDELVPVATGRILHGYAVAAGDGAGGLAELTDDVVRALTGGAA	MRYVHLCVISLFACLPLPLFAGPQPLEQIKISESQLSGRVGYVEMDLASGRTLAAWRADERFPLTSTFKVLLCGAVLARVDAGVERLDRRIHYRQQDLVAYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLDTLGGPAGLTAFLRTIGDNVTRLDRRETQLNEALPGDVRDTTTPASMAATLRKLLTAKHLSARSQQQLVQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARGIVALLGPDGKAERIVVIYMRDTPATIAERNQQIAAIGAALIEHWQR	106.99	gnl|BL_ORD_ID|3724|hsp_num:0	4794			534	627	
BGC0000081.1|Kedarcidin_56 # 67401 # 68036 # 1 # ID=1_56;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=6bp;gc_cont=0.722	BGC0000081.1|Kedarcidin_56 	67401	68036	+	Loose	700	25.0238	PDC-473	30.0	3006839	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGACCCGCCGCCGCCCGCGCGTGTACTTCTCGCTGCGCAGCCCGTACAGCTGGCTGACCGTGCGGCGGCTGCGCGCGGAGGCGCCGACCTGCCTGGACGAGGTGGACTGGCTGCCCTACTGGGATCCCGACCCGATCACGTTGGCGGCCCTGGAGGAGCGCGGCGGCGAGTTCCACTACGTGCAGATGAGCCGGGCCAAGCACCTGTACATGCTGTTGGACACCAAGCGATTGGCGCAGGCGCAAGGCGTCGACATGGCCTGGCCGGTGGACATCGACCCGTGGTGGGAGCTGCCGCACCTGGCGTGGCTCGCGGCGCGCCGCCTCGGTCGGCCGTGGGAGTTCTACGACGCGCTGGTGGCGGCCCGCTGGGGTCGCGGCGACGACATCTGCCTCCCCGAGGTGGTGCGCGTGGCCGCCGAGCAAGCCGGCCTGGACCCGGAGGCGTTGCTGGCCGCGCCCGAGGACCCGGAGATCCGGGAGACCGCGGCCGACTGCCTCCACCAGGCGTACCTGGACGACGTGTTCGGCATCCCCTACCTGAAGTGGGGCCGGCACCGGTTCTGGGGTTACGACCGGCTGGACGCCTTCCTGGACGTCTGGCGACCCGCGCGGGAGGGAGGGAACCCATCGTGA	MTRRRPRVYFSLRSPYSWLTVRRLRAEAPTCLDEVDWLPYWDPDPITLAALEERGGEFHYVQMSRAKHLYMLLDTKRLAQAQGVDMAWPVDIDPWWELPHLAWLAARRLGRPWEFYDALVAARWGRGDDICLPEVVRVAAEQAGLDPEALLAAPEDPEIRETAADCLHQAYLDDVFGIPYLKWGRHRFWGYDRLDAFLDVWRPAREGGNPS	MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTVTLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	53.83	gnl|BL_ORD_ID|4529|hsp_num:0	5599			552	762	
BGC0000081.1|Kedarcidin_57 # 68033 # 68155 # 1 # ID=1_57;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.724	BGC0000081.1|Kedarcidin_57 	68033	68155	+	Loose	1000	22.7126	mcr-10.1	45.83	3007137	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGACCGCACCCGAGGAGCCCGGCGTTCCGGCGACCGAAGAGGACCCGTGGCACGGCATCCCCGTCGAACTGCTCGACGGGACCACCGGCTACGACACCGACACCGCGGGCGGCTGCGGATGA	MTAPEEPGVPATEEDPWHGIPVELLDGTTGYDTDTAGGCG	MPVLFRMRVIPLVLLLALVFAFLLNWPVLLHFYDILSRLEHVRAGFVISIPFVLVAALNFVFMPFSVRYLLKPFFALLLVTGSVVSYATLKYKVMFDQSMIENILETNPQEAHAYLNGSLVLWLVFMGILPAILLFLIKIEYADKWYKGVAHRLLSMLASLILIAGVAALYYQDYASVGRNNPTLNKEIIPANYAYSTFHYVKDTYFTTKMPFRTLGDDARRVTRNGKPTLMFLVIGETARSQNFSMNGYPRDTNAFTSKIDGVISFRNMRSCGTATAVSVPCMFSDMNRTDYDGKKAAGSENVLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEINPGISKKLCDGKTCYDDVMLENLDTEIGKMAGDKLIAFHMIGSHGPTYYQRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTIRHTDYVLAQMIEKLKQYSEQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQLWMSPGFIAAKNINAACLQHNAVNRTYSHDNLFASVLGLWDITTGAYLPESDLFRECRG	7.42	gnl|BL_ORD_ID|4809|hsp_num:0	5798			990	1056	colistin A; colistin B
BGC0000081.1|Kedarcidin_59 # 68923 # 72048 # 1 # ID=1_59;partial=00;start_type=ATG;rbs_motif=GGGGAG;rbs_spacer=8bp;gc_cont=0.743	BGC0000081.1|Kedarcidin_59 	68923	72048	+	Loose	1000	58.5362	almE	21.79	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCCGGCACTGCTGGACGACCACATCGCCGCCGACGGCACGGGCATCGCGATCACCGACGAGACCGGCGAGGTCACCTGGGCCGGTCTCGGCGACCGGGTGAACCGGTGGGTCGACCTGCTGACCCGCCGCGGGCTGGGCCGGGGCGACCGGCTGGCCTGCGTGCTGGGCAACCGGCGGGAGACCGTCGAGGTGCTGCTCGCCGCCCTGCACGCGGGCATCACGGTGGTGCCGGTGAACTGGCACCTGACCGAGCCGGAGATCGAGCACGTCCTGGTCGACTCGGGCAGCCGCGCCCTCGTCGTGGAACCGGCGCACGCGGCGGTGGCCGGCGCGGCGGCCCGCGGCGCGCGGGACTGCGCGGCCCGGCTGGTGCTGGGGGAACACGACGTCGACGGCTTCACGGCGGTGGAACCGCTGCTGGCGGACGCGTCCGGGGACGAACCGGCCGACCAGGTGTGCGGCTCGGTGATGCTCTACACCTCGGGCACGACCGGCGCGCCGAAGGGCGTCGTCAACGGCTTGTTCGTGGTGGGCGCGTCCTTCGACCGGGTCGGCAGGCTCATCGAGTACGCCCGCGTGCTGCTGCACGTGCCGGCCGGCGGGCGTTACCTGCTCGACGGGCCGTGGTACCACTCGTCGCAGCTCTTCTTCGCGTTGCTGGCGTTGCTGCGGGGCGCGCGGCTGTACCTGAGGCCGCGCTTCGACCCCGCGGCCACGCTCCGGCTCATCGACGCCGAGCAGATCACCGCCACCCACCTGGTGCCCACCCAGTTCATCCGGCTGCTGCGGGTCGACCCCGCGGTGCGGTCGGGGTTCTCCGGCGCGAGCCTGCGGCAGGTGTGGCACGGCGGCGGGCCGTGCCCCGTCGAGGTGAAGCACCGGATGATCGAGTGGTGGGGCCCGGTGCTGCTGGAGTATTACGGCGCGACCGAGGGTGGCGCGGTGACCCTGATCGACTCGGCGGACTGGTTGCGCCGTCCGGGCAGCGTCGGGCGGGCCGTGCCGCCGTACGAGGTCGTGGTCCTGGACGACGAGGACCGGCCGCTGCCCGCGGGGCGACGGGGCCGGGTGTTCATCCGCCGCCGGACCGGGCGGACGTTCCACTACCACAACGCGCCGGAGAAGACCCGTGCCGCGCACCTGGGCGCCGCGTTGTTCACCTTCGGCGAGGTGGGGCACCTGGACGAGGCGGGCTTCCTGTTCCTCTCCGGCCGGGCGCAGGACCTGATCGTGTCCGGCGGGGTGAACGTGTACCCCGCGGAGGTGGAGGCCGTGCTGCTGACGCACCCGGCGGTGCGGGACGTGGCGGTGGTCGGCGCGCCGGACGACGAGTTCGGCGAGCGCGTGGTGGCGGTCGTCGAGGCCGACGGCCCGACCACCGACCTGCCGACCGCGCTGGACGAGCACAGCCGCCGCTCGCTGGCGGGCTTCAAGGTGCCGCGCGGGTACCACTTCGTCGCCGAGCTGCCGCGCGAGGCCAACGGCAAGATCCGCAAGGACACCCTCCGCGGTGACGTGGCGACCCTCGCCCCGGCCGGTTCCACACCGGTCGCACCCACCCCGAACGGTTCCGCTTCAGCCACCACCGCTCCGGCCGCTGCCGTTCCAGCCGCTGCCGTTCCGGCCGCCCCCGCTTCGGCAGTCCCCGTTCCGGCCGCTCCCGCGTCGGCCGCCACGGCCCCGGCTGCCCCCGCTCCGGCCGCTGCCGCTCCGGCCGCTGCCGCCCCGGCCGGTTCCGCGTCGGAAGCCCTCGCGCCGGACGGTTCCGCGTCCGCCGCCCCTGCTCCGGCCACCGTCACGTCGCCTGCCCTCGCGTCGCCCGCGCCCGCGTCGCCTGCCCCCGCGTCGACCGCGCCCGTGTCGGCCACACCCGCCGCGTCCGCGGTCGACCGGCCCGACATCGCCCACCCGGCGACGTTCGTCGCCGGTGTGCCGCACGACGAGTTCGCCCGTCGGCGGCGGGAGGAGCCGGTGGGGTGGGTGACCGAGCCGTTGTTGGTGCGGCACAGCGCCATGGGGCGCACCGCCGAGCGCGGTTCCGGCTACTGGGCGGTGACCGGCTACGACGACGTGGTGTCGGTGTCGCGCCGACCCACCGAGTTCTCCTCCGCCGCCAAGGGCGCGTTCCTGGTCGACCCGCGCACGCCGGCGGCGCTGCGCCAGACCAGGCAGCTCCTGATCAACATGGACGACCCGCAGCACGTGGCGATCCGCAAGCTGGTCGCGCCGATGTTCACCCCGCGCGCCATCCGGGAGCTGCTGGACGGCATCGACGCGCACGCGCGGGCGCTGGTCGACAACGTGGTGCGGGCGCGCGAGTTCGACGCCGTCACCGATCTGGCCGCCGAGCTGCCGCTGCTGGTGCTGACCGACCTGCTCGGCGTGCCCCGGCAGGACCGCCACCTGCTCTACCGGTGGAGCAACCACCTGGTCGGCTTCGACGACCCCGAGTACGGCGGCGGCGACGTGGACGTCTACCGGGCGACCTTCGCCGAGGCGTTCCAGTACGCGCTGGACCTGGCCGCCGACCGGCGGGAGAACCCGACCGGCGACCTGGTCAGCCTGCTGGCCAACGCCGAGACCGACGGCAAGCGGTTGAGCGACCGCGAGTTCTGCAACTTCTGGCTGCTGCTCGTGGTCGCGGGCAACGAGACCACGCGGCACCTGGTCAGCGGTTCGCTGGAAGCGCTCGCGCGGCACCCGGCCGAGCGCGCGCGGCTGGTGTCCGGGGAGGTCGGGCTGGACACCGCCGTGGAGGAGCTGATCCGCTGGATCACACCGATCATGCAGTTCCGCCGCACGGCGGTCCGCGACACCGAACTCGGCGGGCAGCGCATCGCCGAGGGCGACAAGGTCGTCATCTACTACACGTCGGCCAACCGGGACGCCGCGGTGTTCCCCGATCCCGACCGGCTCGACCTCGGGCGCGAACCCAACCGGCACCTGGCGTTCGGGATCGGACCGCACTTCTGCCTCGGCGCGCACCTCGCCCGGTTGGAGCTGCGCGCGCTGCTGACGGCCGCCCTGCCGCACCTGGGCGGGTTCGCGCTGACCGGGCCGCCGGTCCGCATGGCGTCCAACTTCGTCAACGCGGTCAAGTCCATGCCTGCCCGGATCGGGTGA	MPALLDDHIAADGTGIAITDETGEVTWAGLGDRVNRWVDLLTRRGLGRGDRLACVLGNRRETVEVLLAALHAGITVVPVNWHLTEPEIEHVLVDSGSRALVVEPAHAAVAGAAARGARDCAARLVLGEHDVDGFTAVEPLLADASGDEPADQVCGSVMLYTSGTTGAPKGVVNGLFVVGASFDRVGRLIEYARVLLHVPAGGRYLLDGPWYHSSQLFFALLALLRGARLYLRPRFDPAATLRLIDAEQITATHLVPTQFIRLLRVDPAVRSGFSGASLRQVWHGGGPCPVEVKHRMIEWWGPVLLEYYGATEGGAVTLIDSADWLRRPGSVGRAVPPYEVVVLDDEDRPLPAGRRGRVFIRRRTGRTFHYHNAPEKTRAAHLGAALFTFGEVGHLDEAGFLFLSGRAQDLIVSGGVNVYPAEVEAVLLTHPAVRDVAVVGAPDDEFGERVVAVVEADGPTTDLPTALDEHSRRSLAGFKVPRGYHFVAELPREANGKIRKDTLRGDVATLAPAGSTPVAPTPNGSASATTAPAAAVPAAAVPAAPASAVPVPAAPASAATAPAAPAPAAAAPAAAAPAGSASEALAPDGSASAAPAPATVTSPALASPAPASPAPASTAPVSATPAASAVDRPDIAHPATFVAGVPHDEFARRRREEPVGWVTEPLLVRHSAMGRTAERGSGYWAVTGYDDVVSVSRRPTEFSSAAKGAFLVDPRTPAALRQTRQLLINMDDPQHVAIRKLVAPMFTPRAIRELLDGIDAHARALVDNVVRAREFDAVTDLAAELPLLVLTDLLGVPRQDRHLLYRWSNHLVGFDDPEYGGGDVDVYRATFAEAFQYALDLAADRRENPTGDLVSLLANAETDGKRLSDREFCNFWLLLVVAGNETTRHLVSGSLEALARHPAERARLVSGEVGLDTAVEELIRWITPIMQFRRTAVRDTELGGQRIAEGDKVVIYYTSANRDAAVFPDPDRLDLGREPNRHLAFGIGPHFCLGAHLARLELRALLTAALPHLGGFALTGPPVRMASNFVNAVKSMPARIG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	187.23	gnl|BL_ORD_ID|4935|hsp_num:0	5928			279	1647	colistin A; colistin B
BGC0000081.1|Kedarcidin_60 # 72052 # 73029 # 1 # ID=1_60;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=6bp;gc_cont=0.758	BGC0000081.1|Kedarcidin_60 	72052	73029	+	Loose	600	30.8018	SME-3	25.64	3002381	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SME beta-lactamase	ATGACGGATCAGCACCTGTTCGGGTCCGTCTTCGCGGCCCGCTCCGACCGGCCGCTGGTGACCGTGCTGGGTGGTTCGGGGTTCATCGGTTCCGCCGTGGTGGACCGGCTCGCCCGCCTGCCGGTCCGGTTGCGCGTGGTCGCGCGCGGACGGCCCGCGCTGCCCGCGCGGCCGGTGGCGGACGTCCGGTTCCACGCGGCGGACCTCACCAACGCGGACGCGGCACGCGCCGCGGTCGCCGACGCCGACGCGGTGATCCACCTGGCCGCCCACATGGGTGACGGCCAGTCGTGGCGGGCGGCGGGTGAAGAACCCGCGCGGCTCAACGCCGACCTGATGCGCGTGCTCATCGCCCCGACCGGCGACGTGCTGCCGGTCGTCGTGTTCGCCAGCACCCTCCAGGCGGAGTCGGGCGCTGCGGCCGGCGCGAGCGACTACGTGCGCCACAAGGCCGAGGCGGAGCAAGTGCTGCTGACGGCGACCAGCGCGGGCCGCGTGCGGGGCATCGCGATCCGGCCGACGACCGTCTACGGGCGCAGCCCGCTGTCCGGGTCGACCGGGCGCGGCGTGATCTCCGTGCTGGCGGGTCGGGCCGTGGCCGGTGAGCCGATCACCATGTGGCACGACGGTTCGGTGCAGCGGGACTTCCTGCACGTCCGCGACGCCGCCGCCGCGTTCGTCGCCGCGCTGGACCACGTCGAGCCGTTGTGCGGCGGGCACTGGCCGGTCGGGACGGGTCGGCAGGAGCGCCTGTCCGAGGTGTTCGGGGCGATCGCCCGTGCCGCGGCGGAACGCACCGGCCGCCCGCCCGTGCCGGTGGTCACCGTGCCGCCGCCGGACTTCGCGAGCGCGCACGACTTCCACAGCCCGGTGGTGGACTTCTCGGCGTTCCCGGCGGTGACCGGGTGGGGTCCGGAGGTGTCGCTGGCCGAGGGGTTGCGCGGGGTGGTCGACGCGGCGGTCGACGGGACGGGCTGA	MTDQHLFGSVFAARSDRPLVTVLGGSGFIGSAVVDRLARLPVRLRVVARGRPALPARPVADVRFHAADLTNADAARAAVADADAVIHLAAHMGDGQSWRAAGEEPARLNADLMRVLIAPTGDVLPVVVFASTLQAESGAAAGASDYVRHKAEAEQVLLTATSAGRVRGIAIRPTTVYGRSPLSGSTGRGVISVLAGRAVAGEPITMWHDGSVQRDFLHVRDAAAAFVAALDHVEPLCGGHWPVGTGRQERLSEVFGAIARAAAERTGRPPVPVVTVPPPDFASAHDFHSPVVDFSAFPAVTGWGPEVSLAEGLRGVVDAAVDGTG	MSNKVNFKTASFLFSVCLALSAFNAHANKSDAAAKQIKKLEEDFDGRIGVFAIDTGSGNTFGYRSDERFPLCSSFKGFLAAAVLERVQQKKLDINQKVKYESRDLEYYSPITTKYKGSGMTLGDMASAALQYSDNGATNIIMERFLGGPEGMTKFMRSIGDNEFRLDRWELELNTAIPGDKRDTSTPKAVANSLNKLALGNVLNAKVKAIYQNWLKGNTTGDARIRASVPADWVVGDKTGSCGAYGTANDYAVIWPKNRAPLIVSIYTTRKSKDDKHSDKTIAEASRIAIQAID	110.54	gnl|BL_ORD_ID|1391|hsp_num:0	1512			171	402	
BGC0000081.1|Kedarcidin_61 # 73373 # 74653 # -1 # ID=1_61;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=10bp;gc_cont=0.705	BGC0000081.1|Kedarcidin_61 	73373	74653	-	Loose	400	30.0314	Erm(47)	19.15	3003908	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACGCCGATCACGAACTGCCGCGTGTGCGGCAACCGCGAGCTGATCCCCGTGCTGGACCTCGGCGAGCAGGCCGTCACCAGCGTGTTCCCGGACTCGCCCGACCAGCCCGTGCCCGTCGTGCCGCTGGAGCTGGTCAGGTGCGGCCCGGACGGGTGCGGCCTGGCGCAGCTGCGGCACTCCACCGACGTGGACCTGATGTACGGCACCGGCTCCTACGGCTACCGGTCGAGCATCCGGCCGTACATGGTGGACCACCTCGGCCGGCAGGTCGAGCGCATCACCGAGGTGGTCGACCTGGAACCCGGCGACCTCGTGCTGGACATCGGCAGCAACGACGCCACCATGCTGCGCGCCTTCCCCCGGCGCGGACTGGAACTGGTCGGCATCGACCCCAACGGCGAGCAGTTCCGGTCGCAGTACCCGCCGGGGATCGAGCTGGTCACCGACTACTTCTCCAAGGACGTCTTCACCGCGCGGTTCGGTGACCGGCGCAAGGCGAAGGTCGTCACGTCGATCGCGATGTTCTACGACCTGCCCAGCCCGTTGGAGACCATGCGCGACATCTACGACGTCCTGGACGAGGACGGCGTGTGGGTGTCCGAGCAGAGCTACCTGCCCGCGATGCTGGCCAAGGGCGCGTACGACGTGGTGTGCCACGAGCACCTGGAGTATTACGCGCTGCGCCAGTTCGAGTGGATGGCCGAGCAGGTCGGGTTCACCGTCGTCCGGGCGGAGATCACCCCCGTGTACGGCGGCAGCCTCAACCTCGTGATGGCGAAGAACGCGCGGCGCCACCGGCCCGACCTCGGCGGCGTCGAGGCCATCCGGCGGGCCGAGGCGGACCTCGGCCTGGACGGGATGCGCCCGTTCACCGCGTTCGCCGACCGGTCCACGCGGCTGCGCGAGGAGCTGCGCGGGTTCCTCGACAGCTCACGGGCGGCGGGGAAGCTGACCCTCGGCTACGGCGCCTCCACCAAGGGCAACGTGATCCTCCAGTTCTGCGGCGTCACGCCGGCGGACCTGCCGTGCGTGGGCGAGGTCAACGAGGACAAGGCCGGCCGGTTCACCCCCGGCACCGGCATCCCGATCGTCTCCGAGCAGGAGGCCCACGCCCGCGAGCCCGACCAGCTGCTGGTGCTGCCGTGGGTGCACCGCGACGACTTCCTGGGCCGGGAACAGCACTTCCTGGACCGCGGCGGCCGAATGGTGTTCCCGCTGCCGGACCTGACCGTCGTCGCCGCCGACACCGACCGGCTGCCGGCCACCGAGACCAACTAG	MTPITNCRVCGNRELIPVLDLGEQAVTSVFPDSPDQPVPVVPLELVRCGPDGCGLAQLRHSTDVDLMYGTGSYGYRSSIRPYMVDHLGRQVERITEVVDLEPGDLVLDIGSNDATMLRAFPRRGLELVGIDPNGEQFRSQYPPGIELVTDYFSKDVFTARFGDRRKAKVVTSIAMFYDLPSPLETMRDIYDVLDEDGVWVSEQSYLPAMLAKGAYDVVCHEHLEYYALRQFEWMAEQVGFTVVRAEITPVYGGSLNLVMAKNARRHRPDLGGVEAIRRAEADLGLDGMRPFTAFADRSTRLREELRGFLDSSRAAGKLTLGYGASTKGNVILQFCGVTPADLPCVGEVNEDKAGRFTPGTGIPIVSEQEAHAREPDQLLVLPWVHRDDFLGREQHFLDRGGRMVFPLPDLTVVAADTDRLPATETN	MNRKSVRFGQNFVTSINDINKICKKIDVNSNDVYFEIGPGKGHFTQYFVERAKEVIAIEIDSELIPILNNKFSDLDNIKIINHDFMSYELPSTFKYKVFGNIPFNLSTSIIRKLSLEKYADEIYLIVELGFAKRLEDLNRKMGLMLAPFYEISILYNIPKRYFHPIPSVEVVLIKLKRTSYNMSMKEYIKYEDFIEKWVKKDYNVLFTKNQLKQAIRYGNIDNLRILKVDQILSIFESYKLFNGLK	173.17	gnl|BL_ORD_ID|2146|hsp_num:0	2387			54	285	erythromycin; lincomycin; clindamycin; spiramycin; azithromycin; quinupristin
BGC0000081.1|Kedarcidin_62 # 74653 # 76326 # -1 # ID=1_62;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.749	BGC0000081.1|Kedarcidin_62 	74653	76326	-	Loose	1000	59.6918	almE	23.77	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACTGTGCGAGCCGTGCGGCCGAGCCGCGCCGGAACCGTGCCCTGGCCAGAGGACGTGGTCGCCGAGTACGTCGCCAAGGGCTACTGGCAGGGCGTTCCGCTGGGCCGCCACTTCCTCGCCGCCGCCGACGCCGCCCCGGACGCCATCGCCCTGGTCGACGGTGACACGCGGCTGACCTTCCACGACCTGGCGGCACGCGCGGACGGCGCGGCGCTGCGACTGCGCGACCTCGGGCTGCGTGCCGACGACCGCGTCCTCGTGCAGCTGCCCAACCGCTGGGAGTTCGTGGTGCTGTTCCTGGCGTGCCTGCGCTCGGGCGTGCTGCCCGTGCTGGCGCTGCCCGCCCACCGCCGGCACGAGCTGTCCTACCTCGCCGAGCACGCGGAGGCCGCGGCGATCGCCGTGCCCGCGACGTTCAAGGGCTTCGACCACCGCGCGCTGGCGGCGGACATCGCGGCCGACCGCCCCACCGTGACGCACCTCCTCGTCTCCGGCGGCGCGCAGCCGGGCGACGTCGACCTGCGCGAGCTGTGCGCGCCCGCGGCCGACCCGGTCGCCGCGCGCGCCGTGCTCGACCGGGAGGAGCCGGGCAGCCGGGACACGGCCCTCTTCCTGCTCTCCGGTGGCACCACCGCGCTCCCGAAGCTGATCGCGCGCACCCACGACGACTACGCGCACTACGTGCACCGCACGGTGGACGCCGCCGGGTACGGCCCGGACACGGTGAACCTGGTGGCGCTGCCGGTCGGCCACAACTTCTCGCTGGGCGTGCTGCTGGCGACGCTGTTCGAGGGTGGCCGCGTGGTGTTCGGCTCCCCCGAGCCGGAGCAGGCGTTCGAGCTGGTCGAGCGCGAGGGCGTCACCCACTCCGGCCTGGTGCCCGCGGTGGCGCAGCGGTGGCTCGAGCACCGCGCCGCCGCTCCCGGCCACGACCTCGGCACGCTGCGCGGCCTGATGGTCGGCGGCTCGCGCCTGCCCGACCACGTCGCGGCCCGCATCGGGCCCGAGCTGGGCTGCGCGTTGCAACAGGGTTACGGGATGGCCGAGGGTCTGGTCTGCCTGACCCGGCCCGCCGAGGGCGACGAGGTGGCCTGCCACACGCAGGGCCGTCCGCTGTCCGGGGGCGATGAGCTGATGGTCGTCGACGAGGCGGGCGATCCGGTGCCCGCGGGCGAGCCGGGTGTGCTGCTCACCCGCGGCCCGTACACGCCGCGGGGCTACTACCGCGCCCCGGAGCAGAACGCCCGCGTGTACACCCCCGACGGGTGGTACCGCACCGGCGACATCGTGCGGCTGCGGCCGGACGGCAACGTGGTCGTGGAGGGTCGGGAGAAGGACATGATCAACCGCGGTGGGGAGAAGGTCTCGGCGGAGGAGGTCGAGAACCTCGCCCTCCAGGTGGACGGCGTGCTGATGGCCGCCGCCGTGGCGATGCCCGACGCCGAGCTGGGCGAGCGGGTCTGCCTGTACGTCGTGCCCCGCACGGGCCGCGAGGTGCGCCTCGCGGACGTGCTCGACCTGATGCGGCGCGTGGGGGTGGCGCGGTACAAGCTGCCCGAACGGCTCGTCGTGGTGGACGCGCTGCCGTTGACCGGGATGCAGAAGGTGGACAAGAAGGCGCTGCGGGCGGACGTCGAGCAGCGCCTCGCGGGCGAACGGGCGGTCGTGTGA	MTVRAVRPSRAGTVPWPEDVVAEYVAKGYWQGVPLGRHFLAAADAAPDAIALVDGDTRLTFHDLAARADGAALRLRDLGLRADDRVLVQLPNRWEFVVLFLACLRSGVLPVLALPAHRRHELSYLAEHAEAAAIAVPATFKGFDHRALAADIAADRPTVTHLLVSGGAQPGDVDLRELCAPAADPVAARAVLDREEPGSRDTALFLLSGGTTALPKLIARTHDDYAHYVHRTVDAAGYGPDTVNLVALPVGHNFSLGVLLATLFEGGRVVFGSPEPEQAFELVEREGVTHSGLVPAVAQRWLEHRAAAPGHDLGTLRGLMVGGSRLPDHVAARIGPELGCALQQGYGMAEGLVCLTRPAEGDEVACHTQGRPLSGGDELMVVDEAGDPVPAGEPGVLLTRGPYTPRGYYRAPEQNARVYTPDGWYRTGDIVRLRPDGNVVVEGREKDMINRGGEKVSAEEVENLALQVDGVLMAAAVAMPDAELGERVCLYVVPRTGREVRLADVLDLMRRVGVARYKLPERLVVVDALPLTGMQKVDKKALRADVEQRLAGERAVV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	100.18	gnl|BL_ORD_ID|4935|hsp_num:0	5928			549	1650	colistin A; colistin B
BGC0000081.1|Kedarcidin_63 # 76590 # 77027 # -1 # ID=1_63;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=9bp;gc_cont=0.721	BGC0000081.1|Kedarcidin_63 	76590	77027	-	Loose	2200	23.8682	rpoB2	28.0	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGCTTCAGTGGAAAACCGCGCTCAAGACCAGTGCCGCTCTCGTGGCCGCGGCCGGGTTCGCGCTGACCCTCGGAACGCCGGCGTCCGCCGCGGCCTCCGCGGCGGTCAGCGTGTCCCCCGCGACCGGCCTGGCCGACGGCGCGACGGTCACCGTGTCCGCGTCCGGCTTCGCGACCAGCACCTCGGCCACCGCTCTCCAGTGCGCGATCCTCGCCGACGGCAGGGGTGCGTGCAACGTGGCGGAGTTCCACGACTTCAGCCTGAGCGGTGGTGAGGGCACGACCTCCGTGGTCGTGCGCCGCAGCTTCACCGGGTACGTCATGCCCGACGGCCCCGAGGTCGGTGCCGTCGACTGCGACACCGCGCCCGGCGGCTGCCAGATCGTGGTCGGTGGCAACACCGGCGAGTACGGCAACGCGGCCATCTCCTTCGGGTGA	MLQWKTALKTSAALVAAAGFALTLGTPASAAASAAVSVSPATGLADGATVTVSASGFATSTSATALQCAILADGRGACNVAEFHDFSLSGGEGTTSVVVRRSFTGYVMPDGPEVGAVDCDTAPGGCQIVVGGNTGEYGNAAISFG	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	12.48	gnl|BL_ORD_ID|2431|hsp_num:0	2831			135	285	rifampin; rifaximin; rifabutin; rifapentine
BGC0000081.1|Kedarcidin_64 # 77230 # 78912 # -1 # ID=1_64;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.715	BGC0000081.1|Kedarcidin_64 	77230	78912	-	Loose	900	323.168	QepA4	45.95	3004379	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCTTCGACACCCGCGCCCGCCGCCGGCCCGATGGCCGGGCGGCGGGAGTGGATCGGCTTGGCGGTGCTGTGCCTGCCCACGCTGCTCGCGTCGGTGGACCTGACCGTCCTGTACCTCGCCCTGCCCCGGTTGAGCGCCGAGCTGGGCACCAGCGCCACCCAGCAGCTCTGGATCGTCGACATCTTCGGCTTCATGACGTCCGGCCTGCTGGTAACCATGGGCACGCTCGGCGACCGGATCGGCAACCGCAAGATGCTGATCATCGGCTGCACGGCGTTCGCCGCCGCCTCCCTGCTGGCCGCCTACTCGCCCAACCCCGAGATGCTGATCGCCGCCAGGGCGCTGCTGGGCGTCGCGGGCGCGGTGGCACTGCCGGCGACGCTGGCCCTGATCACCTTCATGTTCAAGAACCCGGTCCAGCGCGGCATGGCGATCGCCACCTGGATGAGCACCTTCATGGTCGGGCTCATGATCGGCCCGCTGATCGGTGGCGTGCTGCTGGAGTTCTTCTGGTGGGGCTCGGCGTTCCTGCTGGCCGTGCCGGTGATGGTCCTCGTCGTGGTGCTCGCGGTGGCGCTGCTGCCGGAGCGCAAGGACCCGAACGCGGGCAAGCTGGACTGGACGAGCGTCGCCCTGTCGCTGCTGGCGATGATCCCGCTGGTGTTCGGCTTCAAGGAGCTGGCCAAGCAGGGCTTCGCGGTGGCGCCGCTGGTCGCGCTCCTGGTCGGCGTCGTGTTCTCGGTGGTCTTCGTCCGCCGCCAGCGGCAGCTCGACAACCCGCTGCTGGACCTGAAGCTGTTCTCCATCAACACGCTGCGCACCGCACTGGTGCTCGGCATCATGGTGGGCGCCCTGAACAGCGGCGTGTCGCTGCTGGTCACGCAGTTCTTCCAGGTGATCGCGGGCCTGTCGCCGATGGAGGCCGGGCTGTGGCTGCTGCCGCCGTCCGTCGCGATGGTGATCGGCCTGTTCCTCGCGCCGCCGCTGGCCGCGAAGCTGCGCCCCGGTGGCGTGATCGCCCTCGGCCTGGGCATCTCCACGGTCGGCTACGTGATCCTCTCCCAGGTGGAGGCGGCCGGTGGCCTGGCCATGGTGGTGACCGGCTTCGGCGTCCTGCTGTTCGGCATGGGCCTGCCGTCGTCGCTGGGCACCGCCCTGGTGATGGGCGCGGCGCCGCCCGACCGGACCGGCGCGGCCTCCTCGCTCCAGCAGACCGGCAACGAGTTCGGCATCGCGATCGGCATCGCCACCCTCGGCAGCCTCGGCATGGCCGTCTACCGCGGTCAGTTGAGCGAGAACATGCCGTCCAGCGTGCCCGCCGACGCGGCGGACACCGCGCAGCACGGCATCCCCGGCGCGCTGGAGACCGCCGAGCGCTTCCCGGAGGTGCTTGAACCGGCGCGGGCGGCCTTCACGTCCGGGTTGAACGCGGTGTCCCTCGTCAGCGCGGTGCTGATGGTCGGGCTCGCCGTGTTCGCCTACTTCTCGCTGCGCAACGTCGAGGCCGCGCCCATGGGCCCGCCGGACGGGATGGGCGAGGGCGGACCGGCCGGTGGCTACCCGCTCACCGAGAGCGCGGCGGCGGAGGGTCCCGCGCCGGAGGGTCTGCCGGAGCGGTCGGACCCGGCCGAGGACGTCCCGGTGCCCCGCGCGGAACAACGCCGGGGAGGTTCCGAATAA	MPSTPAPAAGPMAGRREWIGLAVLCLPTLLASVDLTVLYLALPRLSAELGTSATQQLWIVDIFGFMTSGLLVTMGTLGDRIGNRKMLIIGCTAFAAASLLAAYSPNPEMLIAARALLGVAGAVALPATLALITFMFKNPVQRGMAIATWMSTFMVGLMIGPLIGGVLLEFFWWGSAFLLAVPVMVLVVVLAVALLPERKDPNAGKLDWTSVALSLLAMIPLVFGFKELAKQGFAVAPLVALLVGVVFSVVFVRRQRQLDNPLLDLKLFSINTLRTALVLGIMVGALNSGVSLLVTQFFQVIAGLSPMEAGLWLLPPSVAMVIGLFLAPPLAAKLRPGGVIALGLGISTVGYVILSQVEAAGGLAMVVTGFGVLLFGMGLPSSLGTALVMGAAPPDRTGAASSLQQTGNEFGIAIGIATLGSLGMAVYRGQLSENMPSSVPADAADTAQHGIPGALETAERFPEVLEPARAAFTSGLNAVSLVSAVLMVGLAVFAYFSLRNVEAAPMGPPDGMGEGGPAGGYPLTESAAAEGPAPEGLPERSDPAEDVPVPRAEQRRGGSE	MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLWILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAALFAFASVLAALADTAALLIAARALLGLAGATIAPSTMALIRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFWLNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASMAALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYLQLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQGLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGSVGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDALQATAWAGAVLVLVAAGLVARLLRKRPALASG	109.59	gnl|BL_ORD_ID|2490|hsp_num:0	2880			42	1476	
BGC0000081.1|Kedarcidin_65 # 79089 # 80699 # -1 # ID=1_65;partial=00;start_type=ATG;rbs_motif=AGTGA;rbs_spacer=7bp;gc_cont=0.714	BGC0000081.1|Kedarcidin_65 	79089	80699	-	Loose	1900	26.5646	MuxB	31.03	3004074	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTCCGGCCGAGACGACCTCCCAGGTCGACTTCGACGGCGAGACGCTCGACATCCCGTCCGTCCGGCGCGTCGCCGAGGGAGGGGCGCCCAGCCGGCTCAGCCCGGCGACCCTGGCCAAGGTGGCCGCGGGCCGGGCGCTGTGCGAGGAGGTCGTCGAGCAGGGTGTGCCGGTGTACGGCATCACCACCGGCTACGGCGACCTGGGCTACATCGCGGTCAACACGACCAAGGAGACCGAGCTCCAGCTGAACCTGGTGCGCAGCCACAGCGCCGGCGTCGGCCCGGTCTTCGCCGAGGACGAGGCGCGCGCGATGGTCGCCGCCCGGCTCAACGCGTTCGCCCGCGGCTACTCGGCGGTGCGCGTGGAGGTGCTCGAACAGCTCGCGACGTACCTCAACCGGGGTATCACGCCCGCCATCCCGGAACTCGGTTCGCTGGGCGCGAGCGGTGACCTGGCGCCGCTGTCGCACATCGCGAGCGCGCTGATCGGCGAGGGCTACGTGCTGCGCGACGGTCAGCCCGTGCCGACCGGCCCGGTGCTGCGCGAACTGGGCATCGAGCCGCTGCAACTCCGGTACAAGGAGGGGCTGTCGCTGATCAACGGCACGTCCGCCATGACCGGCCTGGGCGCGCTGGTCACGGCCCGCGCGCTGGACCAGGTGCGGCAGGCGGAGATCGTGGCGGCGCTCGTGGTGGAGACCATGCGCGGCTCCACCGGCGCGTTCATGGCCGAGGGCCACGAGCTGGCCCGTCCGCACCAGGGGCAGGTCGACAACGCCGCGAACATGCGCGCGCTGCTCAGCGGCAGCCGGATCGCCCTGGACCACGCCGAGCTGCGGCGGCAGGTCAAGGAGCAGACGCAGGACATGGCCAACGTGCAGCGCACGAAGACCTACCTGCAGAAGGCGTACACCCTGCGCGCGGTGCCGCAGGTCGTGGGCGCGATCCGGGACACCGTCTACCACGCGACGCGGGTGGTGGAGACCGAGCTGAACTCGTCGAACGACAACCCCCTGTTCTTCGAGGGGCAGGAGGTGTTCCACGGCGCCAACTTCCACGGTCAGCCGGTGGCCTTCGCGATGGACTTCCTCATGCTCGGGCTCACGCAGCTCGGCGTGATGTCCGAGCGCCGGACCAACCGCCTGCTCAACCGGCACCTCAACGGCGGCCTGCCGGAGTACCTCGTGTCCAACGGGGAGCCCGGCCTGCACAGCGGTTTCACCGCCGTGCAGTACGTGGCGACGGCACTGGTGGCCGAGAACCGGACGGTCGGGCCGGCCAGCACGCAGAGCGTTCCGTCCAACAGCGACAACCAGGACGTCGTGAGCATGGGCCTGATCGCGGCGCGCAACGCGCGGCGGGTGCTGGCCAACAACAACCACATCCTCGCGGTGGAGTTCCTGTCGGCCGCGCAGGCGGTCGACCTCGGGGAGACCTACGACCTCCTCAGCCCGGTCGGCAAGGCGACCTACGACCTGGTGCGCTCGCTCGCGCCGACCCTGGACCGCGACCGGTACATGGCCGACGAGATGGAGCGGGTGGCCGCCGCGGTGGCGCGCGGCGACTTCCTCCGCGCCGCCGCGGAGCACTCGGTGACGCTGCGCTAG	MTPAETTSQVDFDGETLDIPSVRRVAEGGAPSRLSPATLAKVAAGRALCEEVVEQGVPVYGITTGYGDLGYIAVNTTKETELQLNLVRSHSAGVGPVFAEDEARAMVAARLNAFARGYSAVRVEVLEQLATYLNRGITPAIPELGSLGASGDLAPLSHIASALIGEGYVLRDGQPVPTGPVLRELGIEPLQLRYKEGLSLINGTSAMTGLGALVTARALDQVRQAEIVAALVVETMRGSTGAFMAEGHELARPHQGQVDNAANMRALLSGSRIALDHAELRRQVKEQTQDMANVQRTKTYLQKAYTLRAVPQVVGAIRDTVYHATRVVETELNSSNDNPLFFEGQEVFHGANFHGQPVAFAMDFLMLGLTQLGVMSERRTNRLLNRHLNGGLPEYLVSNGEPGLHSGFTAVQYVATALVAENRTVGPASTQSVPSNSDNQDVVSMGLIAARNARRVLANNNHILAVEFLSAAQAVDLGETYDLLSPVGKATYDLVRSLAPTLDRDRYMADEMERVAAAVARGDFLRAAAEHSVTLR	MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMTSSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLPNDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGGQRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADAYRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRIKALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATLIPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSPLEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLTLTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLALTALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYIGVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDRVARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASRLGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQVRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQGSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLALMLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPILMTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRWAAWRKQRGLDLNTEAGFDGDAGR	51.39	gnl|BL_ORD_ID|2364|hsp_num:0	2718			2208	2457	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0000081.1|Kedarcidin_66 # 80707 # 84222 # -1 # ID=1_66;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.770	BGC0000081.1|Kedarcidin_66 	80707	84222	-	Loose	1000	117.087	almE	26.7	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACCGCGCCACGCCGACCGTCCACAGCGGACCAGCCCGCGACACCGGCCCAGCAGGGCCTGTGGTTCCTGCACGAGCTGCTGCCCGACAGCGCGCTCAACACCTGCTTCGCCTACGACGTCACGGGACCGCTCGACGTGGACGCGCTGCGTGCCGCCTGGCGGACGCTGCTGCGCCGGCACGACGCGCTGCGGTGCTCGGTGCGCGAGGTCGGTGGGCTGCCGGTGCTCGACGCGACCGGTCCGGGCGCGGACGCGGTGGTGGTCGACCTGGCCGGTGACGCGGCGGCGGCCGAGCGGCGGCGCGCGGAGATCGCCGCGACACCGTTCGACCTCGCGGCGGGCGGTCCGGTCACGCTCACCGTGCTGCGCGTGCACGACCGGCGGCACCTGGTCGTGCTCGCGGCGCACCGGCTCGTCGCGGACGAGTCGTCGCTCGCGGTCCTGGTGGACGAACTGGGCCGGTGCTACGCCGATCCCGGCGCGCACCTGCCACCGGCGCCGCGGTTCACCGACCGCGGGCCCGTCGGCGAGGAGGCGGCGGCGCTGCGCCGGTGGTGGCGGGCGGCCCTCGCCGCCGGTCCCGCGCCGGCGGCCGTGCCCGCCGACCGCGTCCGCCCCGCCGAACCGTCCCGCGCCGCCGGGGAGATCCGCTTCGACTGGGGTCCCGACCTGGGCCGGGCGCTGGCGGAGCGGTCCGCCGCCGAGGGCGCCGCGCCCGAGGTGTTCCTGCTGGCGGGTTTCCTCGCGCTGCTGTCCCGCTACGGCGGCGAGCGGCGGGTCTCGGTCGGTCACCTGGTCGACGCGCGCCCGGTCGGCGGTCGGTCGGAACGCGTCGTGGGACCGTTCGGCAACCTGGTGCTGGTCGACGCCGACGTGGACCCGACGGCGTCGTTCGGCGACCTCGCGCGGCACGTCGACTGGCGGCGCGCGGACGCGCTCGCCCACCGGCAGCTTCCGTACAGCGACGTGGTGCGGTTGCTGGGCGGTCCCCGCTCGGTGGACCGGATCCCGCTGTGCGACACCACCTTCGCCGTCGAGACCGTGCCGGAGCTGTGGTTGCCGGGCCTGGTCGCGCACGGCACGCGGGTCGGCACCGGCGGGTTGCTCACCGACGTGGCCCTGACCGTGGAACCGGTCGGGACCGCCGTGCGCGGGCGGTTGGAGTACCGGGAGAACCGCTACGACGCGACCACCGCCGCCACGGTGCTCGCCCAGTGGCGCACCCTGCTGACCGCCGCCCTCCGCCACCCGGCGACCCCGGTCGGCGAACTGCCGCTGGAGACGCCGGGCCAGGCCGCCGCGGCGGTGCGGGCGGCCGATTTCGTCGGCGGCGCGCCGGAACCGCGGCGGCCGGTGCACGTGGCCGTGCGCGAGCAGGCCGCGCACCTCCCCGACGCGCCCGCGGTGTCCTGGCAGGGCGAGGTCGTCACGTACGCCGAGCTGACCACCCGGGCCGGCGCCCTCGCCGCCCGCCTGCGACCGGGCGGCGGGCCCGTCGCGGTGCGGGTGCCGACCGGACCGGAGCACGTCGTGGCGCTGCTCGGCGCGTTCACCGCCGGCGGGCACGTGGTGTGCCTGGGCGGCGGGGTCACCGGCGGCCGGGACCGGGAGATCCTGGCCGAGCTGCGACCCCCGTGCCTGGTGGTGGCGGACGCGCGGGACGCGGCCGGCGAGTTGGCGCGGTGGTACCGGGAGGAGATCGGCGGGCAGGTGGTCGCCGTGGCGGACGCGGTGCCCGACGACGAGCCGCACCCCGCCGTGCCCGCCCCGCGCCTGCCGATCCCACCCGGCGCCGCGCTGCCGGACCTGATCCCGTCGGGTCCCGCCGACCGGAACCCGCCGGGCAACGCCCTCGGCGGTGAACCCCGCGGTGGACCTCGCAGCGCACCCGGCAGCGTCCTGGGCGTCCGTCCCCGCGACGAGCCGAGCGACGTCACCGCCGACGACCCGACCACCGCACCCGACGACGAGTCCTTCGCCGGACCTCGCAGCGCACCCGGCAGCGTCCTGGGCGTCGGTCCCGGCGGGTCCCCGGACAGCGCACCGCCGGGCGTCGTCCGCGGTGCCGCCCCGCGCGGCGACACCGCGGACGACGCGCCGCACGACGAGCCGGGCGACGAACCCGACGACGGGCCCGGCGACGAGGCGAACGGGTTGGACGACCTCGCCTACGTCGTCCACACGTCGGGCTCGACCGGGCGTCCCAAGGGCATCGCGCACACCCATGCGAGCTTCGCCCAGTTCGTCGACTGGGTGGTCACCGAGCTGGGCATCGGGCCGGGCGCGCGGGTCGCGCAGTGGTCCGCTCCCGGGTACGACGCGAGCCTGTGCCAGATCTTCACCCCGCTGGTGGCCGGCGCGACGCTGTGCCCGGTGCCGGACAAGGTCCGGGTCGACCCGCGCAAGCTCGTGCGGTGGCTGGTGGACGAGCGCGTGACGTTGTTCGAGACGGTGCCGAGCTTCGCCCGGCAGCTGCTCAAGGCGTTGCGCGAGCGGGACCCCGAGCTGCCCCGGCCCGCGTTGCGGCAGCTCCTGCTGGCGGGCGAACCGCTGCCCGGCGAACTGGCGGGACGGCTGCGGGCGGAGCTGCCGGGTGTCCGGCTGATCAACCTGTACGGCCCGACCGAGGCGATCCTGGCGACCTGGCACGACGTCACGACGCCGGTCCGGGGGATGGTCCCGATCGGACGCCCCCTGCCGGGCCGCCAGGTGCTGGTGCTGGACGACCACGACCGGCCGTGCGCGCCGGGTGTCCCGGGTCAACTCGTGATCCGGAGCCCGTACGTGACGACGGGCTACGTCGGCGGTGGCGGGGAAAGGGCTTTCCGCCGCCTGCGCGACGACGACCCGCTGCCGTGCTACCGCACCGGTGACATCGGTCGGCAGCGCTGGGACGGCCTGCTGGAGTTCCAGGACCGCCGCGACGCGCAGGTCAAGTTCTTCGGCAACCGCCTGGAGCTGACCTCGTTGGAAGCGGCCCTGACCGACCACCCGTCGGTGGCGCAGTGCGCGATCGTCCCGGTGGTCGACGGGGACGGGCTGGTGGTGCGCCTCGCGGCGCACGTGGTGCCCGAACCCACCGCGCCGCGTGAGGCCGCCGCACTCGCGGCGCCGCTGCGGGCGCACCTGAGGGAGCGGTTCGGCACGGCCACGCCGCCCATGGCGTTCACCGCCGTGGCCGACCTGCCGCGCACCGCGAGCGGCAAGCTCGACCGCCGCCGGCTGCCGGCCCCGCCCGCCGCACCGGCGGTGCGGGCCGCGGAGGCCGTCGAGTCCGCGGTGGCGGCGCTGTGGACGGAGCTGGTCGGGACGACACCCGCGCCGGACGACTCCCTGTTCGCGCACGGCGGGCACTCCCTGCTGCTGCTGCACCTGCTGGACCGCGTCCACGCGCGGTTCGGCGTCCGGATCCACCTGCGCGACTGCCTCGCCCGCCCCACGGTGGCCGAGTTCGCCGCGCTGGTCGCCGCGGCCGATGTGGCCGCGGCGCGCACAACGACGAACGAACAGTGA	MTAPRRPSTADQPATPAQQGLWFLHELLPDSALNTCFAYDVTGPLDVDALRAAWRTLLRRHDALRCSVREVGGLPVLDATGPGADAVVVDLAGDAAAAERRRAEIAATPFDLAAGGPVTLTVLRVHDRRHLVVLAAHRLVADESSLAVLVDELGRCYADPGAHLPPAPRFTDRGPVGEEAAALRRWWRAALAAGPAPAAVPADRVRPAEPSRAAGEIRFDWGPDLGRALAERSAAEGAAPEVFLLAGFLALLSRYGGERRVSVGHLVDARPVGGRSERVVGPFGNLVLVDADVDPTASFGDLARHVDWRRADALAHRQLPYSDVVRLLGGPRSVDRIPLCDTTFAVETVPELWLPGLVAHGTRVGTGGLLTDVALTVEPVGTAVRGRLEYRENRYDATTAATVLAQWRTLLTAALRHPATPVGELPLETPGQAAAAVRAADFVGGAPEPRRPVHVAVREQAAHLPDAPAVSWQGEVVTYAELTTRAGALAARLRPGGGPVAVRVPTGPEHVVALLGAFTAGGHVVCLGGGVTGGRDREILAELRPPCLVVADARDAAGELARWYREEIGGQVVAVADAVPDDEPHPAVPAPRLPIPPGAALPDLIPSGPADRNPPGNALGGEPRGGPRSAPGSVLGVRPRDEPSDVTADDPTTAPDDESFAGPRSAPGSVLGVGPGGSPDSAPPGVVRGAAPRGDTADDAPHDEPGDEPDDGPGDEANGLDDLAYVVHTSGSTGRPKGIAHTHASFAQFVDWVVTELGIGPGARVAQWSAPGYDASLCQIFTPLVAGATLCPVPDKVRVDPRKLVRWLVDERVTLFETVPSFARQLLKALRERDPELPRPALRQLLLAGEPLPGELAGRLRAELPGVRLINLYGPTEAILATWHDVTTPVRGMVPIGRPLPGRQVLVLDDHDRPCAPGVPGQLVIRSPYVTTGYVGGGGERAFRRLRDDDPLPCYRTGDIGRQRWDGLLEFQDRRDAQVKFFGNRLELTSLEAALTDHPSVAQCAIVPVVDGDGLVVRLAAHVVPEPTAPREAAALAAPLRAHLRERFGTATPPMAFTAVADLPRTASGKLDRRRLPAPPAAPAVRAAEAVESAVAALWTELVGTTPAPDDSLFAHGGHSLLLLHLLDRVHARFGVRIHLRDCLARPTVAEFAALVAAADVAAARTTTNEQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	210.61	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1668	colistin A; colistin B
BGC0000081.1|Kedarcidin_67 # 84219 # 85595 # -1 # ID=1_67;partial=00;start_type=ATG;rbs_motif=GGAAGG;rbs_spacer=8bp;gc_cont=0.728	BGC0000081.1|Kedarcidin_67 	84219	85595	-	Loose	750	28.4906	LRA-10	29.31	3002489	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase	ATGGGGCAAGGCACCAGCGCTGTGGACGGCTCGCACTTCGCGCTATCCCTGGAGCAGGAGTTCCTGCGAGCGCAGCACGAGCACGACGGTTCGGCCGGTGATTCCGCACCGCGCCTGATCTCCAGCGGCGGGTGGCGGCTGACCGGGGAGCTGGACCTGGCGTTGTTCGAGCGGGCGCTGTCCGATGTGGTGGCACGCCACGAGGCGCTGCGCACCTCCGTCGTGGTCGGCCCGGAGGGGTTGCGCCAGCAGGTGCACGCACCCGCGCCGCCGCCGCTGGAGGTCCGCGTCCTGCCCGACGACCCGGACGTGTCGCGCGACGAGCGGGCCGAGCACTTCCTCAACGAGATCGAGGGCGGCACCTGGGAGGTCGGCGAAGGTCCCGCGTTCCGCGCGTTCCTGGGCCGGTTCGACGACCGGGACGCGGTCCTCGTCCTGGTGGCGCACCTGCTCGTGGTGGACGTGTGGTCGCTGAGCATCGTGGCGCGCGACATCACGACCGCCTACCAGGCGCGTGCCGCCGGCCGGGAGCCGGAGGCCGCCGACATCCCCGCCTACCGGGACTACGCCGCGAAGCAGGCGGCCCAGCGGGGCGCGGGCGAGAACGTCCACGCGTTCTGGCGCGACAAGCTCCAGGGCGCCGAGGCGATCGCCCTGACCGCGGACCGGCCGCCCGCGCCGGACGGCGTCACCGGCACCCGGTGCGACCGGTTCCTGCTGGACGCCGAGCTGGGCGCGGCCACCCGCGAGTTCGCCAAGGCGTCCCGCTGCTCGCTGTTCATGGTGCTGTTCGCCGCCTACCGGCTGCACCTGTTGCGGCGCACCGGGATGCGGGACGGTGTGGTGTGGACGCTGACCTCCGGCCCGGGTCGGCGCGACCGGTGGATGGAGAACACGGTCGGCTACTTCGTCAACATGTTCCCGCTGCGCACGGACCTCGCCGGGTGCACGACGTTCCGCGAGGTGGTGGAGCGGACCAAGGCGACGTGCGTGCAGGCGCTGTCCCGGGAGATCCCGTTCGTGGAGCTGGCGAGCCAGGCGTCCGACGCCATCGGGCAGTTGGAGCGGGGCGGCATGGTGGTGCCCGGTTTCCAGATGTCGCCCTACCCGCTGTCGGTGCGCGCCGAGTCCGCCGGCGGGTTGTCCTGCACGCAGGTGCAGCGGCGGCTGTCGCAGGAGTTCGGCCCGGACATCCCGGACGACGCGATCCTGTGGACGGCGGAGGTCGCGCACTCCGGTGAGCTGCTGTTCGCGGTCAACAGCAGCATCGACCGCTACGACCGGGAGACCATCGCCGCGATGATGGCGGAGTTCCACGCGGTGCTGCGCGACGGGGTGGGCGAGCCGGACGCGCCGCTCGCCGACACCGCCCGATGA	MGQGTSAVDGSHFALSLEQEFLRAQHEHDGSAGDSAPRLISSGGWRLTGELDLALFERALSDVVARHEALRTSVVVGPEGLRQQVHAPAPPPLEVRVLPDDPDVSRDERAEHFLNEIEGGTWEVGEGPAFRAFLGRFDDRDAVLVLVAHLLVVDVWSLSIVARDITTAYQARAAGREPEAADIPAYRDYAAKQAAQRGAGENVHAFWRDKLQGAEAIALTADRPPAPDGVTGTRCDRFLLDAELGAATREFAKASRCSLFMVLFAAYRLHLLRRTGMRDGVVWTLTSGPGRRDRWMENTVGYFVNMFPLRTDLAGCTTFREVVERTKATCVQALSREIPFVELASQASDAIGQLERGGMVVPGFQMSPYPLSVRAESAGGLSCTQVQRRLSQEFGPDIPDDAILWTAEVAHSGELLFAVNSSIDRYDRETIAAMMAEFHAVLRDGVGEPDAPLADTAR	MAIAILSSCFAPLASRAADDSARIRAIVDQAIRPVMAEHDVPGMAVAVTVDGQPFVFNYGVASRESNTPVSDATLFELGSISKTFAATLASYAQVTGKLSLDDHPGKYMPQLKGSAIDKATLLNLGTYTAGGLPLQFPDDVSDQQMASYFQHWKPKAAPGVQRTYSNPSLGLFGHLTSLALKSRFTDALETNVLTQMGMKSTYVHVPQSAMANYAWGYDQANKPGRMNPGVLADGIYGIRSTAADMIRYVQANIAPGKLETPLRRAVEGTHVGYFKVGGMVQGLGWEQYPYPVSLQQLQAGNSTTMAWEANPAQKLTPPSVPSGATLFNKTGSTSRFGAYVAFVPEKKIGIVILANKNIPGPDRIKAAHAILEQL	122.13	gnl|BL_ORD_ID|1915|hsp_num:0	2119			813	987	
BGC0000081.1|Kedarcidin_68 # 85877 # 87367 # 1 # ID=1_68;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=9bp;gc_cont=0.758	BGC0000081.1|Kedarcidin_68 	85877	87367	+	Loose	600	30.4166	rgt1438	39.66	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	GTGTCTCTGCTCCGATTCTGGGAGGCCACCAGGCTGCGCGCGGGCCACGCGCTCCCCGCGGCCGTCGCGGGCGACGGGCCCGCGCGGGATGTCGACGGCTTCCGTTCTGCGCTGGCCCACGTGCTCGGCCGCGGCTGCGGCCCGCGAACCGGGACGGTGGTCGGCAAGCACGGCATCTCCGTGCAGGCGCGCACGACGCCGTCCGCGGGTGCGCTCTACCCGTTCGAGGTCGTCGTCGGGTTGCCCGACGGCACCAGCCACCTCTACGACGTCGACGTGGCGCGCATCCGCGCGCTGCCGGGGTGCGGGGTCGTCCCCCTGCCGGAACTGGTCCGGCGCACCGGGTTGGCGGTGCCGCCGGACCGCTCGCTGCGCGCGGTGGTCACCCTGGTGGCACGACCGTGGAAGGCGATGGTGAAGTACGGGCTGCGCGGTTACCTGTACACGCACCTGGACATCGGCCACGCCGCGAGCAACATCGCGGTGTCGGCCCGGGAACTCGGGCTGGACGCGGTGGTGCACGTGCGGTTCGACCGCCGACGCCTCGCCGAAGCCCTCGCGCTGACCGACATGTGCCGCGAGCCGCAGGTGGTCGTCACGTTGTCCGGCGGCAGGTTCGACGGCGGCGACCCGGTCGCGGCGAGCCCGTCCGCCGGCGCGCCGGCCCCGGTCTGGCACACCGGCCGACCGGCCCGCCTGGATCCGCCGGACGAGGAGGAGCGGGCCAACTGGGACGAGCTGCGCGACGTGAGCCCGTACGCGGCGGACATCCCCGCGCCCAGGCTCGGGCGCTCCACGTCCGTCGAGCCGCCGGAGCAGCCGGCGCGCGAGGTCGTCCCCCTGCCGCACGGTGTTCCCGCGGCGCGGGAGGACTTCACGCGCGTCGCGCTCGACCGCCGCTCGGCGAAGGGCTTCCTCCCGCGACCGCTCACCGCCCGGCAGGTGCTGGACCTGTTCGCCGACGCGGCGGACCCGGCGGACGTCGACTGCGCGGATTCCCGCGGTGTCGGGGTCCGGGTGCTGGTGCGGGCCGCGGACGGGCTCACGCCCGGCGTGTACGCGTACTCGCCGCCCGCGCACGCGCTGCACCTGGTCGGCGAGCCCGCCGGCCGTGCGGTGACCGAGGAGGAGGTCCTCGCGACCTGCATGGGCCAGCCGGGGTTGCGGCACGCCGCCGCGTTCGTCCACCTGCACGTCCCCGTGCGCCGGCTGCTGGCCGAGCGGGGTCGCGCGGGCCTGGCCGAGATCCACTACCACGCGGCGCACGTCGCGCAGTCGCTGTGCCTCAGCGCGGCGCGTCACGGCGTGGGCATCACGTGCATCGGGGGGTTCGACGAAGTGCGGTGCGGTGACCTGATCGGGCTGCCCGACGACGACGAGGTGGTCTACCTGCTGGCGATCGGGGTGCCCGATCCCGGCGCGCGCAAGCTCGACCGCGACGCCATCGCGCACAGCCACGGCCGCGGACCGGCGACCGGGTGGGGTGAGTGA	MSLLRFWEATRLRAGHALPAAVAGDGPARDVDGFRSALAHVLGRGCGPRTGTVVGKHGISVQARTTPSAGALYPFEVVVGLPDGTSHLYDVDVARIRALPGCGVVPLPELVRRTGLAVPPDRSLRAVVTLVARPWKAMVKYGLRGYLYTHLDIGHAASNIAVSARELGLDAVVHVRFDRRRLAEALALTDMCREPQVVVTLSGGRFDGGDPVAASPSAGAPAPVWHTGRPARLDPPDEEERANWDELRDVSPYAADIPAPRLGRSTSVEPPEQPAREVVPLPHGVPAAREDFTRVALDRRSAKGFLPRPLTARQVLDLFADAADPADVDCADSRGVGVRVLVRAADGLTPGVYAYSPPAHALHLVGEPAGRAVTEEEVLATCMGQPGLRHAAAFVHLHVPVRRLLAERGRAGLAEIHYHAAHVAQSLCLSAARHGVGITCIGGFDEVRCGDLIGLPDDDEVVYLLAIGVPDPGARKLDRDAIAHSHGRGPATGWGE	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	120.68	gnl|BL_ORD_ID|116|hsp_num:0	134			438	594	rifampin; rifaximin; rifabutin; rifapentine
BGC0000081.1|Kedarcidin_70 # 88527 # 89987 # 1 # ID=1_70;partial=00;start_type=GTG;rbs_motif=GGGGG;rbs_spacer=7bp;gc_cont=0.758	BGC0000081.1|Kedarcidin_70 	88527	89987	+	Loose	1000	59.3066	almE	23.03	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAACGCCTCGGCGCTCTACGACGACGTGGCCAACGCCTGCCGCCGCGCCGGTGACCGCACCGCGCTCGGCGAGGGCGCGGACCGGTTGTCCTACCGGGACCTGGCGGTCGCGGTGGCGGCCCGCGCCGCCGACGTGGAGGAGGCGCTGCGCGGCCGTGCGACCGACCGGGTGGCGTTGCACGCGGCCAACAGCGCCGAGTACGTCGTCACCTACCTCGCGGTGCTGCGCACCGGTCGCGTGCCGCTGCTGGTGGACGCCGAGTTCGGCGGCTCCGAGCTGGCGGCGATCCGGGAGGGCTGCGGCGTCGAGGTGTTCCTCGTCGACCAGCCGAGGGTGGAGCGGGTGCCGCACGCGGAGCGCGTCGTGCCGCTGCGTGGCGGTCGGTACGCGGCGGTCACCACCGCGCCCGTCGCGGACGACCCGCCCGCGCTGCACCCGGACACGGCGGTGTGCCGGTTCACCTCGGGCAGCACGGGATCGCCCAAGTGCCTGGAGTTCTCCCGCGCGGCGGTGGTGAACGCGGCCCGCAACTGGGTCGAGGGCACGGGGATGACCGCCGACGACCGGACGCTGTGCCTCGCGGCCCTCACCAACGGGTTGGCGTTCAACACGTCCCTGCTGTCGACGTTCCTGGTCGGCGCCGAGCTGCACCTGTTCCGGGGCCTGCCGACCTCGGCCCGCGTCCTGCGGGCGATGGCGGACTCGGGCGCGACCCGGCTGGTCGCGTTCCCCGCCGTCTACCGCGTGCTGGCGGACGCCGACCTGCCCGCCGACCGGTTCACCGGGCTGAGCGTGTCGATCTCGGCGGGCGCGCCGCTGCCGGCGGACGTGCGGGCGCGGTTCGAGCAGCGCTACTCGGTCCGGATCGCCGACTACTACGGCATCGCGGAGACCGGGCCGTGCACGTTCGAGCGCGACCCCGCCCACCGGCGCGGGCTGGGCACGCCGCTGCCCGGGGTGGCGCTGCGCATCGCGCGCAACGCCGCCGGGCAGCAGGAGGTGATGGTGCGCAGCGCTTCCATGGCGACGCGCTACCTCAACGCGCCCGGCGTCCTGGAGGCCGCGCGGGACGTGGACGGCTTCCACCCGAGCGGCGACATCGGGCACTGGGAGGGCGGTCGGCTGTTCGTCACCGGCCGCACCGGCGGTCCGGTCAACCTGGCCGGGCGCAAGGTCGACCCGCGTGAGGTGGAGCAGGTCGTGCGCGCGGTGCCCGGCGTGCGCGACGCCGTCGTGTTCGCCGACCGGGACGCCGACGACCAGGTCTTCCTGCACGCGGCGGTCGCGGCGGACGGGTCCGTGCGGCGGGCCGACGTCGTGGCCGCGTGCCGGGGCTCGCTGGCGCCCTTCAAGGTGCCGCAGAAGGTGACTTTCGTGCCGGACGTCCCGCGCTCGTCGCCGGGCAAGGTCCGGATGACCGACCTGCTGCGGCTGGTGCGCGGCGGAGGGGAGGGGTGA	MNASALYDDVANACRRAGDRTALGEGADRLSYRDLAVAVAARAADVEEALRGRATDRVALHAANSAEYVVTYLAVLRTGRVPLLVDAEFGGSELAAIREGCGVEVFLVDQPRVERVPHAERVVPLRGGRYAAVTTAPVADDPPALHPDTAVCRFTSGSTGSPKCLEFSRAAVVNAARNWVEGTGMTADDRTLCLAALTNGLAFNTSLLSTFLVGAELHLFRGLPTSARVLRAMADSGATRLVAFPAVYRVLADADLPADRFTGLSVSISAGAPLPADVRARFEQRYSVRIADYYGIAETGPCTFERDPAHRRGLGTPLPGVALRIARNAAGQQEVMVRSASMATRYLNAPGVLEAARDVDGFHPSGDIGHWEGGRLFVTGRTGGPVNLAGRKVDPREVEQVVRAVPGVRDAVVFADRDADDQVFLHAAVAADGSVRRADVVAACRGSLAPFKVPQKVTFVPDVPRSSPGKVRMTDLLRLVRGGGEG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	87.41	gnl|BL_ORD_ID|4935|hsp_num:0	5928			171	1629	colistin A; colistin B
BGC0000081.1|Kedarcidin_71 # 89989 # 90264 # 1 # ID=1_71;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=8bp;gc_cont=0.728	BGC0000081.1|Kedarcidin_71 	89989	90264	+	Loose	50	22.7126	vanW gene in vanI cluster	40.0	3003724	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	ATGAGCGCACGGGGTGTCGGAGACGACCTGCGCGACCAGGTGGAGTCGCTGGTGGTGGTCGCCACGGGGCGGGTCGTCACGGCGGAGGACCTGCGGGACAGCGGTGGTTCGCTGGAGGCGGCCGGGGTCAACTCGATCGCCTACCTCAACCTGGTCGAGGCGCTGGACCACCGGTACGGCGTCGTGGTGGACCCGGAGCGGGACGGCGACGCGCTCGCCACGGTGGACGGGATCGCGGGGCTGATCCGGTCGGCGCGTGGCGGTGGCGTCGGATGA	MSARGVGDDLRDQVESLVVVATGRVVTAEDLRDSGGSLEAAGVNSIAYLNLVEALDHRYGVVVDPERDGDALATVDGIAGLIRSARGGGVG	MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK	24.40	gnl|BL_ORD_ID|4746|hsp_num:0	2242			249	309	vancomycin; teicoplanin
BGC0000081.1|Kedarcidin_72 # 90261 # 91151 # 1 # ID=1_72;partial=00;start_type=ATG;rbs_motif=GGCGG;rbs_spacer=9bp;gc_cont=0.768	BGC0000081.1|Kedarcidin_72 	90261	91151	+	Loose	1250	30.4166	mecA	35.71	3000617	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGAGCGCGCTGACCGGGCTGCTGGTCCGGCTCGCGCCGGGCGAACCCGTGCCCGCCGACGTGCCGTTCGTGGTGGCGGCGGCGGCCAACGAGCACCTGTCCGGCGTCCGGCCGCTGCTGGCGGAGTTCCGCGACGAGCGGCACCCGACCCTCGTGGCGGCGCGGGCGGGGCGGCTGCCCACCGCGCTCGCGGCGTTCACCGCGAACGCCGCGCTGGCGTGGGGTGAGCCCGCCGTCCACGCCCGCGAGGAGGGTGGCCGCGTCGTGCTGGCCGGTCGGTTCCGCGTCGCGTTCCCCGGCGCCGCCGCGTTGGTGGTGACGGGTTTCGCGGACGGGACGAGGCTGTGCCTGGTGGACCTGACCGCGCGGGGCGTGGTGGTCGGTGACGCGGGCTGGGTCGACGTGACCGACGCCGTGGTGGACCCCGCGCTGGTGTCCGGACCGGTGCGGGTGCAAGCCCCGGGCGGTCCGTTGCTGCGAGCGATCGACACGTGCGCGTGGGCCTACGCGGGGATCGCGTGGCGGCACGCCACCGCGGTCGTCGCCGACCTGCGGCGCGTGCTCGCCGCCACGGCGACGTCCGGCCCGGTGTTCAGCACGTCGCAGCTCCTCGCGCATGAGTTGACCCGCTTGGACATCGAGCTGTCGCTGTTGGGCGACGCGCTCGCGGAGCACGGCTCGCGCGGTGCGGAGATCGGTGGTGAGGCGGTGGTCGCGGTGCTCGCGGCGGCCACGGACCTCGTGCACCGCACCGGTGCGGTGGCCGCGGACATGGCCGCGGACCTGGGCCTGCCCGCCGGACCCGTCACGCCGGACGGCTACTTCGGCGGGCGGCGGATGGTCGAGGCGGAGTTGGCGCGCCGCATGGGCGTGTCGGGGGGAGCGGGCTGA	MSALTGLLVRLAPGEPVPADVPFVVAAAANEHLSGVRPLLAEFRDERHPTLVAARAGRLPTALAAFTANAALAWGEPAVHAREEGGRVVLAGRFRVAFPGAAALVVTGFADGTRLCLVDLTARGVVVGDAGWVDVTDAVVDPALVSGPVRVQAPGGPLLRAIDTCAWAYAGIAWRHATAVVADLRRVLAATATSGPVFSTSQLLAHELTRLDIELSLLGDALAEHGSRGAEIGGEAVVAVLAAATDLVHRTGAVAADMAADLGLPAGPVTPDGYFGGRRMVEAELARRMGVSGGAG	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	44.31	gnl|BL_ORD_ID|1216|hsp_num:0	1321			1446	1530	methicillin
BGC0000081.1|Kedarcidin_74 # 91884 # 93788 # 1 # ID=1_74;partial=00;start_type=ATG;rbs_motif=GAGGA;rbs_spacer=6bp;gc_cont=0.781	BGC0000081.1|Kedarcidin_74 	91884	93788	+	Loose	1000	79.337	almE	22.73	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCCGGTGACCGACACCGAGGACCACCTGCTCGACGTGCTGGAGGCGCGGGCCGAGGCGCTGGGCGACGCCACCGCGCTGTCCGCGCCCGACCACCGCGACCTCGGCTACCGGGCGCTGGTCGCGCTGGTGCGCCGGACCGGCGAGGCGCTGCGCGGGCTCGGCGTCGGCCGGGACGACGCGGTCGTGCTCGCCCTGCCCAGCGGACCGGCGCTGGCCGCCGCGTTCCTCGGCGTGGCGGCGCACTCGCTCGGCGCGCCGCTCAACCCGGCGCTCCCGGCGGACGAACTGGACCGGTTGTTCACGGACCTGCGCCCGCGTGCCGTGCTGGTGCCGGCGGGCACGGCCGGCGTGGCGGCGGACGTGGCGCGGGCGCACGGCGCGGCGGTGCTGACCGTGACGCCGGACCCCGCGGTCGCGGGTGTGTTCGAGCTGACGGGCGAGCCGGTCGGCCCGCCCGCGCCGGACCGGCCGGCCGCCGCCGGGGACGACGCGCTGGTGCTGTTCACCTCCGGGACGATCGCGCAGCCGCGCCAGGTGCGGCTGACCCACCGCAACCTGTGCGCGGCGGCGCGCAACACCGCGCGTGCCTTCGCGCTCGGCCCCGCCGACCGCTGCCTGAACGTGATGCCGCTGTTCCACGCCCACGGCCTGGTCAGCACGCTGCTGGCGTCGGTGGTGCGCGGCGCGTCGGTGATCTGCCCGCCGGGCTTCGACGCGCACGGGTTCTTCGCCTGGCTGCACGAGTCGCGGCCGACCTGGTACACGGCCGTGCCCGCGATGCACCGGGCGCTGCTGGAAGCCGCGCCCGCGCACGCCGCCGAACTGGCCGCCGCGCGCCTGCGGCTCATCCGCTCGGCGTCCGCGCCGCTGCCCGGTCCCGTGCTGGACGAGTTGGAGCGCGTGTTCCGGGCGCCGGTGATCGAGGCGTACGGCATGACCGAGGGCGCGTCGCTGGTCACCAGCAACCCGCTGCCGCCGGGCGTCCGGAAGCGGGGTTCGGTGGGCCTGCCGGTGGGCGAGCCGGTCCGCGTGCTCGACGCGGCCGGTCACGACGTGCCCACCGGGACCGAGGGCGAGATCGCCATCCGGGGCGCGAACGTGACGCGCGGGTACCACGGCGACCCGGCGGCGACCGCCGCCGCGCGCGTCGGCGACTGGCTGCGCACCGGCGACTTCGGCCGGCTGGACGAGGACGGGTACCTGCACCTCGTCGGCCGGGTCAAGGAGATCGTGAACCGGGGCGGGTCGAAGGTGGCGCCCGCCGAGGTGGACGCCGTGCTGGCCGACCACCCGGACCTGGCGCAGGCCGCCGCGTTCGCGCTGCCGCACGCCACCCTCGGCGAGGACGTGGCGGTGGCCGTCGTGCCGCGGCCCGGGGTCGAGGTGGACGAGGAGCGGGTGCGGGCGCACGTCGCCGCGCGGCTCGCGCCGCACAAGGTGCCCAGCCGCGTGTTCGTGGTCGACGACCTGCCGCGCAACGCCACCGGCAAGGTGCGCCGGCTCCGGCTGGCCGAGCTGTTCGCCGCCCGCGCGGACGTGCCGGGCGCACCGCCCGGCACCGGCACGGAACGGGCGGTCGCCGCGATCTGGGGCGAGGTGCTGGGCCGGGAGGTGGTGGACGCGCGGGTCAACTTCTTCGACCTGGACGGCGATTCGCTGGCCATGGTGCGGGTCGCGGACCTGATCGGGGCGCGGATGGGTCACGAGGTGCCGGTGTCGGTGCTGCTCGTGCACCCCACCGTGCGTGCGCTCGCCCGCTACCTGGACGACCCCGCGGCGGTGCGCGACGCGGTCGCGCCCGGTCCCGGGGACGTCGCCGCCGGCGCCGCCCGGCTCGCCGCCGGCCGCGACCGCCTGCTGCGCGCGCGGCGCCGGGCCGACCAGGGTGGGGAGGACGCGTGA	MPVTDTEDHLLDVLEARAEALGDATALSAPDHRDLGYRALVALVRRTGEALRGLGVGRDDAVVLALPSGPALAAAFLGVAAHSLGAPLNPALPADELDRLFTDLRPRAVLVPAGTAGVAADVARAHGAAVLTVTPDPAVAGVFELTGEPVGPPAPDRPAAAGDDALVLFTSGTIAQPRQVRLTHRNLCAAARNTARAFALGPADRCLNVMPLFHAHGLVSTLLASVVRGASVICPPGFDAHGFFAWLHESRPTWYTAVPAMHRALLEAAPAHAAELAAARLRLIRSASAPLPGPVLDELERVFRAPVIEAYGMTEGASLVTSNPLPPGVRKRGSVGLPVGEPVRVLDAAGHDVPTGTEGEIAIRGANVTRGYHGDPAATAAARVGDWLRTGDFGRLDEDGYLHLVGRVKEIVNRGGSKVAPAEVDAVLADHPDLAQAAAFALPHATLGEDVAVAVVPRPGVEVDEERVRAHVAARLAPHKVPSRVFVVDDLPRNATGKVRRLRLAELFAARADVPGAPPGTGTERAVAAIWGEVLGREVVDARVNFFDLDGDSLAMVRVADLIGARMGHEVPVSVLLVHPTVRALARYLDDPAAVRDAVAPGPGDVAAGAARLAAGRDRLLRARRRADQGGEDA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	114.03	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1653	colistin A; colistin B
BGC0000081.1|Kedarcidin_75 # 93785 # 99193 # 1 # ID=1_75;partial=00;start_type=GTG;rbs_motif=GGGAGG;rbs_spacer=4bp;gc_cont=0.766	BGC0000081.1|Kedarcidin_75 	93785	99193	+	Loose	2070	33.4982	smeE	36.05	3003056	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCACCGGTCTGGAGATCGCGATCGTCGGCATGGCGTGCCGGTTCCCCGGCGCGCGCGACCGGGACGAGTTCTGGCGCAACCTGCGCGGCGGCGTCGAGTCGATCACGCGCTTCACCGCGCGGGAACTGGCTGACGCGGGCGTGCCCGAGGACGTCCTGGCCGACCCGGCGTACGTGCGGGCGCACGGCGTGCTCGCCGGGTCCGACCTGTTCGACGCGGGCTTCTTCGGCTTGAGCCCCAAGGAGGCCGACCTGGTCGACCCCCAGCAACGCGCGTTGCTGGAGTGCGCGTGGGAGGCGTTGGAGGACGCGGGGTGGGACCCGGCACGCGTGCCCGGTCCGGTCGGCGTCTTCGCGGGCACCTACTACAACAGCTACCTGCCTGGGTTGCCGGCGACGGACGACCCGGCGGAGCGGTTCGCGCGCGACATCGCGAACGAGAAGGACTACGTGGCGTCCCGCATCGCCTACAAGCTGGACCTGACCGGTCCGGCGGTGACGGTCCAGTCCGCCTGCTCCACCTCGCTGGTCGCGGTGCACCTGGCCGGGCAGGCGTTGCTGAGCGGCAGCTGCGACCTCGCGCTCGCGGGCGGCGCGACGGTGCGGGCCCGCCAGGTGGTGGGCTACCACCACCAGCCCGGCGGGATCTTCTCCGCCGACGGCAGCTGCCGCGCGTTCGACGCCCACGCCGACGGCACGGTGCCGGGCAACGGCGCGGGTGTCGTGGTGCTCAAGCGGCTGGCCGACGCGCTCGCCGACGGGGACACCGTGCACGCCGTGATCCTCGGCTCGGCGATCGGCAACGACGGCGCCGACCGCGCGGGTTTCACCGCGCCCGGTGTGCCGGGCCAGGCCGCGGTGATCAGGGCGGCGCACGCGATGGCGGGCACGGACCCGGCGAGCGTCGGCTACGTGGAGACCCACGGCAGCGCGACCCGGCTCGGCGACCCGATCGAGGTCGAGGCGCTGACCCGGGTGTTCCGCGCGGCGGGCGCGCCCGCCGGGGGGTGCGCGATCGGTTCGGTGAAGACCAACATCGGGCACACCCACGCGGCGTCGGGCGTCGCCGGGCTGATCAAGGCGGCGTTGTCGGTCCGCGACGGCGTGCTGCCGCCGAGCCTGCACTTCGCCCGCCCCAACCCGGAGATCCCGTTCGACCGCACGCCGTTCCACGTCAACACCGAGCTGCGCGACTGGCCCGCGGACGGGCGTCCGCGCCGCGCCGGGGTGACGTCGCTGGGCATGGGCGGCACCAACGCGCACGTGGTGCTGGAGGAGCCGCCACCGCCGCCGCCCGCCCCGACCGGTGGTTCGGCGCGGCTGCTGGTGCTCTCGGCACGCACCGCGGACGCGTTGGAGGAGGCGACCGACCGGCTCGCCGGGCACCTGGCGCGCACGGACCAGGAACCGGCCGACGTCGAGCACACCCTGCGCACCGGTCGGCGCGCGTTCGCCCACCGGCGGTTCGTCATCGCCGACGACCTGGCCGCCGCCGCGCGGTCGCTGGCCACCCGCGACCCGCGTGCCGTGCACACCGGCCCGCCCGCGGGGCGGGAGCGGCCGATCGCCTTCATGTTCCCCGGCCTCGGCGAGCAGCGCCCCGGCATGGGCGCGGGCCTGTACCGGACGCAGCCGGCGTACCGGGCGGCGGTGGACCGCTGCGCCGAGCTGCTGCGCCCGGAACTGGGCCGCGACATCCGCGAGCTGCTGCACCCGGCGGACGCCGGGGAGGGCGGCCGGGTCGACCTCCGCCGCGTGCTCGGCCGCGGTGGCGCGCCCCGGACGTCGGAGCTGGACCGGACCCGGTACGCGCAGCCGGCCGTCTTCGTCACCGAGTACGCGCTCGCACAGCTGTGGCTGGCGCACGGCGTGCGCCCGGACGCCATGATCGGCTACAGCATCGGCGAGTACGTCGCCGCGTGCCTGTCCGGGGTGCTGGCGCTGGAGGACGCGCTGCGCCTGGTCGCGTGCCGGGCGCGGTTGATCGACGACCTGCCGCCCGGCGCGATGCTGGCCGTGCCGCTCGCCGAGGACGAGGTCTCCGCGTCGCTGCCGCCCGGTGTCGCGGTGGCGGCGGTCAACGGGCCGCGCCTGTGCGTGGTCGCGGGACCGGTGGACGAGGTCGCCGCGCTGCGCGACCGGCTCGCCGCGCGGGGCGTGGCGGCCACCGCCGTGCAGACCTCGCACGCCTTCCACTCGCCCATGATGGACCCGATCGCCGAGGAGTTCGCCGAACTGGTGGCCGGCACGCCCGCCGGCGCGCCGCGCATCCCGTACCTGTCCAACGTGGACGGTCGCTGGGTGACGGCGGACGACGTGGCGGACCCCGCCTACTGGGTGCGGCACCTGCGGATGCCGGTGCGCTTCGCGCAGGGCGTCGAGCGGCTGTGGGAGCAGCCGGGCAGGTTGCTGCTGGAGGTCGGTCCCGGTAGGACGTTGAGCAGCCTCGCGCTCCAGCTCGCGCCCGACGACCCGGACCAGGGCGTCCGCGCGGTGCCCAGCCTGCCCGGCGTGTTCGACCGCGAACCCGAGGACCGGTTCTTCCTCGGCGCGGTCGGGAAGCTCTGGCTGTCCGGGGTGGACGTCGGTCGGCCGGCCGCGCCGGGGCCCGCGCCCCGCCGGGTTCCCCTGCCCACGTACCCGTTCCAGCGCGAGCGCCACTGGGTGGAACCCGCGCCGGAGCCCACGCGGGCGCGACCGCCGGTCACGCGTGAACCCGCCGTGGCCGACTGGTTCCACGCGCCCGCCTGGGCGCCGCTGCCGCCGCACCCGCGGCACGCGGCCGTCCCGACGTCGACCGGCGAGCACTGGTTGTTGCTGGCCGACCGGTCCGGGGCCTGCCGCGACCTCGCGGACGCGTTGGCCGCGGCCGGTCACGAGGTGACCGTCCAAGGCGGCCCGCCGCCGGACCACGACTACGACGCGCTGCTCACCGGGCTGCGGGAGCAGGACCGGGCACCCCGGCGGATCGCGTACCTGCTCGGCCCGGACGCGGTCGGCGAGGACGGTTCGACCGCGTTCTCCGACCTGCTCGCGCTGACCGGCGCGCTCGGCAGGCGACCGGGCGCCGACCCCGTCGACCTGGCCGTCGTGACGCGCGAGCTGATGGTGGTCACCGGCGCGGAGCGCGGCTCGCCGGAGCAGGCGGCGGTCCTCGGCCCGTGCCGGGTGCTGCCGCTGGAGCACCCGCACCTGGCGTGCCGCGTCGTCGACATCGCGCTGGACGGCGACCCGACCGAGCGCACCGGGGGCCTGTTCGCGGAACTGGTCGACCCCTCCGGGGAGGCGGTCGTCGCGTTGCGCGGCAGGCGGCGCTGGCGGCAGGTGTTCCAACGGGTGCGGCTGGCCGTCGACCGGCCCGCGGCGCCCGGCCGCCACTACGTGATCACCGGTGGTCTCGGCGGTGTCGGCCTCGCCCTCGCCGACCACCTGGTGCGCGTGGAGCGCGCCGTGGTGACGGTGATCGGCCGCACCCCGCTGCCGGACCGGGCGGAGTGGCCGGACTGGCTCGCCCGCGCCGGCCACGCCGACGCGACCACGGCCCGCATCCGGGCGGTCGCCGCGCTGGAGGAGGCGGGCGGACCGGTGCTCGTGCTCGCCGCCGACGTCACCGACACCGCGCGGCTGCGTGCCGCGTTCGCCCGCGCCGCGCGGGTCGCGCCGATCGACTGCGTCGTGCACGCCGCGGGTGTCGCGGGCGGCGGGCTCATCCAGCTCAAGGACCACGAGGCGGCGGAGCGCGTGCTCGCGCCGAAGGTGCGCGGCGGCGCGGCGGTGGTGGAGCTGGCCGAGGAGTTCGACGTGGCGCAGGTGGTGCTGTGCTCGTCGACGCTGGCCGTCACCGGCGCGATCGGCCAGGTCGACTACGTGGCGGGCAACGCCGTGCTGGACGCGCTCGCCCACCACGCCGCCGCGCGGGGCCACCGCGCGGAGGTCGTCGCGGTCGACTGGGACGCCTGGCGGCAGGCGGGCATGGCGCACCGCCACCTCGCGGGCGACCAGGGCGGACCGGGGCCGGTGGACCACCCGCTGCTGGACGCGTGCCTGGAGCACACCAGCACCCACGCGGTGTACCGGGCGGCGCTCGACGGCCCGGCCGCGTGGTTGACCGACGAGCACCGGATGCTGGGCGAACCGGTGGTGCCCGGCACCGGCCACCTCGAACTGGTCCGCGCGGTGTGCGCCCAACTGACCGGACCGGGCCCGGTGACGCTGACCGACGTGCGGTTCTACACGCCCTTCATGGCGAGCGCGGGGCGTGAGTTGCGCGTGGTCGTGGACAAGACCGAGGTGCCCTGGCAGTTCACCACGGTGAGCCGGCTGCCCGACGGGCGGTGGCAGGCGCACGCCGCGGGCGGCGTGGGCCCCGCGCCCGCCGCCGAACCGCGGGTGTTCGACCTCGCGGCGATCACCGCGCGCACCGCGGACCTGGGCCGGGTCGAGCACGTGGGACCGATGGGCTTCGGCCCGCGATCCCGCTGCGTGCGGCGGATTTACGCGGGCGAGCGGGAAGCGCTGGCCGAGCTGGAGCTGCCCGCGGAGTTCGCGGGCGACCTGGACCACCTGGAGCTGCACCCGTCGCTGCTGGACCTGGCCGCCGGTTTCGTCGGCCTGCACCTGGACGAGGAGTTCCGCGTCCCGGTCACGTACGGCGAGTTGCGCTGCCTGCGGCCGATGCCGCGCCGCCTCTTCAGCTACCACCGCTACGCCGACACCGCCGCCGAGCGCGCCGGCCGGGAGACGACCACGGCCGACTTCGTCCTGCTGGACGAGGACGGGCGGGAACTGGTGGCCGTCGACGGTTTCGTGCTCAAGCGGGTCGGCGAACTGGGCGAGGTGCTGGCCGGCGCCCGCGCCGGCGACAGCCGGGAGATCGCCGTGTTCCGGTACCCGGAGTCGGCGACGCCCGCCGCCGGCGGCGCGCCGCTCGCGGCGCACCTGGAGACCGGCATCCGGCCCGCCGAGGGCGGTGTGGCGCTGAGCCGCGTGCTGGCCGCGGGCATCGGGCCGCAGGTCGTGGTGTGCACCAGGGACCTCGCCGCGGTGGCGGCCGACATCGCCCGCGACGCCGCGGGCGACCGGACGTCGATCAGCAGGCGGGCGGGTGACGGCGACCGGCGGCGCGACGTCCTGACGCCCTACCGCGCGCCGGGCGACGAGCTGGAGCGGCTGCTCGCGGGCATCTGGCAGGAGCTGCTGGGCGTCGGCCGGGTCGGCGTGGACGACGTGTTCGCCGAACTGGGCGGTCACTCGCTGACCGGGCTGGAGGTGGTGGGCCGCATCAACCGGCAGCTCGGCGTGCGCGCGTCGCTGGCCGAGTTGCTGGCGGCGCCCACGGTGGCCGAGCTGGCGGCGCTGCTGCGACCGGCGGTGGCGCGGACGTGGGCCGGTGGGGTGGACGCATGA	MTTGLEIAIVGMACRFPGARDRDEFWRNLRGGVESITRFTARELADAGVPEDVLADPAYVRAHGVLAGSDLFDAGFFGLSPKEADLVDPQQRALLECAWEALEDAGWDPARVPGPVGVFAGTYYNSYLPGLPATDDPAERFARDIANEKDYVASRIAYKLDLTGPAVTVQSACSTSLVAVHLAGQALLSGSCDLALAGGATVRARQVVGYHHQPGGIFSADGSCRAFDAHADGTVPGNGAGVVVLKRLADALADGDTVHAVILGSAIGNDGADRAGFTAPGVPGQAAVIRAAHAMAGTDPASVGYVETHGSATRLGDPIEVEALTRVFRAAGAPAGGCAIGSVKTNIGHTHAASGVAGLIKAALSVRDGVLPPSLHFARPNPEIPFDRTPFHVNTELRDWPADGRPRRAGVTSLGMGGTNAHVVLEEPPPPPPAPTGGSARLLVLSARTADALEEATDRLAGHLARTDQEPADVEHTLRTGRRAFAHRRFVIADDLAAAARSLATRDPRAVHTGPPAGRERPIAFMFPGLGEQRPGMGAGLYRTQPAYRAAVDRCAELLRPELGRDIRELLHPADAGEGGRVDLRRVLGRGGAPRTSELDRTRYAQPAVFVTEYALAQLWLAHGVRPDAMIGYSIGEYVAACLSGVLALEDALRLVACRARLIDDLPPGAMLAVPLAEDEVSASLPPGVAVAAVNGPRLCVVAGPVDEVAALRDRLAARGVAATAVQTSHAFHSPMMDPIAEEFAELVAGTPAGAPRIPYLSNVDGRWVTADDVADPAYWVRHLRMPVRFAQGVERLWEQPGRLLLEVGPGRTLSSLALQLAPDDPDQGVRAVPSLPGVFDREPEDRFFLGAVGKLWLSGVDVGRPAAPGPAPRRVPLPTYPFQRERHWVEPAPEPTRARPPVTREPAVADWFHAPAWAPLPPHPRHAAVPTSTGEHWLLLADRSGACRDLADALAAAGHEVTVQGGPPPDHDYDALLTGLREQDRAPRRIAYLLGPDAVGEDGSTAFSDLLALTGALGRRPGADPVDLAVVTRELMVVTGAERGSPEQAAVLGPCRVLPLEHPHLACRVVDIALDGDPTERTGGLFAELVDPSGEAVVALRGRRRWRQVFQRVRLAVDRPAAPGRHYVITGGLGGVGLALADHLVRVERAVVTVIGRTPLPDRAEWPDWLARAGHADATTARIRAVAALEEAGGPVLVLAADVTDTARLRAAFARAARVAPIDCVVHAAGVAGGGLIQLKDHEAAERVLAPKVRGGAAVVELAEEFDVAQVVLCSSTLAVTGAIGQVDYVAGNAVLDALAHHAAARGHRAEVVAVDWDAWRQAGMAHRHLAGDQGGPGPVDHPLLDACLEHTSTHAVYRAALDGPAAWLTDEHRMLGEPVVPGTGHLELVRAVCAQLTGPGPVTLTDVRFYTPFMASAGRELRVVVDKTEVPWQFTTVSRLPDGRWQAHAAGGVGPAPAAEPRVFDLAAITARTADLGRVEHVGPMGFGPRSRCVRRIYAGEREALAELELPAEFAGDLDHLELHPSLLDLAAGFVGLHLDEEFRVPVTYGELRCLRPMPRRLFSYHRYADTAAERAGRETTTADFVLLDEDGRELVAVDGFVLKRVGELGEVLAGARAGDSREIAVFRYPESATPAAGGAPLAAHLETGIRPAEGGVALSRVLAAGIGPQVVVCTRDLAAVAADIARDAAGDRTSISRRAGDGDRRRDVLTPYRAPGDELERLLAGIWQELLGVGRVGVDDVFAELGGHSLTGLEVVGRINRQLGVRASLAELLAAPTVAELAALLRPAVARTWAGGVDA	MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDSVTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQEVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGGKYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRLQTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANALDTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMALSVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIHRPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALENHFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQIKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRPNGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQAFRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASGDAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVPTAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGASLIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGVFFVPLFFVVVQRVFKRRSTT	173.27	gnl|BL_ORD_ID|807|hsp_num:0	876			768	996	tetracycline; chloramphenicol
BGC0000081.1|Kedarcidin_76 # 99214 # 100086 # 1 # ID=1_76;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=4bp;gc_cont=0.711	BGC0000081.1|Kedarcidin_76 	99214	100086	+	Loose	750	26.9498	tet(54)	33.33	3004590	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGCGGCACAGAGCTGGTGGGCGTCGTCGGGGCCGGGGTGATCGGCACCGGGGTGGCGCAGGCCGTGGCGGCGGCCGGGTACGGGGTGGTCCTCGTCGACCGCACCGAGGAGGTCCTGGACACCGCCCGGCGGGGCGTGCGGGACGGGCTGCGGATGCGCCGCCTGCTCGGCAGCGGTGGTTCGCGCGAGGAGGACGCGCGCACGCTCGACCGGATCGCGTTCACCACCGATCCCGCCGAGCTGGCGCCCGTCGACTTCGTGATCGAGAACGTCACCGAGGACTGGGACGTCAAGAAGTCGGTGTACCGGGTGCTGGACGAGGTCTGCCGCCCGGACCGCGTGCTCGCCGCGAACACGTCGGTCATCCCGATCACCGGCATCGCGGGCCTGGTCCGCGAACCGGGGCGGGTGCTGGGGATGCACTTCATGAACCCGGTGCCGTTGAAGGCCGTGGTGGAGGTGGTCCGCGGGCACTACACCACCGACGCGACGGTGGGCACCGCGCTGGACCTGCTCGCGCGCATGGGCGCGGAGGGCGTGGTGGTGGGCGACTCGCCCGGTTTCGTCACCAACCGGGTGCTGATGCCGACCATCAACGAGGCGGTGTTCCTCCTCCAGGAACGGGTGGCGGGCGTCGAGGAGATCGACCGGATCTTCAAGGGCTGCTTCCACCACCGCATGGGTCCGCTGGAGACGGCCGACCTGATCGGGCTGGACACCGTGCTGCGCTCCATCGAGGGGCTGTTCCACAGCTTCGCGGACAGCAAGTACCGGCCGTGCCCGCTGCTGCGCAGCATGGTCGACGCCGGTCTCCTGGGGCGCAAGAGCGGGCAGGGCTTCTACTCCTACCGAGGGGACGTGGCGCGGTGA	MSGTELVGVVGAGVIGTGVAQAVAAAGYGVVLVDRTEEVLDTARRGVRDGLRMRRLLGSGGSREEDARTLDRIAFTTDPAELAPVDFVIENVTEDWDVKKSVYRVLDEVCRPDRVLAANTSVIPITGIAGLVREPGRVLGMHFMNPVPLKAVVEVVRGHYTTDATVGTALDLLARMGAEGVVVGDSPGFVTNRVLMPTINEAVFLLQERVAGVEEIDRIFKGCFHHRMGPLETADLIGLDTVLRSIEGLFHSFADSKYRPCPLLRSMVDAGLLGRKSGQGFYSYRGDVAR	MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKEVAEERSNRILQKVQIISNAIKLPEYE	74.74	gnl|BL_ORD_ID|2726|hsp_num:0	3292			0	108	tetracycline; oxytetracycline
BGC0000081.1|Kedarcidin_78 # 100364 # 101557 # 1 # ID=1_78;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=9bp;gc_cont=0.755	BGC0000081.1|Kedarcidin_78 	100364	101557	+	Loose	770	27.7202	tet(V)	38.6	3000181	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACGTTCGCGAGCACCGGGCTCGACCCGGACCAGCGGCTGGCGCGGGAGCGGTTCGCGGCGTTCGCCGACGAGCACCTCGTGCCGCACGCCGACGCGTGGGACGCGGCAGGCGGGCTGCCGCCCGCCGTGGTGGCGCTGCTGGCCGACCACGGCTACCTCGGCGCCGCCGTGCCGGTCGGGCACGGCGGCGAAGGACTGGACGAGATCGGCTTCGGGATGCTGTGCGAGGAGGTGGGTCGCGCGTGCTCGTCGGTGCGCAGCCTGCTCACCGTGCACAGCATGGTGTCGCACGCCGTGGCCAGGTGGGGCAGCGCGGGCCAGCGGGAGCGCTGGCTGCCCGAGCTGGCGTCCGGCCGCGCGGTGGGCGCGTTCGCCCTCACCGAGCCGGGTGCGGGCAGCGACGCGGGCGCGATCACCACCCGCGCCGAGCGCGTGCCCGGCGGGTACGCGTTGACCGGGCACAAGCACTGGATCACCTGCGCGGGCATCGCGGGTGTCTTCCTGGTGTTCGCCAAGCTGGACGGCGCGCCGACCGCGTTCCTGGTGGAGCGCGACCGGCCGGGGCTGTCCGTGGTGCCGCGCGAGGGCGCGCTGGGCACCCGCGCGTCACACCTGGGCGACGTGCTGCTGGACGACTGCCGGGTGCCCGCCGACGCGCGGGTGTCGCGGCCCGGTTTCGGGTTGACGGCGGTCGGCGCGAGCGCGTTGGAACTCGGCCGGTACAGCGTCGCCTGGGGCTGCGTCGGGCTGGTCGAGGCGTGCGCGGCGGCCTCGTTGGCGCACGCCGACACCCGCGAGCAGTTCGGCCGGCCGCTGCGCGAGCACCAGCTCGTGCAGCGGATGCTCGCGGACATGGTCACCGCCGCCGCGGCGGCGCGGCTGCTGTGCCGCCAGGCGGGTCTGCTGCGGCAGGCGGGCGACCCGCGGTCCGTGCAGGCCACGTGGCTGGCCAAGTATTTCGCCGCGGGCGCCGCGATGCGTGCCGCCGACGACGCGGTGCAGGTGCACGGCGCGCGGGGTGTCGCCGGCGACCACCCCGTGCAGCGCTACCTGAGGGACGCGAAGGTCATGGAGATCATCGAGGGCAGCACCCAGCTCCAGCAGATCACCATCGCCGAAGCCGCCTACATGTTCCGCGACCGGTCCGAACCGGACCGGTCGCCCGGACGGCAGTGGAGTGTGACGACGTGA	MTFASTGLDPDQRLARERFAAFADEHLVPHADAWDAAGGLPPAVVALLADHGYLGAAVPVGHGGEGLDEIGFGMLCEEVGRACSSVRSLLTVHSMVSHAVARWGSAGQRERWLPELASGRAVGAFALTEPGAGSDAGAITTRAERVPGGYALTGHKHWITCAGIAGVFLVFAKLDGAPTAFLVERDRPGLSVVPREGALGTRASHLGDVLLDDCRVPADARVSRPGFGLTAVGASALELGRYSVAWGCVGLVEACAAASLAHADTREQFGRPLREHQLVQRMLADMVTAAAAARLLCRQAGLLRQAGDPRSVQATWLAKYFAAGAAMRAADDAVQVHGARGVAGDHPVQRYLRDAKVMEIIEGSTQLQQITIAEAAYMFRDRSEPDRSPGRQWSVTT	MRSPRPVAGWRVLAPFRIREYRLLIAAVTLSIFAEGMWSVVMALQVIAIDNDPASLSLVATCLGVGLVAFVLVGGITADRINQRTIIIAVEVVNFVTVAVISALALLGVLKIWHMAVAAGILGIAAAFFFPAYSAILPRILPPEQLLAANGVEGVVRPVFQRSVGPAVAGMVIGATMPSIGAVVVAVLFALGLALLVATRPPAQPASEHHERPHVLRDLREGFAFVLKTPWLLWTVLFASMFVLVVLGPIEVLLPFIAQDRFADGARAYGFILAFFGIGSAMGALTVSSRRMPRRYLTTMMLMWGLGSIPLVIVGYTSSFPLMAAATFVIGVTDGAGMVIWGTLLQRRVPTEMLGRVSSLDFFVSLAFMPLSFAIVGPLSKVVSMEVIFATAGLVPVAIAAVAFTAARMHRDEVANPLL	94.75	gnl|BL_ORD_ID|1041|hsp_num:0	1006			741	912	tetracycline
BGC0000081.1|Kedarcidin_79 # 101554 # 102621 # 1 # ID=1_79;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.733	BGC0000081.1|Kedarcidin_79 	101554	102621	+	Loose	1650	32.7278	Brucella suis mprF	28.17	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GTGACGACCCGACCCGCGCGCCCGCGCGCCCGAACCGTCAAGTGCGTGGTCTGGGACCTCGACCACACGCTGTGGGACGGGATCCTGCTGGAGGACGGCGAGGTGACGCCGCGACCCGAGGTCGTGGAGGTCATCCGGGAGCTGGACGGCCGCGGTGTGCTGCACTCCATCGCGAGCCGCAACGACCACGACGCGGCCACGGCGGCGCTGCGCCGGTTCGGGCTGCTGGACTACTTCCTGCACCCGCAGATCAACTGGGGCGCGAAGTCGGAGTCGGTGCGCGCGGTCGCCGAGGCGTTGAACATCGGGCTGGACGCGCTCGCGTTCGTCGACGACGACGAGTTCGAGCGCGCCGAGGTGGCGTTCGCCGTGCCCGAGGTGCTGTGCCTGGACGCCCGCGACCCGGGGCGGCTGACCGGGCTGTCGGAGCTGACGCCCGCCGTGGTCACCGAGGACGCCTCCCGGCGGCGCGAGATGTACCGCGCCGAGGAGCGCCGCCGGGAGGTGGAGGAGCGGTACACCGGCGCGCCCGCGGAGTTCCTGGCGACGCTCGACATGCGGTTGCGCATCGCGCCCGCCCGGGAGGGCGACCTGGCGCGGGCGCACGAGCTGACCGTGCGGACCAACCAGCTCAACACGACGGGCCGGACCTACTCCCGCGAGCAGCTTGACCGGCTGCGGCTGTCCGCGGACCACCAGCTGCTGGTGGCCCGGTTGGACGACCGGTTCGGGCCCTACGGCACGATCGGGCTCGCCCTGCTGGAGACCGGCGAGCGGGTGTGGACGGTCAAGCTGCTGCTGATGTCCTGCCGGGTGCTCTCGCGCGGTGTCGGCGGCGTCCTCATCACGCACCTGCGCCGGCTCGCCGAGGAGGCCGGGGTGCGGCTGCGGGCGGACTTCGTGCCGACCGACCGGAACCGGATGATGCGGGTGACCTACCGGATGAACGGCTTCCGCGAGGTCGACCGGGACGGCGACCAGGTGGTGCTGGAGGCCCGCCCGGACGATGTCCCGCCCTTCCCGCCGTACCTGCGGGTGGAGACGTCGTCGTGGCGGGAGGACGGGTGA	MTTRPARPRARTVKCVVWDLDHTLWDGILLEDGEVTPRPEVVEVIRELDGRGVLHSIASRNDHDAATAALRRFGLLDYFLHPQINWGAKSESVRAVAEALNIGLDALAFVDDDEFERAEVAFAVPEVLCLDARDPGRLTGLSELTPAVVTEDASRRREMYRAEERRREVEERYTGAPAEFLATLDMRLRIAPAREGDLARAHELTVRTNQLNTTGRTYSREQLDRLRLSADHQLLVARLDDRFGPYGTIGLALLETGERVWTVKLLLMSCRVLSRGVGGVLITHLRRLAEEAGVRLRADFVPTDRNRMMRVTYRMNGFREVDRDGDQVVLEARPDDVPPFPPYLRVETSSWREDG	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	40.34	gnl|BL_ORD_ID|2057|hsp_num:0	2281			1716	2133	defensin
BGC0000081.1|Kedarcidin_81 # 103375 # 103923 # 1 # ID=1_81;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.754	BGC0000081.1|Kedarcidin_81 	103375	103923	+	Loose	550	25.0238	SHV-24	50.0	3001082	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGGCGGACGTCGCCGGGCCGTTGGGCGAGCGCGCGGTGTTCACCGACCTGACGCACGACCTCACCGGCACGGCGATCACGGTCCGCACCGACGGGCCCGGCGACGTGCCGGCGGCCCTGGCGGCGGCCGGCGCGATCGCCGACCTGCTCACCGCGTGGCCGTCCGCGTCCGGGTTCGAGACCCGCTTCGTGGTGCCCCGCGACCGGCTCGCCGCCGTGCTCGCCGCGCTGGCGGCGGCCGGTCGGCGGGACGTGCGGGTCGTGGAAGTGGTCCGATTGGCGGTACACGGGATCGGCATCCGCGTCGAGCCCGCGGTGGTGGCGCGGATCCGGTGGGCGCTGGGCGCGGCGGGCGTCGACGTGCTGGCGGCGTCGGTGTCGAACCGGCGGATCACGGTGGTCTGCCCGGAAGGGCAGCTCAACGCCGCTATTGGTGCGCTTCGGGGCACGTTCGCGCCCGAATCGCTCGCCGGGACGCTTCGGGATGTCGAAGTCACTCGCGTCGAGCGGCGCACGACGGAAGATGCGGCGGCCCGCGTCGGCGAGTGA	MADVAGPLGERAVFTDLTHDLTGTAITVRTDGPGDVPAALAAAGAIADLLTAWPSASGFETRFVVPRDRLAAVLAALAAAGRRDVRVVEVVRLAVHGIGIRVEPAVVARIRWALGAAGVDVLAASVSNRRITVVCPEGQLNAAIGALRGTFAPESLAGTLRDVEVTRVERRTTEDAAARVGE	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARGTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	63.64	gnl|BL_ORD_ID|47|hsp_num:0	57			483	567	
BGC0000081.1|Kedarcidin_82 # 103934 # 105124 # 1 # ID=1_82;partial=00;start_type=ATG;rbs_motif=AGTGA;rbs_spacer=10bp;gc_cont=0.731	BGC0000081.1|Kedarcidin_82 	103934	105124	+	Loose	500	28.1054	tet(C)	23.24	3000167	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAACAAGATCTACAAAGCACCGAGTTCCTGTTCGCGGGTGCGTCGCAGCGGCACGCCGGCAACGCGCGCCTGCACACCCGAGGCCCGGTGCACCAGGTCACCCTGCCCTCCGGCGGGGAGGCGTGGCTGGTCACCGGCTACGAAGCCGCCCGCCGCGCGCTGGCCGACCCGAGGTTGCGGGGTCGGACCGGCGCGGTGGGCGACCGCCGCCGGCTGTCGGCCGAGACCGACCTGGGCATGAACACGCACATGCTGAACCTGGAACCGCCCGACCACACCCGGCTCCGCCGGCTCGTGTCGGCGCCGTTCACCCACCACCGGACGGCGGCGCTGCGCGCGGACGTGCAGCGCATCACCGACGGGCTGCTGGACGACCTGGCCGACCGGGACGAGGTCGACCTGGTCGAGGAGTTCGCGCTGCCGCTGCCGATCCGGGTGCTCACCCGGCTGCTCGGCGTGCCGGCGGAGGACACCGACGCGTTCCACCGCTGGACGGCGCTGCTCACCGCCAGCGGTGTGCCGTTGGCGGAACTCGACGAGACCGCCCTGCGGATGCTCGCCTACGTGCGGGAACTGCTGGCGGAGAAGCGCCGCGCGCCCGGTGACGACCTGCTGTCGGAGTTGTGCGCCCCGCGTGACGGGCAGGACCGGCTCGAAGAGTACGAATTGACCTCCATGGTGTTCCTGCTGCTGATCGCGGGGCACGAGACCACGGTGAACCTGATCGGCAACGGGTTGCTCGCGGTGCTTTCGGACCCGGAGCTGGAGGCTCGGGCGCGGGAGGGCGAGGACGCCGTCGCCACCGTGGTGGAGGAGGTGCTGCGGCACGAGAGCCCCGTCCAGGCGGCCATGCGGATCAGCACCGAGGAGGTCGACCTGGCCGGTGTGACGATCCCGGCCGGTGCTGTGGTGATCGTCTCGCTGCTGGCCGCCAACCGCGACCCGGCCCGGTTCCCCGGCGCCGACCGGTTCGACCCGGTCCGGCCCGACAACCAGCACCTGGCCTTCGGGCACGGCATCCACCACTGCCTCGGCGCGCCGCTGGCCCGCCTGGAGGGCCGGATCGCGCTGCACTCCCTGCTCACCCGCTTCCCGCGGCTGCGCCTGGCCGGGCCGCGGGAGGAGCCGGTGTGGCGGCGGAGCCTGATCATGCACGGCCTCGTCGGGTTACCCGCGCGCACCCGCTGA	MQQDLQSTEFLFAGASQRHAGNARLHTRGPVHQVTLPSGGEAWLVTGYEAARRALADPRLRGRTGAVGDRRRLSAETDLGMNTHMLNLEPPDHTRLRRLVSAPFTHHRTAALRADVQRITDGLLDDLADRDEVDLVEEFALPLPIRVLTRLLGVPAEDTDAFHRWTALLTASGVPLAELDETALRMLAYVRELLAEKRRAPGDDLLSELCAPRDGQDRLEEYELTSMVFLLLIAGHETTVNLIGNGLLAVLSDPELEARAREGEDAVATVVEEVLRHESPVQAAMRISTEEVDLAGVTIPAGAVVIVSLLAANRDPARFPGADRFDPVRPDNQHLAFGHGIHHCLGAPLARLEGRIALHSLLTRFPRLRLAGPREEPVWRRSLIMHGLVGLPARTR	MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCAPVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYIADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFLMQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPAALWVIFGEDRFRWSATMIGLSLAVFGILHALAQAFVTGPATKRFGEKQAIIAGMAADALGYVLLAFATRGWMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSLAALTSLTSIIGPLIVTAIYAASASTWNGLAWIVGAALYLVCLPALRRGAWSRATST	100.00	gnl|BL_ORD_ID|892|hsp_num:0	900			69	474	tetracycline
BGC0000081.1|Kedarcidin_83 # 105550 # 106356 # 1 # ID=1_83;partial=00;start_type=GTG;rbs_motif=GGGG;rbs_spacer=5bp;gc_cont=0.711	BGC0000081.1|Kedarcidin_83 	105550	106356	+	Loose	230	54.299	ramA	33.33	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	GTGCTTCTAGCTATCCGCGATGCGATTTCAATGATGCATGAGCGATACCTCTACCCCATCACCATCAACGACATCTCGGCGGCTGTCTTCGTCAGTCCTTTCCACTTCTCGCGCACCTTCTCGAAATTCACCGGGGTGGCGCCGGGGAGGTACCTCACGGCGGTGCGGCTGTTCGAGGCCAAGCGCCTGCTGCTGACCACCGACCACACGGTGTCGAACATCGTGTGCAGCGTGGGGTACAGCAGCGTCGGCACCTTCACCAGCCGCTTCAGCCGGTCGGTCGGCATGACGCCGACCCAGTACCGCGACCCGCTGGTCGGCGACCTGCTCGTGTCGTGCGCGCCGCACTTCCAGCACCTGGCGCCGCTGGACGTGCTGCTGGCCGAGAGCGAGAGCTGGGCGGCCGAGCGGCAGGGTGGGGGAACGGTGTCGGGACGCCTGGAGCTGCCCGCGTCGGCCGGTGGCGGGCACGCCGTGGTCGGCCTGTTCGACGAGCTGATCCCGCAGCGCGGGCCGGTCGCGTTCACGGCCGTGCCGATCGGGCCGGGCACGTCCGAGGTCGTGCTGGACAACGTGCCGCCCGGCCGCTGGTACGTGCTCGCCGCCGCCGAGCACGTCGACGGGCGCACCGGCGAGAAGAGGTTCGCGGTGGGCCACCGGCGCACCCCGATCAAGGTGGTCGAGGGGGGCTCGGCCGCGTTCTCGGTCCCGCTGCGCGCGAGCCGGCCGACCGACCCGCCCATCGCGGTCACCCTGGCCCGCCAGTCGGACCTGGGCGCCCGGCGGCCCCTGTGCACGGTGGCCTGA	MLLAIRDAISMMHERYLYPITINDISAAVFVSPFHFSRTFSKFTGVAPGRYLTAVRLFEAKRLLLTTDHTVSNIVCSVGYSSVGTFTSRFSRSVGMTPTQYRDPLVGDLLVSCAPHFQHLAPLDVLLAESESWAAERQGGGTVSGRLELPASAGGGHAVVGLFDELIPQRGPVAFTAVPIGPGTSEVVLDNVPPGRWYVLAAAEHVDGRTGEKRFAVGHRRTPIKVVEGGSAAFSVPLRASRPTDPPIAVTLARQSDLGARRPLCTVA	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	216.13	gnl|BL_ORD_ID|1537|hsp_num:0	1665			96	348	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000081.1|Kedarcidin_84 # 106411 # 106680 # -1 # ID=1_84;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=9bp;gc_cont=0.674	BGC0000081.1|Kedarcidin_84 	106411	106680	-	Loose	400	22.7126	vanR gene in vanL cluster	42.5	3002927	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGACCGACCAGAGCCGGGCGGACCGGACGACCGTCGTAGCGGTGGTCGAGGAGATCTGGCGCGACGTCCTGGACGTGCCCAGCGGGTACGAGGACGCGACGTTCATCGAGCTGAACGGCCAGTCGATCACCGCGGTGCTGATCGTGAACCGGATCGAGGAGGAACTGGGGGTGGTCGTCGACATCGGCGAGCTGTTCGAGGACCCGCGCCTGGACCAGTTCATCGAGCACGTCGCCCGGCTGTCCCGTGAGTCGCTCGCCGACCGCTGA	MTDQSRADRTTVVAVVEEIWRDVLDVPSGYEDATFIELNGQSITAVLIVNRIEEELGVVVDIGELFEDPRLDQFIEHVARLSRESLADR	MTDRIVVVDDEQEIANLITTFLENEGFQVTTFYKGEDFLTYIARESISLAILDVMLPDIDGFRILQEIRKNFYFPVLMLTAKEENMDKIMGLTLGADDYITKPFNPIEVVARVKTQLRRVQKYNRKVENESVIEFNKDGLTLKKDSHQVFLFDKEITVTPIEFNLLLYLFEHQGVVVSSEELFEAVWKEKYLENNNTIMAHIARLREKLDEQPRKPKFIKTVWGVGYIIEK	38.53	gnl|BL_ORD_ID|455|hsp_num:0	409			510	627	vancomycin
BGC0000081.1|Kedarcidin_85 # 106948 # 108423 # 1 # ID=1_85;partial=00;start_type=GTG;rbs_motif=AGAGGA;rbs_spacer=6bp;gc_cont=0.711	BGC0000081.1|Kedarcidin_85 	106948	108423	+	Loose	600	51.9878	Streptomyces venezuelae rox	29.34	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGAAGGACGAAGACCGGTACGACGTCGTCGTCGCGGGTGGTGGGCCTGGCGGCTCCACCGCGGCGGCGCTGATCCGGCAGCGCGGGCACCGCGTGCTGCTGCTGGAGAAGGAGCGCTTCCCGCGCTACCAGATCGGCGAGTCCCTGCTGCCCGCGACCGTGCACGGCATCGCGCACCTGCTGGGCGTCCAGGACGAGCTGAAGCGGGCCGGTTTCACGCACAAGCTCGGCGGCACCTTCAAGTGGGGCGTCAACCCCGAGCCGTGGACGTTCGAGTTCGCGGTGTCCCGCAAGATGGCGGGTCCGACGTCGTACGCCTACCAGGTCGAGCGGATGGAGTTCGACCGCATCCTGCTGGACAACGCGCGCAGGCTCGGCGTCGACGTGCGCGAGAATAGCCCCGTCACCGAGGTCCTGCGCAGCGACGACCGGGTCGTGGGCGTGCGGTACCGGGACGCCGACGGCGTGGTCCACGAGGTGGCCGCGAAGTACGTCGTGGACGCCACCGGCAACACCAGCAGGCTCTACGGCGCGACCGGGACGAAGCGCGAGTACTCGCCGTTCTTCCGCAACCTGGCCCTGTTCGGCTACTTCGAGGGTGGTCGCCGGCTGGACGCGCCCCTGTCGGGCAACATCCTCAGCGTCGCGTTCGAGCACGGCTGGTTCTGGTACATCCCGCTGCGCCCCAACCTGACCAGCGTGGGCGCGGTGGTCAGCCGCGAGTCGGCCGGCCTGGTGCAGGGCGACCCCGAGCGGGCGATGCGCGAGTTCATCGAGGCGTGCCCGCTGATCTCGGAGATGCTGACCGACGCGACCCGGGTCACCGAGGGCCCGTACGGGCAGCTGCGCGTGCGCAAGGACTGGTCGTACCTCAACACCCGCTTCTGGTCACCGGGCATGGCCCTCGTCGGCGACGCCGCGTGCTTCGTGGACCCGGTGTTCTCCTCCGGCGTCCACCTGGCCACCTACGGCGCGCTGCTCGCCGCGCGGTCGATCAACTCGTGCCTGGCGGGCACGGTGGACGAGGAGAGCGCGTTCGGCGAGTTCGAGCGCCGGTACCGCAAGGAGTACGGGCTGTTCCACGAGTTCCTGGTCGGCTTCTACGACATGGAGCAGTCCGAGGACTCCTACTTCTGGCAGGCCCGGCGGCTGTCCAACCGGGACCAGACCGAGGTGGAGGCGTTCGTCGAGCTGGTGGGCGGCGTCGCCTCGGACGACATCGCCGACGGCGCGATGCTCAAGGCGCGGCTCACCTCGGGCGCGCGCAACATCAGCCGGATGCTGGACGACAGCACGGACGACCGGGTGATCGGCGCGAGCGCGGGCCAGCTCCTCGAACAGGGCACCGCGCTCCAGGCCCGCGCGCTGGTCGGCGCGAAGTCCCGCGAGGGGCGTGCCGTGAAGCCGGACGGGCTCGCGGCCTCGGAGGACGGCCTGAGCTGGGTCCCGCAGGGCGGGACCGGCGAGGGGCGATGA	MKDEDRYDVVVAGGGPGGSTAAALIRQRGHRVLLLEKERFPRYQIGESLLPATVHGIAHLLGVQDELKRAGFTHKLGGTFKWGVNPEPWTFEFAVSRKMAGPTSYAYQVERMEFDRILLDNARRLGVDVRENSPVTEVLRSDDRVVGVRYRDADGVVHEVAAKYVVDATGNTSRLYGATGTKREYSPFFRNLALFGYFEGGRRLDAPLSGNILSVAFEHGWFWYIPLRPNLTSVGAVVSRESAGLVQGDPERAMREFIEACPLISEMLTDATRVTEGPYGQLRVRKDWSYLNTRFWSPGMALVGDAACFVDPVFSSGVHLATYGALLAARSINSCLAGTVDEESAFGEFERRYRKEYGLFHEFLVGFYDMEQSEDSYFWQARRLSNRDQTEVEAFVELVGGVASDDIADGAMLKARLTSGARNISRMLDDSTDDRVIGASAGQLLEQGTALQARALVGAKSREGRAVKPDGLAASEDGLSWVPQGGTGEGR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.15	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	465	rifampin; rifaximin; rifapentine
BGC0000081.1|Kedarcidin_86 # 108420 # 109418 # 1 # ID=1_86;partial=00;start_type=ATG;rbs_motif=GAGGG;rbs_spacer=3bp;gc_cont=0.760	BGC0000081.1|Kedarcidin_86 	108420	109418	+	Loose	500	25.7942	mphE	24.0	3003741	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGACCCGGGTCCGGGTCGGCGTGCTCGGGTGCGCCGACATCGCGGCGCGGCGCACCGTGCCCGCGATGCGGCGCACACCGGGGCTGGAGGTGGTGGCGGTCGCGAGCCGGGACCCGGCCAGGGCCGAGCGGTTCGGCGAGCGCTTCGGCCTCCGGCCCGTGCCGGGGTACGAGCGACTGCTCGCGGACGACGGTGTCGACGCCGTGTACGTGCCCCTGCCCGCCGCGCTGCACGCGGAGTGGGTCGAACGCGCGCTGCACGCCGGGAAGCACGTGTTCGCCGAGAAGCCGCTGACCGACCGGCACGACCGGACCGCAACACTGGTCGACCTGGCCCGCGAGCGCGGGCTCGTGCTGATGGAGAACACCATGTTCCTCCACCACTCCCAGCACACGGAGGTGCGGCGGCTGCTCGCCGAGGGCGTGCTCGGCGAGTTGCGCGGCCTGTCGGCCGCGTTCACGATCCCGCCGAAACCGCCGGGCGACATGCGGTACCTGCCCGACGTGGGCGGCGGCGCGCTGCTGGACGTCGGCGTGTACCCGGTGCGGACCGCGCTGCACTTCCTCGGCCCGGACTGCGACGTGGTCGGCGCGGTGCTGCGGGACTCGCCACGCGGCGCGACCCTGTCCGGCCACGTGCTGCTGGCCGCGCCCGGCGGCGTGGCCGCCGAGCTGTCGTTCGGCATGGAGCACTCCTACCGGTCCCGCTACGAGCTGACCGGCAGCCTCGGCCGGCTCCGGCTGGACCGGGCGTACACCCCGCCCGCCGACCACCGCCCCGTGCTGGAGCTGGACCGGGGCGACCGGGTCGAGCGGGTGGTCCTCGCGCCGGACGACCAGTTCGCCGGCAGCACCGCCGCGTTCGCCCGCGCGGTGGTGGCGGGCCAGGCGCCCGCCGAGCACCTGGAGGGCGTGCTGCGGCAGGCGGCGCTGGTCGACCGGATCAGCACCGCCGCCCGGCGGGTGGTCATCGAACCCGATCCCGGAAGGACGTGGTGA	MTRVRVGVLGCADIAARRTVPAMRRTPGLEVVAVASRDPARAERFGERFGLRPVPGYERLLADDGVDAVYVPLPAALHAEWVERALHAGKHVFAEKPLTDRHDRTATLVDLARERGLVLMENTMFLHHSQHTEVRRLLAEGVLGELRGLSAAFTIPPKPPGDMRYLPDVGGGALLDVGVYPVRTALHFLGPDCDVVGAVLRDSPRGATLSGHVLLAAPGGVAAELSFGMEHSYRSRYELTGSLGRLRLDRAYTPPADHRPVLELDRGDRVERVVLAPDDQFAGSTAAFARAVVAGQAPAEHLEGVLRQAALVDRISTAARRVVIEPDPGRTW	MTIQDIQSLAEAHGLLLTDKMNFNEMGIDFKVVFALDTKGQQWLLRIPRRDGMREQIKKEKRILELVKKHLSVEVPDWRISSTELVAYPILKDNPVLNLDAETYEIIWNMDKDSPKYITSLAKTLFEIHSIPEKEVRENDLKIMKPSDLRPEIANNLQLVKSEIGISEQLETRYRKWLDNDVLWADFTQFIHGDLYAGHVLASKDGAVSGVIDWSTAHIDDPAIDFAGHVTLFGEESLKTLIIEYEKLGGKVWNKLYEQTLERAAASPLMYGLFALETQNESLIVGAKAQLGVI	112.93	gnl|BL_ORD_ID|2687|hsp_num:0	2614			435	654	erythromycin
BGC0000081.1|Kedarcidin_87 # 109441 # 110022 # 1 # ID=1_87;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.708	BGC0000081.1|Kedarcidin_87 	109441	110022	+	Loose	540	26.9498	OXA-288	40.0	3001743	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCGGTCCCGGGTTGCTTCCGCCTCACGCCCGACGTCCACCGCGACCAGCGGGGCCTGTTCTACGAGGCGTTCCGCCACGAACCGCTCGCGGAGGCGATCGGGCACCCGTTCACCGTCCGGCAGGCCAACTGCTCGGTGTCCCGCTACAACACCATCCGCGGCATCCACGGCACCGTGCTGCCGCCCGGCCAGGAGAAGCTGGTGACGTGCGTGGACGGCGCCGTGCTGGACGTGGCGGTGGACATCCGCGTCGGCTCGCCGACGTTCGGCATGTTCGACGCGACGCGGCTGGAGGAGGGTTCCGGCGTGTCGGTGTACCTGGCCGACGGCATCGGGCACGCCTTCCTGGTGCTGACGCCGACCGCGCGGGTGAACTACCTGGTGTCGACCGAGTACGTGCCCGGCACGATGATCGACCTCGACGCCATGGACCCGGACCTCGGTCTGCCCTGGGACACCCGGGAACCACCGATCAGGTCCGAGAAGGACACCACCGCGCCCACCCTCGCACAAGCCGCCGCGGCCGGTCTGCTGCCGACCTACCGGGAGTGCCTGGACTTCGCGGCGGGGTTGCGCTGA	MAVPGCFRLTPDVHRDQRGLFYEAFRHEPLAEAIGHPFTVRQANCSVSRYNTIRGIHGTVLPPGQEKLVTCVDGAVLDVAVDIRVGSPTFGMFDATRLEEGSGVSVYLADGIGHAFLVLTPTARVNYLVSTEYVPGTMIDLDAMDPDLGLPWDTREPPIRSEKDTTAPTLAQAAAAGLLPTYRECLDFAAGLR	MMMSKKLKCLAFFTAIFFAIPMTACQSFSQQKQQLSTQKNEQQQISSLFQSAQTSGVLVIYDGKKIQSYGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEMFKWDGKKRAFSSWEKDLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEEVRFAYALAKQKLPFDQSTQQQVKGMLLIDEVQGTKIYAKSGWGMDVSPQVGWWTGWIEQANGKITAFSLNMEMSRPEHAEARKAIVYQALQQLDLLAN	68.93	gnl|BL_ORD_ID|2033|hsp_num:0	3452			303	414	cloxacillin; oxacillin; cefalotin
BGC0000081.1|Kedarcidin_88 # 110041 # 110475 # -1 # ID=1_88;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.729	BGC0000081.1|Kedarcidin_88 	110041	110475	-	Loose	550	24.6386	LRG-1	30.95	3006941	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	LRG beta-lactamase	GTGGACGACTACCGCTCGCGGCTCCGGCAGGTTCTCGACGCGCACTCCGCGGAGGTGGGCGCTCGGCTGCGGTTCATCGCGGACGCCGTCACCGACGACGTGCGGGGCGTGGTGCTCGACGTGTTCACCGACCAGGACGGTGAGGGCTCCTTCAACGTCTGGGCCCGGTTCGACGGCCCCGACTTCTTCGCGCTGAACAAGCCCATCGACGCCCACCGCCACCTGTTCGGCGTCGTGCACGGCGCGGAGGGCTGGGAGCCCGACGTGCCGTTCCTGCCGCGGTCCGCCGACCAGGACGTGCTCGTCGACACCGTCGCCGACTGGCTCCGGGCCGTGTGGGGCGAGCACGTGCGCGGCGGCACGACGACCGGGTGGGAGGTCGACTCACCGGACGGTCTCGGGACCGACCTCCCCCGGCCGCTCACGCACGACTAG	MDDYRSRLRQVLDAHSAEVGARLRFIADAVTDDVRGVVLDVFTDQDGEGSFNVWARFDGPDFFALNKPIDAHRHLFGVVHGAEGWEPDVPFLPRSADQDVLVDTVADWLRAVWGEHVRGGTTTGWEVDSPDGLGTDLPRPLTHD	MNSIFSLSRRKYLLAAAGLTIAALFPPSVVLAEQPATLAAQLSALEASANGRLGVALIDSGSSRQLSYRGEERFAMASTFKALAAAAVLQRSVEQPALLNKRIIYQQSELITYSPVTEKHLQQGMTVAELCAAAVELSDNTAGNILLREIGGPQGITQLARRLGDNQTRLDRREPALNSAIPGDVRDTSTPLAMAGNLNQLALGKALPSAQQQLLIQWLKQSKTGAQSIRAGVPQGWQVGDKTGAGGYGTTNDLAILWPPQGKPLVLAVYFTQHNPQAEARRDVLASATRLVLAAWEKQ	48.16	gnl|BL_ORD_ID|3682|hsp_num:0	4752			624	738	
